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L A ﬁbrillation auriculaire (FA) est le type le plus re´pondu d’arythmie. Elle aﬀecteenviron 2% de la population totale et 8% a` 11% des personnes aˆge´es de plus de 65 ans.
Jusqu’a` pre´sent, le traitement de l’arythmie auriculaire a toujours e´te´ base´ sur des con-
side´rations empiriques et habituellement re´alise´ lors d’e´tudes cliniques ou lors d’expe´riences
animales. Les inconve´nients majeures de telles expe´riences re´sident dans la diﬃculte´ d’acce´der
a` l’ensemble des oreillettes et a` la diﬀe´rence entre l’anatomie animale et humaine.
Durant ces dernie`res anne´es, la puissance toujours croissante des ordinateurs a permis
le de´veloppement d’un mode`le biophysique des oreillettes humaines. Re´cemment, il est
devenu possible de simuler la propagation e´lectrique re´sultant de l’activite´ cellulaire dans
toutes les parties du coeur humain. Compare´e aux e´tudes cliniques et animales, l’approche
in sillico a l’avantage d’eˆtre reproductible et de pre´senter des conditions controˆle´es.
Dans cette the`se un mode`le biophysique des oreillettes humaines est utilise´ pour l’inves-
tigation des the´rapies auriculaires suivantes: les ablations chirurgicales et les stimulations
e´lectriques.
Premie`rement, les concepts utilise´s pour la mode´lisation biophysique des oreillettes hu-
maines sont passe´s rapidement en revue. Les diﬀe´rents types d’arythmie pouvant eˆtre
ge´ne´re´s avec un tel mode`le sont pre´sente´s.
Deuxie`mement, des mesures d’organisation ont e´te´ de´veloppe´es pour e´valuer et classiﬁer
les diﬀe´rents types de FA. L’organisation de la FA est e´value´e a` partir des e´lectrocardiogrammes
aussi bien qu’a` partir du potentiel transmembranaire des cellules. Quatre types d’arythmies
ont e´te´ diﬀe´rencie´s avec le mode`le biophysique : le ﬂutter, la FA chronique, la FA me´andreuse
et la FA cholinergique.
Finalement, les simulations de the´rapies auriculaires ont e´te´ investigue´es. Le mode`le
biophysique a e´te´ employe´ pour e´valuer l’eﬃcacite´ des lignes d’ablation, en particulier la
proce´dure Maze-III a prouve´ son eﬃcacite´ dans le traitement de la FA chronique. Cepen-
dant, en raison des diﬃculte´s techniques et des risques d’une telle proce´dure, des lignes
d’ablation moins invasives ont e´te´ propose´es. Les re´sultats des simulations ont conﬁrme´
la supe´riorite´ des proce´dures agressives pour terminer la FA, tel que de´crite dans les
e´tudes cliniques. En outre, un mode`le de lignes d’ablation ide´al a e´te´ propose´ a` l’aide
du mode`le. Un mode`le ide´al doit eˆtre capable d’empeˆcher la FA avec un nombre limite´
xiii
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de lignes d’ablation et une longueur minimale, en tenant compte de la maintenance ou du
re´tablissement de l’activite´ me´canique des deux oreillettes pendant le rythme cardiaque
normal.
La deuxie`me approche the´rapeutique examine´e est la stimulation e´lectrique a` basse
e´nergie. Un algorithme de stimulation the´rapeutique est propose´ et teste´ pour diﬀe´rentes
positions des e´lectrodes. Les simulations montrent que les arythmies plus organise´es comme
le ﬂutter peuvent eˆtre termine´es par stimulation. Par contre, seulement un controˆle local
est observe´ pour les FA plus complexes. Les re´sultats obtenus avec le mode`le biophysique
sont en accord avec les e´tudes cliniques.
Les re´sultats obtenus de cette recherche prouvent que les the´rapies auriculaires peuvent
eˆtre e´tudie´es par un mode`le biophysique des oreillettes humaines. Cet outil peut eˆtre
employe´ a` examiner plus en de´tail les techniques the´rapeutiques aﬁn d’ame´liorer la qualite´
de vie des patients.
Abstract
THE most common type of sustained arrhythmia is atrial ﬁbrillation (AF), aﬀectingabout 2% of the general population and 8% to 11% of the elderly, more than 65 years
of age.
The treatment of atrial arrythmia is still based on empirical considerations and is usually
evaluated in clinical studies or in animal experiments. The main drawbacks of animal
experiments lie in the diﬃculty of technically accessing the whole atria and in the diﬀerences
between animal and human anatomy.
In the last years, ever-increasing computer power has permitted the development of
biophysical models of the human atria. It has become possible to simulate cellular electrical
propagation in the whole human heart. Compared to clinical and animal studies, an in
silico approach has the advantages of repeatability and reproducibility under controlled
conditions.
In this thesis, a biophysical model of the human atria has been used to investigate
therapies of atrial arrhythmias: surgical ablation and therapeutic pacing.
First, a brief review of the concepts of biophysical modeling of human atria developed
until now is presented, as well as a brief description of several types of arrhythmia that can
be simulated with the biophysical model.
Second, measures of organization are considered to quantify and classify the diﬀerent
types of AF. With these measures, AF organization is evaluated at the electrogram signals
level as well as at the cellular level. Four types of atrial arrhythmia are diﬀerentiated with
the use of the biophysical model: atrial ﬂutter, chronic AF, meandering AF and cholinergic
AF.
Finally, simulations of atrial therapies are investigated. The biophysical model has been
used to test the eﬃcacy of ablation lines. The surgical Maze-III procedure has proven to
be highly eﬀective in treating chronic AF. However, due to the technical diﬃculty and
the risk of the procedure, less invasive ablation techniques have been investigated. The
results conﬁrm the superiority of aggressive surgical procedures in the termination of AF, as
described in the clinical studies. Furthermore, an ideal ablation pattern has been proposed
using the biophysical model. The ideal pattern should be able to prevent AF with a limited
number of ablation lines of minimal length, while allowing for the maintenance or recovery
xv
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of mechanical activity of both atria during sinus rhythm.
The second therapeutic approach investigated is that of pacing. An algorithm of pacing
and diﬀerent pacing sites are investigated during this research. Antitachycardia pacing
on diﬀerent types of AF are carried out. The simulations showed that more organized
arrhythmia such as atrial ﬂutter can be pace-terminated. On the other hand, only local
capture is possible on more complex AF. The results obtained with the biophysical model
are in agreement with the clinical studies.
The results of the present research prove that atrial therapies can be approached by
means of a biophysical model of the human atria. This tool can be used to investigate
further therapeutic techniques and thus, improve the quality of life of patients.
Symbols and Acronyms
Principal symbols
αy Opening rate of generic gating variable
βy Closing rate of generic gating variable
σl Conductance velocity longitudinal [cm s−1]
σt Conductance velocity transverse [cm s−1]
θ(r, t) Phase variable [rad]
ρ Resistivity [Ω cm]
λ Wavelength [cm]
µ Eigenvalue
Φe Extracellular potential [mV]
Φi Intracellular potential [mV]
c Conductance velocity [cm s−1]
Cm Membrane capacitance [µF mm−2]
CEig95% Number of principal components needed to obtain 95% of the energy (4.5)
CEnt Quantiﬁes the ﬂatness of the eigenvalue distribution (4.6)
De Extracellular conductivity tensor [S cm−1]
Di,D Intracellular conductivity tensor [S cm−1]
F Faraday’s constant: 9.649104 [C mol−1]
g¯k Maximum conductance of the ion channel k [mS cm−2]
Gk Conductance of the ion channel k [mS cm−2]
Im (Sum of) transmembrane currents [µA cm−2]
Istim Transmembrane stimulus current [µA cm−2]
R Gas constant: 8.314 [J mol−1K−1]
Sv Surface-to-volume ratio [µm−1]
t Time [ms], [s]
T Absolute temperature [K]
Vm Transmembrane potential [mV]
xvii
xviii Symbols and Acronyms
z Valence of the ions
Acronyms
1D/2D/3D 1 or 2 or 3 Dimension(al)
ABBI Average beat-to-beat interval
AF Atrial ﬁbrillation
AFL Atrial ﬂutter
APD Action potential duration
AVN Atrio-ventricular node
BB Bachmann’s bundle
BBI Beat-to-beat interval
CCW Counterclockwise ﬂutter
CL Cycle length
CS Coronary sinus
CT Crista terminalis
CTI Cavotricuspid isthmus dependent
CTI Cavotricuspid isthmus
CRN Courtemanche-Ramirez-Nattel
CW Clockwise ﬂutter
DI Diastolic interval
DWT Double wave reentry ﬂutter
ECG Electrocardiogram
ERP Eﬀective refractory period
FO Fossa ovalis
IIR Intraisthmus reentry ﬂutter
IVC Inferior vena cava
LA Left atrium
LAA Left atrium appendage
LLR Lower-loop reentry ﬂutter
LRI Luo-Rudy I
LRII Luo-Rudy II
MV Mitral valve
PM Pectinate muscles
PV Pulmonary vein
RA Right atrium
RAA Right atrium appendage
Symbols and Acronyms xix
RF Radiofrequency
SAF Sustained atrial ﬁbrillation
SAN Sinoatrial node
SVC Superior vena cava
TAFT Time to AF termination
TMPDM Transmembrane potential distribution map
TV Tricuspid valve
ULR Upper loop reentry
UFP Unstable ﬁxed point
xx Symbols and Acronyms
List of Figures
2.1 Transport pathways through the cell membrane and the basic mechanism of
transport . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
2.2 Electrical response of cardiac cells . . . . . . . . . . . . . . . . . . . . . . . 14
2.3 Deﬁnition of APD-DI for the Luo-Rudy membrane kinetics model . . . . . 15
2.4 Geometry of human atria based on MR images . . . . . . . . . . . . . . . . 21
2.5 Geometry of the multilayer 3D atria showing the position of the atrial bundles 22
3.1 Activation time map and isochrones during normal sinoatrial propagation. . 26
3.2 Flutter in the monolayer model: action potential and restitution curve using
the CRN membrane kinetics model . . . . . . . . . . . . . . . . . . . . . . . 29
3.3 Initiation of atrial ﬂutter using the CRN membrane kinetics model. . . . . . 30
3.4 Atrial ﬂutter using the CRN membrane kinetics model (at 4 s) . . . . . . . 31
3.5 Atrial ﬂutter using the Courtemanche model (at 5 s) . . . . . . . . . . . . . 32
3.6 Atrial ﬂutter pathway using the 3D model . . . . . . . . . . . . . . . . . . . 34
3.7 Atrial ﬂutter using the 3D model: TMPDM . . . . . . . . . . . . . . . . . . 35
3.8 Flutter on the multilayer 3D model: action potential and restitution curve
using the CRN membrane kinetics model . . . . . . . . . . . . . . . . . . . 35
3.9 Chronic atrial ﬁbrillation: action potential and restitution curve . . . . . . 37
3.10 Chronic AF in isotropic tissue using the LRI membrane kinetics model . . . 38
3.11 Atrial ﬁbrillation restitution curve using the CRN membrane kinetics model 39
3.12 Meandering AF in isotropic tissue using the Courtemanche model. . . . . . 40
3.13 Cholinergic AF in isotropic tissue using the Courtemanche model. . . . . . 41
4.1 Local high density mapping . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
4.2 Global high density mapping with respect to split level . . . . . . . . . . . . 49
4.3 Spatial correlation at the anterior right atrium. . . . . . . . . . . . . . . . . 52
xxi
xxii List of Figures
4.4 Measure of complexity as a function of the split level using no ﬁltered elec-
trogram signals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
4.5 Measure of complexity as a function of the split level using ﬁltered electro-
gram signals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
4.6 Measures of complexity over time using ﬁltered electrogram signals . . . . . 54
5.1 Illustration of the meaning of the phase variable . . . . . . . . . . . . . . . 59
5.2 Phase space in function of diﬀerent time delay τ . . . . . . . . . . . . . . . 59
5.3 (A) Transmembrane potential distribution map. (B) Its corresponding phase
map . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
5.4 Phase variable on a triangular mesh. . . . . . . . . . . . . . . . . . . . . . . 62
5.5 Determination of the rotation direction at veins/valves using the sign of a
scalar product . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
5.6 Illustration of true and false phase singularities detected when several singu-
larities are anchored around a macroscopic anatomical obstacle . . . . . . . 64
5.7 Illustration of a jumping phase singularity . . . . . . . . . . . . . . . . . . . 65
5.8 Illustration of an exclusion of a PS already assigned . . . . . . . . . . . . . 66
5.9 Illustration of the constraint on the creation of new trajectories starting at
an oriﬁce . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
5.10 Illustration of the weaknesses on the constraint on the creation of new tra-
jectories at vein oriﬁce or valve ring . . . . . . . . . . . . . . . . . . . . . . 67
5.11 Time evolution of phase singularities. . . . . . . . . . . . . . . . . . . . . . . 68
5.12 Phase singularities in the septum . . . . . . . . . . . . . . . . . . . . . . . . 69
5.13 Distribution of PSs with respect to Gsi. . . . . . . . . . . . . . . . . . . . . 70
5.14 Lifespan histogram . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71
5.15 Illustration of provenance of long-lasting PSs . . . . . . . . . . . . . . . . . 72
5.16 Phase singularities localizations. . . . . . . . . . . . . . . . . . . . . . . . . 73
5.17 Phase singularities trajectories . . . . . . . . . . . . . . . . . . . . . . . . . 75
6.1 Ablation line implementation. . . . . . . . . . . . . . . . . . . . . . . . . . . 81
6.2 Standard maze patterns . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
6.3 Simpler surigical/RF patterns. . . . . . . . . . . . . . . . . . . . . . . . . . 83
6.4 Isolation of the pulmonary veins . . . . . . . . . . . . . . . . . . . . . . . . 84
6.5 Modiﬁed Maze III patterns . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
6.6 Ablation gap types. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86
6.7 Imperfect Maze-III procedure. . . . . . . . . . . . . . . . . . . . . . . . . . . 86
6.8 Initial conditions selected for the application of ablation patterns. . . . . . . 88
List of Figures xxiii
6.9 TAFT vs. percentage of excited tissue and TAFT vs. Number of initial
wavelets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
6.10 Percentage of success rate and distributions of the average beat-to-beat in-
tervals (ABBI) for each of the standard maze procedures . . . . . . . . . . . 91
6.11 RID-Maze uncommon ﬂutter . . . . . . . . . . . . . . . . . . . . . . . . . . 92
6.12 Percentage of success rate and distributions of the average beat-to-beat in-
tervals (ABBI) for each of the 11 simpler ablation patterns studied. . . . . . 94
6.13 Uncommon ﬂutter around mitral valve. . . . . . . . . . . . . . . . . . . . . 96
6.14 Percentage of cardioversions vs. TAFT for the modiﬁed Maze III patterns . 99
7.1 Excitable gap . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104
7.2 Flow chart of the closed-loop pacing algorithm . . . . . . . . . . . . . . . . 106
7.3 BBI histograms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107
7.4 Pacing sites . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
7.5 Unsuccessful termination of AFL pacing. . . . . . . . . . . . . . . . . . . . . 110
7.6 Pacing atrial ﬂutter in the right atrium . . . . . . . . . . . . . . . . . . . . 111
7.7 Pacing atrial ﬂutter: reentry in the isthmus . . . . . . . . . . . . . . . . . . 112
7.8 Spatial correlation during pacing of chronic AF . . . . . . . . . . . . . . . . 113
7.9 Measure of complexity during pacing of chronic AF. . . . . . . . . . . . . . 113
7.10 Pacing in the right atrium free wall during chronic AF . . . . . . . . . . . . 114
7.11 Decrementing the pacing rate after control during chronic AF . . . . . . . . 115
7.12 Pacing in superior septum during chronic AF . . . . . . . . . . . . . . . . . 116
7.13 Spatial correlation during pacing of meandering AF . . . . . . . . . . . . . 117
7.14 Measure of complexity during pacing of meandering AF . . . . . . . . . . . 117
7.15 Pacing in the septum (site S4) during meandering AF . . . . . . . . . . . . 119
7.16 Spatial correlation during pacing of chronic AF . . . . . . . . . . . . . . . . 119
7.17 Measure of complexity during pacing of cholinergic AF . . . . . . . . . . . . 120
xxiv List of Figures
List of Tables
2.1 Mathematical membrane kinetics models: continuous equation representations 12
2.2 Ionic currents in the LRI membrane kinetics model. . . . . . . . . . . . . . 17
2.3 Ionic currents in the CRN membrane kinetics model. . . . . . . . . . . . . . 18
2.4 Dimensions of the atrial geometry . . . . . . . . . . . . . . . . . . . . . . . 21
4.1 Main methods to analyze atrial ﬁbrillation. . . . . . . . . . . . . . . . . . . 47
5.1 PSs lifespan for diﬀerent values of Gsi for the LRI membrane kinetics model. 72
5.2 PSs lifespan for diﬀerent types of Inhomogeneities. . . . . . . . . . . . . . . 75
6.1 Mean TAFT for the standard maze procedure patterns. . . . . . . . . . . . 90
6.2 Mean TAFT for the simpler patterns. . . . . . . . . . . . . . . . . . . . . . 93
6.3 Eﬀect of discontinuities in the Maze-III: mean TAFT and percentage of suc-
cessful termination. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
6.4 Pulmonary veins isolations. Simulations performed with a gap are denoted
with W.G. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97
6.5 Comparison between clinical data and biophysical simulations. . . . . . . . 98
6.6 Statistic for the modiﬁed Maze III patterns. . . . . . . . . . . . . . . . . . . 99
xxv
xxvi List of Tables
Dissertation
1

Introduction 1
1.1 Motivations and problem statement
Atrial ﬁbrillation
THE heart is the main organ of the cardiovascular system. Its role is to provide thebody with the blood and oxygen it needs to function properly. It is divided into
four chambers or cavities. The upper chambers, called atria, collect blood returning to
the heart. The right atrium accumulates blood from the body that is poor in oxygen and
the left atrium receives blood replenished with oxygen from the lungs. The atria empty
blood into the lower chambers, respectively right and left ventricles. The blood in the right
ventricle is passed into the lungs to be reoxygenate and the blood in the left ventricle is
pumped out to the rest of the body.
During a normal heart beat, an electrical impulse originates in the right atrium in the
sinoatrial node (SAN), the intrinsic pacemaker, and spreads throughout both the right and
left atria and down the interatrial septum to the atrioventricular node (AVN). The impulse
slows down brieﬂy at the AVN and then travels down a common pathway, the His bundle,
splitting oﬀ into the left and right bundle branches located in both ventricles. This electrical
activation causes the muscular contraction, which allows the ejection of the blood through
the cardiovascular system. The whole process is repeated at a rate of 60 to 100 beats per
minute.
When the heart does not beat at a steady rate, the episodes are called arrhythmias. If
the heartbeat is too slow, it is called a bradyarrhythmia or bradycardia. If it is too fast, it
is called a tachyarrhythmia or tachycardia. However, depending on the part of the heart
aﬀected, the consequences for the person involved are quite diﬀerent. The most serious
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cardiac rhythm disturbance is called ventricular ﬁbrillation. Here, the ventricles quiver,
which is due to a chaotic, uncoordinated electrical activity and the heart is prevented from
pumping, leading inevitably to cardiac arrest and sudden death.
The most common type of sustained arrhythmia is atrial ﬁbrillation (AF), which aﬀects
about 2% of the general population and 8-11% of those older than 65 years of age and its
incidence is increasing [1, 2]. Typically, AF is characterized by an unsynchronized electrical
activity that travels in spinning wavelets across both atria, causing these upper chambers
to quiver or to ﬁbrillate at a rate of 300 to 600 times per minute. If abnormalities occur in
the heart’s electrical impulses, the heart is not able to pump the blood out suﬃciently well,
and as a result blood may pool and clot. If a blood clot moves to an artery in the brain, AF
can lead to a stroke. AF is also associated with increased risks of congestive heart failure
and cardiomyopathy.
Atrial ﬁbrillation can be divided into acute and chronic forms [1]. Acute AF generally
refer to AF lasting less than 48 hours, and has a high likelihood of a successful conversion
to sinoatrial rhythm. There are three types of chronic forms: paroxysmal, persistent and
permanent. Paroxysmal atrial ﬁbrillation is deﬁned as recurrent episodes of spontaneously
terminating atrial ﬁbrillation. Persistent atrial ﬁbrillation is deﬁned by the persistence of
the arrhythmia until cardioversion, the process that converts AF back to normal rhythm.
Permanent atrial ﬁbrillation is refractory to attempts at cardioversion. Thus, cardioversion
is used only in cases of acute and chronic persistent atrial ﬁbrillation and not in cases
previously demonstrated to be refractory.
Current therapies
Several approaches are used to treat and prevent an abnormal beating of the heart, de-
pending on the course of AF. In the current state, methods to prevent AF and restore sinus
rhythm are: medication, surgical procedure, radiofrequency catheter ablation and electrical
stimulation. Medications are used to slow down the rapid heart rate associated with AF.
These treatments may include drugs such as digoxin, beta blockers, quinidine, etc. Surgical
or radiofrequency catheter ablation may be eﬀective in some patients when medications
fails to work. A surgical incision or a burst of radiofrequency energy is delivered to destroy
tissue that triggers abnormal electrical signals or to block abnormal electrical pathways.
Electrical cardioversion may also be used to restore normal heart rhythm by means of an
electric shock, or an atrial pacemaker can be implanted to regulate the heart rhythm.
Investigation approaches
These days, simulation has been adapted for a wide variety of contexts: basic science,
life science, engineering, economy etc. Simulation is the process of designing a model1
of a real or imagined system2 and the conducting of experiments with that model. The
1A model is a simpliﬁed description of a complex entity or process.
2A system is an assemblage of inter-related elements comprising a uniﬁed whole.
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purpose of simulation experiments is to understand the behavior of the system or evaluate
strategies for the operation of the system [3]. Models have been constructed for almost every
system imaginable such as: factories, communications, computers networks, integrated
circuites, highway systems, ﬂight dynamics, national economies, social interactions, and
virtual worlds. The modeling of systems has proved to be more cost eﬀective, less dangerous,
faster or otherwise more practical than experimenting with real systems. On the other hand,
a model is not a faithful representation of the real system due to the availability of data for
describing the behavior of the system. This issue must be addressed prior to the design of
the model to minimize its impact once the model is completed. For this reason, simulations
usually do not provide an exact solution for a speciﬁc situation but merely an indication of
general trends.
The various treatments of atrial arrhythmia remain largely based on empirical con-
siderations. Thus new approaches to investigate and understand AF are clearly required.
That is why numerical models to simulate AF have been proposed to answer questions such
as the mechanism involved in AF initiation or perpetration and the eﬃciency of therapy
techniques. Despite their inherent limitations, this due to trade-oﬀs between accuracy of
the representation of atrial electrical activity details and computation requirements, a bio-
physical model provides a framework to test hypotheses and suggest new experimental or
clinical studies and atrial therapies.
In the early days, only a small patch of tissue was modeled, with highly simpliﬁed elec-
trical propagation properties. Thanks to advances in the development and improvement of
various technologies, it has been possible to design more realistic models. These new tech-
niques have assisted investigations from the molecular level (e.g., patch clamp techniques)
to the whole organ (e.g, MR images).
The integration of current knowledge from various ﬁelds such as math, engineering,
biology and medicine have led to the implementation of a biophysical model of the human
atria. Biophysical models (experiments performed in silico) have several advantages when
compared to animal or human experiments (experiments performed in vitro):
• reproducibility of the experiments and results;
• full access to data compared to a small set of parameters accessible in electrophysio-
logical experiments;
• uncoupling of several phenomena, due to the fact that it is possible to control each
parameter individually.
Objectives
The work presented in this thesis is a part of a larger project attempting the establishment
of a general research framework for AF. It is the continuation of the two previous theses
accomplished by Olivier Blanc in 1998 [4] and Vincent Jacquemet 2004 [5]. With an ad-
ditional contribution by Steeve Zozor in 2003 [6]. This above mentioned research focused
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mainly on the development of a biophysical model of the human atria: development of an
atrial geometry, implementation of membrane kinetics models and to study of electrogram
signal morphology. Based on this biophysical model of the human atria the objectives of
this present study are:
• to characterize diﬀerent types of AF, which can be generated by the biophysical model
of human atria;
• to investigate the eﬀectiveness of surgical and radiofrequency catheter therapies;
• to investigate electrical therapies, particulary atrial antitachypacing.
The present research presented here has been realized in the framework of a project
linking Medtronic Europe, the Service of Cardiology of the Vaud University Hospital and
the Signal Processing institute Laboratory of the Swiss Federal Institute of Technology, with
the support of the Commission for Innovative Technology and the Theo-Rossi-Di-Montelera
Foundation.
1.2 Organization of the dissertation
The dissertation is organized in eight chapters, divided into three main parts:
Part I (chapter 2-3): The ﬁrst chapter (chapter 2) reviews brieﬂy the biophysical mod-
eling of human atria. The concepts of cell excitability and action potential are intro-
duced. An overview of modeling atrial tissue and electrical propagation is presented using
a bottom-up approach, starting from the microscopic level with membrane kinetics mod-
els and carries through to the organ level. Two membrane kinetics models (Luo-Rudy I
and Courtemanche-Ramirez-Nattel), which are used throughout this work, are summarized.
The second chapter (chapter 3) presents the diﬀerent type of AF, which can be generated
with such a biophysical model. First, simple arrythmia such as atrial ﬂutter is presented
and then more complex arrythmias lasting from several seconds up to several minutes of
simulated time are discussed.
Part II (chapter 4-5): The second part describes several methods to measure and quanti-
fy the spatio-temporal organization during atrial ﬁbrillation. Chapter 4 presents a measure
of organization based on simulated electrogram signals computed on the surface of the atria.
Local and global atrial activity during AF are quantiﬁed by a high density mapping system,
as well as by electrodes placed uniformly on the surface of the atrial geometry. In addition,
chapter 5 describes spatio-temporal organization at the cellular level. The mechanisms
responsible for AF perpetuation are analyzed for diﬀerent types of AFs.
Part III (chapter 6-7): The last part of this dissertation investigates atrial therapies.
Chapter 6 concentrates on the eﬀect of diﬀerent ablation patterns during chronic AF. The
protocol of ablation lines are described as well as the modeling of the lines. The results are
compared with those obtained from clinical studies. Chapter 7 shows results of electrical
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stimulation during diﬀerent type of arrythmia. First, a new algorithm of electrical stimu-
lation is presented. Then it is used to pace several types of arrythmias in the biophysical
model.
Finally, chapter 8 concludes the dissertation with a summary of this research and its
possible future extensions.
1.3 Original contributions
The major contributions1 of the research presented in this dissertation are summarized as
follows.
• Simulation of atrial arrythmias (chapter 3):
– simulation of atrial ﬂutters.
• Measures of organization (chapter 4-5):
– implementation of algorithm to measure organization during diﬀerent type of
AF;
– phase singularities tracking during AF.
• Investigation of ablation procedure (chapter 6):
– implementation of ablation procedure;
– comparison between standard ablation procedures;
– study of simpler ablation patterns;
– validation of the biophysical model with clinical data;
– proposition of an ideal ablation pattern;
• Investigation of pacing (chapter 7):
– detection of pacing gap;
– implementation of pacing algorithms;
– pacing of atrial ﬂutter;
– pacing of atrial ﬁbrillation.
1See also the list of publication in the curriculum vitae attached at the end of the dissertation.
8 Chapter 1. Introduction
Part I
A biophysical model of the human
atria
The ﬁrst part of this thesis presents the biophysical modeling of human atria. Its ﬁrst
chapter (chapter 2) reviews brieﬂy the concepts developed until now in previous
works: cardiac cell properties and mathematical formulations. The second chapter
(chapter 3) is focused on the diﬀerent types of arrythmia that can be reproduced by
means of the biophysical model.
9

From the cell to the
biophysical model 2
2.1 Introduction
SINCE the last century, the development and improvement of various technologies haveallowed scientists to gain a better understanding of the function of the heart. These
new techniques have assisted the investigations from the molecular level (e.g., patch clamp
techniques [7]) to the whole organ (e.g, MR images [8]). A broader understanding has
led to the development of a number of mathematical models (table 2.1) based on these
experimental investigations, which can successfully simulate the form and functions of the
heart, as we currently understand them. These models can be separated into two ﬁelds: the
cell structures or the membrane kinetics modeling and the entire cardiac system modeling.
Prior research has been devoted mainly to the modeling of the ventricles, due to the fact
that its dysfunctionality can directly lead to death.
It is only since the 1960s that scientists have focused their interest on the modeling of
atrial electrical activities: Moe (1964) [9], Macchi (1974) [10], Kafer (1991) [11], Killmannn
(1991) [12], Lorange (1993) [13], Wei (1995) [14], Gray (1998) [15], Blanc (1999) [16], Ellis
(2000) [17], Zemlin (2000) [18], Harrild (2000) [19], Vigmond (2001) [20], Virag (2002) [21],
Ho¨per (2003) [22].
This chapter reviews the biophysical model of the atria that was initiated by Olivier
Blanc [4] in 1998, developed by Steeve Zozor [6] and Vincent Jacquemet [5] in 2000. The
bottom-up approach was used to model the electrical activity of the atria. Firstly the
cellular properties of this model are presented. Subsequently, the tissue level and the whole
organ is exposed.
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Action potential models Domains Year
Nerve action potential model
Hodgkin Huxley Squid giant axon 1952
Cardiac action potential models
FitzHugh-Nagumo Cardiac action potential model 1961
Noble Purkinje ﬁber 1962
Bassingthwaighte Cardiac excitation contraction 1973
McAllister-Noble-Tsien Calf Purkinje ﬁbre 1975
Beeler-Reuter Calf ventricular ﬁber 1976
DiFrancesco-Noble Ventricular ﬁbre 1984
Luo-Rudy Guinea pig ventricle 1991
Demir-Giles Sinoatrial node 1998
Courtemanche-Ramirez-Nattel Human atria 1998
Nygreen et al. Human atria 1998
Winslow et al. Canine ventricle 1999
Michailova-McCulloch Canine ventricle 2001
Table 2.1 – Mathematical membrane kinetics models: continuous equation representations.
2.2 Modeling the cardiac cell membrane
2.2.1 Cardiac cell properties
The cardiac tissue consists of more than one billion cells; 250·106 of which form the atria
and about 109 the ventricles. Cardiac cells are represented by a cylinder shape of 30-
100 µm long and 8-20 µm wide [23]. They are surrounded by a lipid bilayer1 membrane
which separates the intracellular medium from the extracellular medium. The membrane is
selective in which molecules or ions are allowed to pass in and out and is, therefore, semi-
permeable. The diﬀerent mechanisms involved in the transport of particles are schematically
represented in ﬁgure 2.1. Transport through the cell membrane occurs either by passive
transport or active transport [7]. Passive transport consists of two types: 1) simple diﬀusion
which allows small molecules to cross directly the membrane via diﬀusion and 2) facilitated
diﬀusion which utilizes particular protein channels. Active transport is also divided into
two categories: 1) primary active transport and 2) secondary active transport. Primary
active transport involves the use of energy (usually through adenosime triphosphate (ATP)
hydrolysis) within the membrane protein itself to cause a conformational change that results
1lipid bilayer is composed of a thin ﬁlm of lipids only 2 molecules thick that is continuous over the entire
cell surface [7].
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Figure 2.1 – Transport pathways through the cell membrane and the basic mechanism of transport.
Passive transport constitutes of simple diﬀusion and facilitated diﬀusion. Active transport requires the
expenditure of energy to transport molecules across the membrane.
in the transport of the molecule through the protein. Secondary active transport involves
using energy to establish a gradient across the cell membrane, and then utilizing that
gradient to transport a molecule of interest up its concentration gradient. In both instances,
transport depends on carrier proteins that penetrate through the membrane, the same as
is true for facilitated diﬀusion. However, in active transport, the carrier protein functions
diﬀerently from the carrier in facilitated diﬀusion because it is capable of imparting energy
to the transported substance to move it against an electrochemical gradient. Furthermore,
intracellular transport ﬂows from one cell to another due to the gap junctions that allow
relatively free diﬀusion of ions.
Electrical potential diﬀerences are set up across the membrane, determined primarily
by three factors: 1) the concentration of ions on the intracellular medium and extracellular
medium; 2) the permeability of the cell membrane to those ions (i.e., ion conductance);
and 3) by the activity of electrogenic pumps (e.g., Na+/K+-ATPase and Ca2+ transport
pumps) that maintain the ion concentration diﬀerences across the membrane. In any elec-
trical model of a cardiac cell, the ions of primary interest are potassium (K+), sodium
(Na+), and calcium (Ca2+). At steady-state equilibrium, the diﬀerence potential between
the intracellular domain and the extracellular domain, also called membrane potential or
transmembrane potential Vm, is maintained approximately at -80 mV.
Cardiac cells become excited when they undergo an external stimuli and produce an
action potential , which constitutes a rapid change in the membrane potential (ﬁgure 2.2).
This is a fast, all-or-none signal, which propagates along the surface of the cell and transmits
from cell to cell through gap junctions. Once voltage-gated channels1 begin to open, ion
inﬂux through them produces further changes in the membrane potential, in turn recruiting
1Voltage-gated channels are ion channels in a membrane that open and close in response to changes in
membrane potential.
14 Chapter 2. From the cell to the biophysical model
0 100 200 300 400 500
−100
−50
0
50
Time [ms]
V m
 
[m
V]
0
1
2
3
4
Figure 2.2 – Electrical response of cardiac cells. The continuous line is a ventricular action potential
using the Luo-Rudy [24] membrane kinetics model and the dashed line is an atrial action potential
produced by the Courtemanche-Ramirez-Nattel [25] membrane kinetics model. (0) Upstroke, (1) Early
repolarization. (2) Plateau. (3) Late repolarization. (4) Resting potential.
additional channels to open. Ca2+ ions move down its electro-chemical gradient introducing
positive charges to the cell thus producing additional depolarization which in turn activates
more Ca2+ channels until the entire population is activated. A similar process activates
Na+ channels in contractile cells (atrial, ventricular). Thus, a rapid inﬂux of Ca2+ or Na+
ions produces an inward current which depolarizes the cell membrane synchronously.
When an outside stimulation is applied and reaches a threshold, membrane potential
Vm is depolarized following the curve in ﬁgure 2.2. Five distinct phases in the time course
are deﬁned: (0) Upstroke, (1) Early repolarization. (2) Plateau. (3) Late repolarization.
(4) Resting potential.
During the phase (0)-(2) and a part of phase (3), no stimulus can generate a new action
potential, this interval is called the eﬀective refractory period (ERP).
In order to determine the ERP, several stimuli were applied at diﬀerent time instants
until a new propagation was generated. As this method is time consuming, the action
potential duration (APD) is used instead and it is related to the ERP [26]. APD is deﬁned
as the time interval between the upstroke and 90% of the repolarization level. The APD
depends on the previous diastolic interval (DI), i.e. the time interval between the end of
the ﬁrst action potential (S1) and the onset of the second one (S2) (ﬁgure 2.3(A)). The
relation between APD and DI is described by the restitution curve (ﬁgure 2.3(B)). The
cycle length (CL) is the sum of APD and DI, i.e., the elapsed time between the ﬁrst and
second stimuli.
The APD curve is known to play a crucial role in the initiation and perpetuation of
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Figure 2.3 – Deﬁnition of APD-DI for the Luo-Rudy membrane kinetics model. (A) Action potential
duration (APD), diastolic interval (DI) and cycle length (CL). (B) Restitution curve.
reentrant wave1 patterns like the spiral waves that are measured during same type of atrial
arrythmia (see chapter 3 and [27, 28]).
2.2.2 Modeling the active membrane properties
The conception of both realistic and complex models has become possible due to recent ad-
vances in experimental technologies and the increase in computing power. When modeling
a system, major steps forward have to be taken into account; realistic representation of the
logical process and computation costs. Simpliﬁcations and approximations are needed to
ensure reasonable computation time, while keeping the representation precise enough.
In the case of the cardiac cell, the active transport mechanism is generally neglected
and gap junctions are considered as passive and non-selective ionic exchangers. Based
on a number of experiments in giant squid axons, Hodgkin and Huxley [29] implemented
the ﬁrst quantitative model of electrical excitability of neurons. This model describes three
ionic currents: fast inward sodium current, time-dependent outward potassium current, and
time-independent leakage current. The total transmembrane current Im can be expressed
as:
Im = Cm
dVm
dt
+ Iion − Istim, (2.1)
where Cm is the transmembrane capacitance, Vm is the diﬀerence between the intra-
and extra-cellular potential (Φi and Φe):
Vm = Φi −Φe, (2.2)
Iion is the sum of the ion currents and Istim, an external stimulation current. In the case of
an isolated cell, by conservation of current, Im = 0. The transmembrane potential can be
1A reentrant wave is a circulating excitation wave in the heart, rather than moving outward and then
stopping.
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written as:
dVm
dt
= − 1
Cm
(Iion − Istim). (2.3)
Each of the individual currents summed under the term Iion has the form:
Ik = g¯k y(Vm − Ek). (2.4)
Ik is the current associated with the ion of type k, g¯k is the maximum conductance of the
corresponding ion channels, y a gating variable (0 ≤ y ≤ 1) expressing the mean state of
these ion channels. The term Ek represents the Nernst potential [7] of an ion of the type k
given by:
Ek =
RT
zF
· ln
(
[k]e
[k]i
)
, (2.5)
with R the universal gas constant, T the absolute temperature, z the valence of ion k, F ,
Faraday’s constant and [k]e and [k]i the extracellar and intracellular ion concentrations.
The transition of the gating variable y between the closed (y = 0) and opened states
(y = 1) can be written:
Closed
αy

βy
Opened, (2.6)
where the gate rate αy and βy in ms−1 correspond respectively to the opening and closing
of the ion channels. In an intermediate state, the fraction of gates open (or in their α state)
is y. Then the fraction of gates closed (or in their β state) is 1-y. The change in the fraction
of the gates open is hence governed by:
dy
dt
= αy(1− y)− βyy. (2.7)
The temporal evolution of the gating variable y is thus described by this ﬁrst order diﬀer-
ential equation. This process of the opening and closing of the gates is called gate kinetics.
The following sections summarize each of the two membrane kinetics models used in
this particular research.
The Luo-Rudy membrane kinetics model
The Luo–Rudy membrane kinetics model [24] is the next signiﬁcant update to the Beeler–
Reuter [30] mammalian ventricular model. It is known as the Luo-Rudy I (LRI) model
because it is the ﬁrst of the two Luo–Rudy models. The total current Iion is composed of
six individual currents and eight gating variables:
Iion = INa + Isi + IK + IK1 + IKp + Ib. (2.8)
Each individual ion current is handled by gate kinetics equations of the form (2.7) and
table 2.2 presents the main characteristics of each current.
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Current Time dependency Direction Gating variables
Sodium channel
INa Yes Inward m,h, j
Calcium channel
Isi Yes Inward d, f
Potassium channels
IK Yes Outward X,Xi
IK1 No Outward K1
IKp No Outward
Ib No Outward
Table 2.2 – Ionic currents in the LRI membrane kinetics model.
An improved version of this model, the Luo-Rudy Phase II (LRII) model was published
in 1994 [31]. The main improvement to the previous version was the inclusion of intracellular
ionic homeostasis,1 for sodium and potassium.
The Courtemanche-Ramirez-Nattel membrane kinetics model
The Courtemanche-Ramirez-Nattel membrane kinetics model (CRN) [25] is based on the
Luo–Rudy II one and it attempts to simulate action potentials of human atria. This model
includes the dynamics of intracellular currents of the sarcoplasmic reticulum2 (SR) and the
non-junctional sarcoplasmic reticulum (NSR). The total current Iion is composed of twelve
individual currents:
Iion = INa + INa,b+ IK1+ Ito + IKs+ IKr+ IKur+ ICa,L+ ICa,b+ Ip,Ca+ INaK+ INaCa. (2.9)
The ionic gating variables corresponding to each current are all governed by diﬀerential
equations as formulated by (2.7). The details of each current are fully described in [25].
Table 2.3 summarizes the main properties of each current.
2.3 Modeling myocardial tissue
2.3.1 The bidomain model
Recently, the bidomain model has been widely accepted as the most widely used approach
for theoretical and numerical investigations of macroscopic electric phenomena in cardiac
tissue [32, 33]. It is based on the representation of tissue as two interpenetrating domains:
1The ability to maintain a relatively constant internal environment
2A sarcoplasmic reticulum is a membrane network within the cytoplasm of muscle cells involved in the
synthesis, modiﬁcation, and transport of cellular materials.
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Current Time dependency Direction Gating variables
Sodium channels
INa Yes Inward m,h, j
INa,b No Inward
Potassium channels
IK1 No Inward
Ito Yes Outward oa, oi
IKs Yes Outward xs
IKr Yes Outward xr
IKur Yes Outward ua, ui
Calcium channels
ICa,L No Inward d, f, fCa
ICa,b No Inward
Pumps
Ip,Ca No Outward
INaK No Outward
Ion exchanger
INaCa No Inward
Sacrcoplasmic reticulum ﬂuxes
Ileak No NSR → I
Iup No I→ NSR
Itr No NSR→ JSR
Irel Yes JSR→ I u, v, w
Table 2.3 – Ionic currents in the CRN membrane kinetics model. NSR: network sarcoplasmic reticulum.
JSR: junctional sarcoplamic reticulum. I: intracellular space.
the extra- and the intracellular domain. The current ﬂows are described by the coupled
reaction-diﬀusion equations constituting the bidomain model:
1
Sv
∇ · (Di∇Φi) = Im, (2.10)
1
Sv
∇ · (De∇Φe) = −Im, (2.11)
where Sv is the cell surface-to-volume ratio, Di and De are the intracellular and extracellular
conductivity tensors determined by gap junction resistivities and Im is the transmembrane
current per unit area that is a function of the transmembrane potential Vm. The ratio Sv
is related to the interaction of two kinds of contributions: volumetric ﬂows through the
intra and extracellular spaces and ﬂows through the membrane surface. Because of the
continuous nature of the tissue model, the conductivity tensors Di and De reﬂect electrical
properties that are spatially averaged over several cardiac cells.
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Replacing (2.2) in (2.10) and (2.11), the two following equations describe the current
ﬂow in the intracellular domain and the current conservation between the two domains:
1
Sv
∇ · (Di[∇Vm +∇Φe]) = Im, (2.12)
∇ · (De∇Φe) +∇ · (Di[∇Vm +∇Φe]) = 0. (2.13)
It is assumed that there is no current ﬂow between the intracellular and extracellular
domain through the gap junctions:
nT ·Di∇Φi = 0, (2.14)
where n is a unit vector normal to the tissue interface. On the exterior boundary of the
bath, corresponding to the body surface a no–ﬂux boundary condition is also assumed:
nT ·De∇Φe = 0, (2.15)
In the extracellular domain, in the absence of any source current, it is assumed that:
∇ ·De∇Φe = 0. (2.16)
Other boundary conditions may also be taken into account [32, 34]. For example,
when modeling deﬁbrillation, the deﬁbrillation electrodes applied directly to the thorax or
through a conductive bath, are considered.
2.3.2 The monodomain model
The numerical resolution of the biodmain equations is not a straightforward task in the
general case, it requires the simultaneous comutation of the two potential ﬁelds Φe and
Vm [35, 36]. It is fortunately possible to simplify eﬃciently the bidomain formalution for-
malism and restrain the computation to the intracellular domain only [23]. A commonly
used simpliﬁcation of the bidomain equations to save computation costs results from as-
suming that [6]:
• the tissue is thin and lies in an extensive bath;
• the extracellular potential variations are suﬃciently small, so that the intracellular
potential variations are approximately equal to the transmembrane potential varia-
tions;
• the eﬀect of the extracellular potential on the transmembrane current sources is small,
so the bidomain equations can be decoupled.
Under these assumptions, a cardiac tissue can be described by a monodomain equation:
1
Sv
∇ · (D∇Vm) = Cm∂Vm
∂t
+ Iion − Istim, (2.17)
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where the conductivity tensor D is equal to Di. The no-ﬂux boundary condition in the
intracellular domain can be written as:
nTDi∇Vm = 0. (2.18)
An alternative way for conceiving a monodomain model is to assume an isotropic tissue or
a tissue with a constant (Di = kDe, where k is a constant [5]).
In this context the conductivity tensor can be conveniently expressed as a function of
the intracellular tissue resistivity ρ with:
D =
1
ρ
I, (2.19)
where I is the identity matrix. By modifying the conductivity tensor ﬁeld D, anisotropic
conduction can be generated. The conduction velocity (CV) is related to the resistivity ρ,
by the approximate law: ρ ∝ CV−2 [37].
2.3.3 Electrograms
Clinical electrophysiology data of the heart are mainly based on electrical signal recordings
such as the electrocardiogram (ECG)1. Transmembrane potentials of the atria tissue are not
directly accessible in clinical studies. Therefore, it is necessary to compute electrical signals
measured on the atrial surface (atrial electrogram signals), corresponding to endocardial
cathether electrode recordings or electrical mappings, to obtain comparable measurements.
The Unipolar electrogram, Φ are computed according to the current source approxima-
tion [5]. The extracellular potential at the position x and at time t is given by:
Φ(x, t) =
1
4πD
∫
Ωepi
dy δ
SvIm(y, t)
‖x− y‖ , (2.20)
where Ωepi represents the epicardial surface, dy is an inﬁnitesimal surface element, δ is
the thickness of the tissue, D the surruonding bath conductivity, Im the current source per
unit area of membrane surface, and Sv is the cell surface-to-volume ratio.
2.4 Geometry of human atria
2.4.1 Monolayer 3D surface
The atrial model is based on MR images acquired from a healthy adult female subject,
provided by Medtronic Inc. The surface of the atria was semi-automatically segmented slice-
by-slice and a 3D atrial structure was reconstructed. Its coarse, meshed surface represented
the epi- and endo-surfaces of the atrial walls with major geometrical problems, such as valve
1An electrocardiogram is a graphic produced by an electrocardiograph, which records the electrical
voltage in the heart in the form of a continuous strip graph. It is constructed by measuring electrical
potential diﬀerences between various points on the body surface using a galvanometer.
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and vein delimitations [4]. Therefore, the surface was reﬁned using 3D splines provided by
Ideas (SDRC Inc.). Finally, from the parameterized surface, several triangular meshes
of diﬀerent spatial resolutions (∆x = 0.6 mm (50’000 nodes) and ∆x = 0.4 mm (100’000
nodes)) were generated [5]. This last one is used to run standard simulations. The ﬁnal
geometry represents a monolayer 3D-surface shown in ﬁgure 2.4 including the opening
corresponding to all valves and veins, as well as the septum. Table 2.4 summarizes the
dimensions of this complex geometry representing the atria.
Anterior view Posterior view
Figure 2.4 – Geometry of human atria based on MR images. The left/right atrium appendages are
indicated by LAA/RAA. The major vessels and valves are included: tricuspid valve (TV), mitral valve
(MV), inferior vena cava (IVC), superior vena cava (SVC), pulmonary veins (LSPV, RSPV, LIPV and
RIPV), coronary sinus (CS) and fossa ovalis (FO). The sinoatrial node (SAN) is represented by a dot.
Right atrium RA SVC IVC TV CS
84.20 2.84 3.14 4.29 0.54
Left atrium LA LSPV RSPV LIPV RIPV MV
72.10 1.07 1.02 0.89 1.08 4.57
Septum SEPT FO
3.79 1.17
Table 2.4 – Dimensions of the atrial geometry. The right/left atrium are indicated by RA/LA;
dimensions are indicated in cm2.
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2.4.2 Multilayer 3D structure
Based on the monolayer surface, thickness was ﬁrst added by duplicating the ﬁrst layer
in the direction perpendicular to the surface. Each vertex was replaced by a cable (1D
structured mesh) and the connections between each layer were completed [5].
The current version, also based on the triangular mesh surface Σ, uses a spatial regular
discretization. The formulation of the domain Ω representing the atrial wall is:
Ω =
{
x|min
y∈Σ
||x− y|| < R
}
, (2.21)
where, R > 0 is half of the wall thickness and x, y are spatial coordinates. The domain is
described by computing its intersection with a regular grid:
Ωdiscr = Ω ∩ {x = (i∆x; j∆x; k∆x)| i, j, k ∈ Z} , (2.22)
where ∆x is the space step. The atrial wall thickness is set to 1.2 mm with a spatial dis-
cretization of 300 µm, leading on average to 4-5 layers. The total number of nodes is inferior
to 1’000’000, which corresponds to a reasonable computation time. Besides the thickness,
fast conduction boundaries such as the crista terminalis (CT), the pectinate muscles (PM)
and the Bachmann’s bundle (BB) were included in the biophysical model (ﬁgure 2.5). These
structures were implemented manually based on data from the literature [5, 38, 39].
2.5 Implementation of a biophysical model
The spatial and temporal coupling of the reaction-diﬀusion process described in (2.17)
and (2.18) are spatially and temporally discretized using an unstructured meshed [6] and
an adaptive time step [40] method, in the case of the monolayer surface. Whereas, ﬁnite
diﬀerence methods are used for the structured 3D monolayer surface [41, 42].
Equations (2.5) and (2.18) are solved in two stages [40]. Firstly, the diﬀusion part is
considered and secondly the reaction part, which leads to the following set of equations:
PM
PM
BB CT
Figure 2.5 – Geometry of the multilayer 3D atria showing the position of the atrial bundles: Crista
terminalis (CT), pectinate muscles (PM) and Bachmann’s bundle (BB). (Produced by V. Jacquemet)
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Diﬀusion:
∂Vm
∂t
=
1
CmSv
∇ · (D∇Vm), (2.23)
with the no–ﬂux boundary condition:
nTDi∇Vm = 0. (2.24)
These equations are solved by means of the forward Euler scheme [4].
Reaction:
∂Vm
∂t
= − 1
Cm
(Iion − Istim), (2.25)
which is solved using an adaptive time step to optimize computation time [40].
2.6 Summary
In this chapter, the atrial biophysical model developed in the two previous theses by O.
Blanc [4] and V. Jacquemet [5], has been brieﬂy discussed. An overview of modeling
methods has been presented using a bottom-up approach. This approach starts from the
microscopic level with cellular membrane kinetics models and carries it through to the organ
level.
The cellular membrane structure has been presented with its simpliﬁcations required for
its implementation in a biophysical model. The electrical activity, at steady-state and under
an external stimulus, has been discussed. The engendered currents have been exposed and
the two membrane kinetics models (the Luo-Rudy I and the Courtemanche-Ramirez-Nattel)
used later in this dissertation have been summarized.
The principle of coupled tissue models and their implementations have been touched
upon. The geometry of the atria based on MR images has been presented.
This chapter lays down the principles, the terms and the tools that will be used through-
out the dissertation.
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Simulations of atrial
arrhythmias 3
3.1 Introduction
THE goal of this project is the development of a biophysical model of human atrialarrhythmias. The model will ﬁrst be an instrument to assist electrophysiologists and
clinicians to understand more fully the occurrences of arrhythmias and their behavior.
Second, it will be used to investigate therapeutic interventions. The state of the art in
modeling normal atrial conduction is the work of Harrild and Henriquez [19], entailing a
full real 3D atrial structure and the Nygren et al. [43] membrane kinetics model. But alas,
as pointed by their authors, such a detailed model is not suitable for studying complex
arrhythmic propagation because of its computational requirements. In the present study, a
tradeoﬀ was made between model complexity and computational load in such a way as to
allow several arrhythmias such as atrial ﬂutter (AFL) and sustained atrial ﬁbrillation (AF)
to be simulated during several seconds of real time.
The previous chapter described brieﬂy the membrane kinetics models and the atrial
geometry used in the biophysical model. In the present chapter, the diﬀerent types of
atrial arrythmia that can be simulated with such a model are presented. The mechanisms
underlying the initiation and the perpetuation of atrial arrhythmias are discussed: action
potential duration (APD), restitution curve and heterogeneity. The diﬀerent dynamics of
the several types of arrythmia are analyzed.
First, the atrial ﬂutter, which is the most organized arrythmia, is presented using the
Courtemanche-Ramirez-Nattel (CRN) membrane kinetics model in the 3D monolayer sur-
face and there afterwards on the 3D multylayer structure. Second, Jacquemet’s results [5]
on less organized arrythmia are recapitulated. The experiments were performed using the
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Luo-Rudy I (LRI) and the CRN membrane kinetics models in the monolayer surface.
These various types of arrythmia will be used to investigate atrial therapies in chapter 6
and 7.
3.1.1 Sinoatrial rhythm
In healthy atria, the cardiac rhythm is governed by the sinoatrial node (SAN), the intrinsic
pacemaker, which delivers an electrical impulse approximatively every second. This impulse
spreads throughout both the right and left atria and down the interatrial septum to the
atrio-ventricular node (AVN). The total activation time from the SAN to the left atrium
appendage is about 110 ms, as shown in ﬁgure 3.1. An example of an electrogram signal
complex, computed (see section 2.3.3) in the middle of the right anterior atrium free wall,
is displayed (ﬁgure 3.1, E1).
During atrial arrhythmias, this rhythm may be perturbed either by a diﬀerent pathway
used by the wavefront or by multiple wavebreaks.
3.1.2 Atrial ﬂutter
The earliest usage of the term atrial ﬂutter has been attributed to MacWilliam [44], who
observed in 1886 a rapid, seemingly regular excitation of the atrium. In 1911, Jolly and
Ritchie clearly distinguished AFL from AF: the typical ﬂutter was described as inducing
negative sawtooth waves in the electrocardiogram (ECG) leads II, III and aVF [45].
A typical atrial ﬂutter results from a right macro-reentrant circuit bounded anteriorly
by the tricuspid valve oriﬁce (TV), posteriorly by the speciﬁc arrangement of anatomi-
cal obstacles (oriﬁce of the superior vena cava (SVC), the inferior vena cava (IVC) and
Eustachian ridge), and functional barriers (regions of the crista terminalis (CT)) [46]. In
Activation time [ms]
0 20 40 60 80 100
SAN
E
1
E
1
Figure 3.1 – Activation time map and isochrones during normal sinoatrial propagation. Isochrones
are drawn in black every 10 ms. The point E1 denotes the position of the unipolar electrodes used to
compute the electrogram. (Reprinted with permission from V. Jacquemet)
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humans, the most common direction of activation of the AFL circuit (90%) follows a path-
way between TV and IVC along the isthmus in the direction of the septum. This has been
described as counter-clockwise reentry and clockwise reentry if the activation occurs in the
opposite direction. Depending on the rate of the cycle length (CL), two classes of AFL
were initially established: AFL type I and AFL type II. The former one is characterized by
an atrial rate ranging from 240 to 340 beats per minute (bpm) and the latter, by an atrial
rate ranging from 240 to 433 bpm [47].
More recently, as the result of advanced mapping techniques [48], a new classiﬁcation
and terminology of AFL has been deﬁned [49–51]. The ﬁrst category regroups right atrium
AFL and the second one, left atrium AFL. Right atrium AFL is divided into two subgroups:
cavotricuspid isthmus dependent (CTI) AFL and non-CTI dependent AFL.
In the CTI AFL subgroup, the majority of the ﬂutter circuits involve electrical activation
around the tricuspid annulus (TA), and the isthmus represents a critical part of the circuit.
Among the CTI AFL, ﬁve diﬀerent types of ﬂutters have been described: counter-clockwise
(CCW)/clockwise (CW) atrial ﬂutter, double-wave reeentry (DWR), lower-loop reentry
(LLR) and intra-isthmus reentry (IIR), whose circuit is bounded by the medial CTI and
the coronary sinus ostium; the lateral CTI not being involved [52, 53]. CCW and CW
ﬂutters have been detailed in the previous paragraph (AFL type I). The DWR ﬂutter
appears if a premature beat is able to invade the circuit. Then two wavefronts may occupy
the original circuit. DWR is usually produced by extrastimuli and is usually, short-lived.
It may also serve as a trigger for AF. The LLR ﬂutter involves a reentrant circuit around
the IVC. This ﬂutter may coexist with a typical CCW or CW ﬂutter and involves posterior
break-through(s) across the CT.
In the non-CTI AFL subgroup, electro-anatomic voltage maps from the right atrium
often reveal scars, the result of surgical repair of congenital heart defects; or low voltage
areas which act as the central obstacle to the reentrant. Tai et al. [54] have described an
upper loop reentry (ULR), this type of atypical ﬂutter involves the upper portion of the
right atrium with transverse conduction over the CT.
The second category, regroups left atrium atrial ﬂutters are far less common than right
atrial CTI. Three subgroups have been identiﬁed: mitral annulus AFL [55], pulmonary vein
AFL [56] and left septal circuits AFL [57].
3.1.3 Atrial ﬁbrillation
The earliest concept of atrial ﬁbrillation was proposed by Winterberg [58] in 1906 and Lewis,
in 1912, who advocated that rapid focal activity from one or more centers accounted for
AF. In the 1960s Moe [9] proposed the theory of randomly propagating multiple wavelets
as the main mechanism underlying AF. A critical mass of atrial tissue is required to sustain
the minimal number of simultaneous circuits necessary for arrhythmia perpetuation. In
humans, approximatively six wavelets are required to sustain AF [59]. The wavelets in AF
travel largely in a random fashion around islets of refractory atrial tissue. This hypothe-
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sis has became widely accepted, particularly after the appearance of mapping studies by
Allessie et al. [59].
Recently, Jalife and his colleagues [60] have questioned the randomness of atrial activity
in AF. Their study suggests the presence of a possible mother rotor1 that serves as a periodic
background focus. The presence of anatomical obstacles such as scars and oriﬁces lead to
a break up of the wavefront from the mother rotor into multiple wavelets.
In 2002, Kneller et al. [61] proposed a two-dimensional computer model of cholinergic
AF using a model of canine atrial tissue. Vagal actions were formulated based on patch-
clamp studies of acetylcholine (ACh) eﬀects. Their results suggest that heterogeneities in
ACh concentration are suﬃcient to create ﬁbrillatory conditions despite the complete loss
of rate adaptation (i.e. restitution curve ﬂattened) [62, 63].
3.2 Atrial ﬂutter in the biophysical model
The selection of a membrane kinetics model is determined by the desired accuracy of the
representation of the cell properties and by the available computer power. Since the atrial
ﬂutter is the most organized arrythmia and does not involve several wavelets, it is not nec-
essary to follow temporal evolution for a long period. The Courtemanche-Ramirez-Nattel
membrane kinetics model, designed speciﬁcally to reproduce human atrial cell electrophys-
iology, is well adapted for this purpose.
3.2.1 Atrial ﬂutter in the monolayer 3D model
In the present approach, it was decided not to include anisotropic fast-conducting regions,
ﬁber orientation, crista terminalis (CT) and pectinate muscles (PM), to simplify the com-
plexity of the model and retain a better control over the simulations. In spite of these
limitations, an uncommon sustained atrial ﬂutter could be simulated.
When using the unmodiﬁed CRN membrane kinetics model, the spatial wavelength λ is
too long to sustain a ﬂutter. The wavelength is longer than the circuit around the tricuspid
valve leading the wavefront to collide with the wave tail and to collapse. The TV perimeter
is 5.19 cm and the wavelength of the CRN baseline membrane kinetics model is 21 cm. The
wavelength is the result of the product between the conductance velocity (c = 70 cm/s)
and the action potential duration (APD = 300 ms).
In order to induce self-sustained AFL, the parameters of the membrane were modiﬁed to
reasonably approximate APD restitution curve of remodeled human atria cells measured by
Kim et al. [64]. Figure 3.2 presents the remodeled action potential shapes and restitution
curves. Such changes (remodeling) in APD are often seen experimentally and clinically
after many seconds of atrial arrythmia. Remodelled cells were shown to be characterized
by shorter APDs and reduce rate adaptation, i.e ﬂattened APD restitution.
1A mother rotor is a stable source of reentry that generates multiple wavelet breaks
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Figure 3.2 – Flutter on the monolayer model: action potential and restitution curve using the
CRN membrane kinetics model. (A) Action potential. (B) Restitution curve. (1) Baseline model,
(2) Remodeled with: Ito, ICa,L, IKur reduced to 20%, 70%, 10%, and IKr increased to 600%. (3)
Remodeled with: Ito, ICa,L, IKur reduced to 20%, 70%, 10%, and IKr increased to 450%.
The simulations were conducted with a normal conductive tissue (ρ  200 Ωcm, c = 70
cm/s). The APD was reduced to 100 ms by modifying some currents (see table 2.3). The
transient outward current (Ito), the calcium current (ICa,L) and the ultra rapid potassium
(IKur) was reduced to 20%, 70% and 10%, respectively, and the time-independent potassium
(IKr) was increased ﬁrst to 600% (ﬁgure 3.2, curve (2)) and then reduced to 450% to obtain
the appropriate restitution curve (ﬁgure 3.2, curve (3)). It was not possible to initiate the
ﬂutter directly by setting the IKr too 450%; the wavelength would be too long and the
wavefront and wave tail would collide.
The ﬂutter was artiﬁcially initiated by placing a block of conduction (c = 0 cm/s)
between TV and IVC. The conduction block was removed after 150 ms.
Figure 3.3 presents a transmembrane potential distribution map (TMPDM) during AFL
initiation. A stimulus was applied in the isthmus region. Since there was the conduction
block, the generated wavefront could only be propagated in the septum direction. The
two wavefront extremities remained automatically anchored around TV and IVC. At 120
ms, the wavefront completed a cycle around the valve and vein, and was stopped by the
conduction block. At 150 ms, the conduction block was removed and the wavefront could
continue to propagate, but remained anchored around the valves. The time instant at
which the conduction block is removed is critical. If it is removed too early, the wavefront
may collide with the wave tail leading so to AFL termination. On the other hand, if it is
removed too late, not enough current can propagate. By remodeling, not only the APD
was shortened (ﬁgure 3.2(B)), but also the wavelength (λ = c ·APD), allowing a complete
cycle to be obtained around TV. The wavelength should be shorter than the perimeter of
the TV to ensure ﬂutter. The cycle length was 150 ms (400 bpm), which corresponds to
the rate of an AFL type II [47].
The steady-state was reached after one second. The wavefront extremity, which was
anchored previously around the IVC during the initiation phase, was then anchored around
the SVC. Figure 3.4 displays the TMPDM, the membrane potential and the unipolar elec-
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Figure 3.3 – Initiation of atrial ﬂutter using the CRN membrane kinetics model. Superior and
inferior view of the atria. TMPDM: (A) Stimulation with a conduction block between TV and IVC. (B)
Propagation of the wavefront in the direction of the septum and blocked in the opposite direction due
to the conduction block. (C-E) Propagation of the wavefront around valves/veins. (F) Wavefront has
completed a cycle around TV. (G) The conduction block removed. (G) Perpetuation of the wavefront
around TV and IVC.
trogram computed in the middle of the anterior right atrium, the percentage of excited
tissue1, and the number of wavelets after 4 s of simulated time. The steady state was sub-
sequently achieved, the AFL remained stably anchored around TV and SVC (ﬁgure 3.4(A)).
At 4.14 s the wavefront around SVC started to release from it (indicated by an arrow on
ﬁgure 3.4(G-H)). This instability was due to the fact that the time taken for the wavefront
extremity to cross the SVC perimeter was shorter than the CL. The wavefront extremity
collapsed with its tail and was unable to stay stable around the SVC. The potential mem-
brane and unipolar electrogram showed alternations between short and long potentials.
The percentage of the excited tissue does not evolve regularly. Around 4.5 s, wave breaks
appeared, as shown in ﬁgure 3.4(L).
Figure 3.5 displays the TMPDM after 4.6 s. The wavefront extremity previously
anchored around the SVC was completely detached and evolved freely, as shown in ﬁg-
ure 3.5(E-H) by the arrows.
1The percentage of excited tissue is deﬁned as the the percentage of nodes with an action potential above
a ﬁxed threshold (-60 mV)
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Figure 3.4 – Atrial ﬂutter using the CRN membrane kinetics model (at 4 s). (A-F) TMPDM: Wave-
front anchored around TV and SVC. (G-H) TMPDM: instability, wavefront leaving SVC. (I) Membrane
potential computed in the middle of the anterior right atrium. (J) Unipolar electrogram computed in the
middle of the anterior right atrium. (K) Percentage of excited tissue. (L) Number of wavelets.
The AFL presented in this section cannot be considered as an AFL type I in the strict
sense. First, the ﬂutter rate was twice as fast (400 bpm). Secondly, the ﬂutter was unstable
and did not have a constant circuit. It can be considered as an atypical right ﬂutter or a
CTI AFL, not previously reported in the literature.
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Figure 3.5 – Atrial Flutter using the Courtemanche model (at 5 s). (A)-(H) TMPDM: One wavefront
extremity is anchored to TV and the second one (indicated by an arrow) evolves freely. (I) Membrane
potential computed in the middle of the anterior right atrium. (J) Unipolar electrogram computed in the
middle of the anterior right atrium. (K) Percentage of excited tissue. (L) Number of wavelets.
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3.2.2 Atrial ﬂutter in the multilayer 3D model
Since the slow and fast conduction velocity boundaries plays a crucial role during AFL [46],
in the present section, the 3D multilayer model is used to study atrial ﬂutter. It includes
anisotropic fast-conducting regions: the crista terminalis (CT), the pectinate muscles (PM)
and the Bachmann’s bundle (BB). Two slow regions was also considered: the isthmus region
and the septum ring region. To obtain a sustained AFL, the APD was be reduced using
the CRN membrane kinetics model, as in the previous section.
The simulation was conducted with a normal conductive tissue (ρ  150 Ωcm, c = 75
cm/s). Diﬀerent conduction regions were considered: the crista terminalis (ρ  80 Ωcm, c
= 115 cm/s), the pectinate muscle (ρ  80 Ωcm, c = 115 cm/s) the Bachmann’s bundle
(ρ  50 Ωcm, c = 135 cm/s), the isthmus region (ρ  500 Ωcm, c = 40 cm/s), the septum
ring region (ρ  800 Ωcm, c = 10 cm/s) and the septum region (ρ  500 Ωcm, c = 40
cm/s) [65–68].
The APD was reduced to 150 ms with a transient outward current (ICa,L), the calci-
um current (ICa,L) and the ultra rapid potassium (IKur) reduced to 20%, 50% and 10%,
respectively. The time-independent potassium (IKr) was increased ﬁrst to 600% and then
reduced to 250%, compared to 450% in the monolayer 3D model. Since a slow conduction
region was added, it was possible to increase the APD duration slightly. The isthmus region
allowed the macro-reentrant to slow down around TV and avoided the wavefront colliding
with its tail. The membrane kinetics was not modiﬁed in the CT. The initiation protocol
involved a line of conduction block as in the previous experiment.
Figure 3.6 represents schematically the AFL pathway in the presence of anisotropic
fast-conduction regions. First, the wavefront coming from the isthmus region crosses the
CT, which depolarizes (ﬁgure 3.6(A-B)). Second, due to the diﬀerence of action potential
durations in the CT and the tissue, the CT creates a line of functional block (ﬁgure 3.6(C-
E)). The action potential duration along the CT is much longer than in the tissue. So,
when a wavefront has performed a cycle around the IVC, it cannot go through the CT,
because it is still in the refractory period. Finally, the CT arrives in a resting state and the
wavefront can cross and depolarized it (ﬁgure 3.6(F)).
Figure 3.7 presents the TMPDM of the AFL in the 3D biophysical model. With the
APD modiﬁcation on the CT and the functional block, the CL was increased to 180 ms
(333 bmp). The depolarization of the CT is shown in ﬁgure 3.7(A-B). Consequently the
CT was blocked, and the wavefront propagated along the CT (ﬁgure 3.7(C-G)). Finally the
CT was repolarized and a new wavefront could cross it (ﬁgure 3.7(H)).
Despite the addition of major fast conduction structures and a slow conduction region,
this ﬂutter cannot be considered as a typical ﬂutter, because during the cycle, the functional
block is not always persistent. According to the literature, the CT should be always blocked
and no transverse conduction are possible during AFL [65–67]. This ﬂutter looks more like
a LLR ﬂutter, involving a reentrant circuit around the IVC and a superior circuit around
the SVC.
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Figure 3.6 – Atrial ﬂutter pathway using the 3D model. The pathway is indicated by arrows. (A)-(B)
Wave is anchored to TV and IVC and the wavefront crosses the CT. (C)-(E) CT functional block due
to the long action potential duration. (F) The CT is repolarized and the wavefront can cross it.
To remedy to this situation, the APD needs to be readjusted as shown in ﬁgure 3.8. In
the tissue, the currents ICa,L and IKr were reduced to 10% and in the CT, besides the two
previous currents, the current Ito, was reduced to 50%. The APD curve was complectly
ﬂattened.
The induction of the ﬂutter was initiated as done previously and furthermore the CT was
blocked momentarily (by setting the conductivity to zero). After initiation, the classical
circuit was established, the CT was unblocked and the AFL type I was maintained for
several cycles. After a while, the same mechanism as described in ﬁgure 3.6 became visible.
The instability of the ﬂutter around the CT may be explained by the fact that in the
present biophysical model, the conductivity of the CT is homogenous. In reality, myocardial
ﬁbers packed in parallel along the SVC and IVC exhibit rapid conduction in a longitudinal
direction, but very slowly in a transverse direction, with a ratio of 10:1 [69]. This remarkable
diﬀerence in conduction velocity is due to a high resistivity of side-to-side cell coupling [70],
related to a preferential distribution of gap junctions in end-to-end locations [71].
An alternative to creating a constant AFL type I, was to maintain the conductivity of
the CT region at zero and to initiat an AFL as previously described. The AFL obtained
followed a pathway such as that described in the literature. But this is unrealistic, because
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Figure 3.7 – Atrial ﬂutter using the 3D model: TMPDM. (A) Depolarization of the CT. (B) Repo-
larization of the CT and tissue. (C)-(G) Functional block of the CT. (H) CT is excitable.
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Figure 3.8 – Flutter on the multilayer 3D model: action potential and restitution curve using the
CRN membrane kinetics model. (A) Action potential. (B) Restitution curve. (1) Baseline model. (2)
Remodeled with ICa,L and IKr reduced to 10% in the tissue (3) Remodeled with ICa,L and IKr reduced
to 10% and Ito reduced to 50% in the CT.
CT would not recover its conductivity after cardioversion1 or during sinus rhythm.
1Cardioversion refers to the process of restoring the heart’s normal rhythm by applying a controlled
electric shock.
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3.3 Atrial ﬁbrillation in the biophysical model
In the following sections, various type of AF, which can be reproduced in the biophysical
model are brieﬂy reviewed (see more details in [5]). Three diﬀerent mechanisms of AF have
been reproduced with the model: chronic AF, meandering AF and cholinergic AF. It has
been decided not to consider ﬁring focus activity maintaining AF[72], which would have
required the design of a subset of the atrial tissue in order to achieve adequate automaticity,
or a rapid pacing of this region this region.
3.3.1 Initiation of atrial ﬁbrillation
Initiation of atrial ﬁbrillation was performed by means of an injection of intracellular current
(Istim = 80 µA/cm2) in a small region of 3 mm2 during 2 ms. Several clinical protocols
are possible [73, 74]:
• programme stimulation protocol (S1 − S2 − S3): three sites are selected and each
stimulus Si is delivered at each site with a diﬀerent timing;
• burst pacing protocol: periodic pacing of 20-50 Hz;
• ramp protocol: incremental pacing, until AF is detected.
In the biophysical computer model, in most of the cases, a burst pacing protocol is prefer-
able, because it does not need time adjustment between stimuli, which is a time consuming
task.
3.3.2 Perpetuation of atrial ﬁbrillation
Initiation of AF is not the only requirement of a biophysical model of human atria. It should
be able to produce a number of wavefronts and wavelets that are self-sustaining. The ﬁrst
source of instability and induction of wavelet breakup is a steep restitution curve [5, 28,
75, 76]. While spontaneous wave breaks are associated with an increase in the slope of
the restitution, AF is usually associated with a loss of rate adaptation and in general a
ﬂattening of the restitution dependence.
The second mechanism that can also lead to AF perpetuation is the inclusion of struc-
tural heterogeneities and gradients in APD. Kneller et al. [61] have recently developed a
two-dimensional membrane kinetics model of cholinergic AF. Their results suggest that
heterogeneities in acetylcholine concentration are suﬃcient to create ﬁbrillatory conditions
despite the complete loss of rate adaptation.
These mechanisms maintaining sustained AF (SAF) are used to simulate the diﬀerent
types of AF in the following sections.
3.3. Atrial fibrillation in the biophysical model 37
3.3.3 Chronic atrial ﬁbrillation
The ﬁrst type of AF that can be generated by the biophysical model uses the coarse surface
mesh (50,000 nodes, with a spatial resolution of ∆x = 0.6 mm ). A ﬁner mesh (100,000
nodes, ∆x = 0.4 mm) was used to check the accuracy and to ensure the absence of artifacts.
The membrane kinetics model used was the LRI model. This model was originally developed
to represent the electrical activity of ventricles.
The choice of the model was motivated by both the desire to reduce computation load
and the simplicity of the model, which involves only six internal currents. To approximate
the speciﬁc electrical properties of atrial cells, action potential duration (APD) was adapted
by adjusting channel conductances GNa to 16 mS/cm2, GK to 0.423 mS/cm2 and GSi to
0.085 mS/cm2, corresponding to the membrane current INa, IK and ISi, respectively (see
table 2.2). This setting corresponds to the baseline model (ﬁgure 3.9, curve (1)) with
a maximum slope of the restitution curve greater than 1, which allows the initiation of
AF [28, 77, 78]. After initiation, APD restitution plays a key role in maintaining sustained
AF. The restitution curve should be ﬂattened, therefore conductance channel GSi was set to
0.055 mS/cm2 (ﬁgure 3.9, curve (3)) with a maximum slope of the restitution curve being
smaller than 1, which allows the maintenance of a sustained AF [5].
Figure 3.10 illustrates the TMPDM during SAF. The main characteristic of this model
is very a short action potential duration (mean CL 75 ms); the percentage of exited tissue
ranges between 40% and 60% and the number of wavelets varies between 1 and 11. Based on
the latest information, it is shown that the number of wavelets does not indicate whatever
AF will self terminate or not. An abrupt change appears in the percentage of excited tissue
and number of wavelets (ﬁgure 3.10(L)). Thus, a single isolated wavelet may generate or
maintain a sustained AF. Conversely, multiple wavelets may block or lead to annihilation
of each other.
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Figure 3.10 – Chronic AF in isotropic tissue using the LRI membrane kinetics model. (A)-(H):
TMPDM during SAF. (I) Membrane potential computed in the middle of the anterior right atrium. (J)
Unipolar electrogram computed in the middle of the anterior right atrium. (K) Percentage of excited
tissue. (L) Number of wavelets.
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3.3.4 Meandering atrial ﬁbrillation
The second type of AF was reproduced using the CRN membrane kinetics model. This
model was designed to reproduce more realistically the human atrial cell electrophysiology.
The action potential duration is much longer than the LRI. SAF occurred only for a few
seconds [5], when it was initiated. In order to maintain SAF, the restitution curve should
be modiﬁed (ﬁgure 3.11, curve (2)) as proposed by Courtemanche et al. The currents Ito,
ICaL and IKur, were reduced by 80%, 30% and 90%, and IKr increased by 50%.
Figure 3.12 presents the TMPDM. Contrary to the previous model, this one presents
a lower rate and beat-to-beat interval as shown in ﬁgure 3.12(I,J). Note also the eﬀect of
alternance between a short and a long action potential. The percentage of excited tissue
could reach 80% mainly due to the long APD ranging from 150 to 200 ms (ﬁgure 3.11(B),
curve (2)). The reduced complexity in this simulated AF can be observed in the number of
wavelets that ranges between 1 and 3.
3.3.5 Cholinergic atrial ﬁbrillation
Several animal experiments used isolated atria with acetylcholine addition to initiate AF [79,
80]. Kneller et al. have recently developed a two-dimensional computer model of cholinergic
AF using canine atrial tissue [61]. This model based on the Courtemanche model, includes
additionally an acetylcholine-driven potassium current IK(ACh) to the list of membrane
currents (table 2.3). The parameter associated with this current allowing it to modify the
APD is gK(ACh) [5]. The resulting action potential has a triangular shape (ﬁgure 3.11(A),
curves (3,4)) and the restitution curve is almost constant (ﬁgure 3.11(B), curves (3,4)).
The presence of heterogeneities presumes to be an arrhythmogenic factor [81–83]. The
inclusion of some random heterogeneity patch size, in the range of 1.5 mm to 2.5 mm,
facilitates a ﬁbrillatory condition [5]. The ERP was set to 95 ms in the heterogeneity
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Figure 3.11 – Atrial ﬁbrillation restitution curve using the CRN membrane kinetics model. (A)
Action potentials. (B) Restitution curves. (1) Baseline model. (2) Remodeled for the meandering AF.
(3) Remodeled for the cholinergic AF with acetylcholine-driven potassium current gK(Ach) = 7 ms
−1.
(4) Remodeled for the cholinergic AF with acetylcholine-driven potassium current gK(ACh) = 25 ms
−1.
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Figure 3.12 – Meandering AF in isotropic tissue using the Courtemanche model. (A)-(H): TMPDM.
(I) Membrane potential computed in the middle of the anterior right atrium. (J) Unipolar electrogram
computed in the middle of the anterior right atrium. (K) Percentage of excited tissue. (L) Number of
wavelets.
region (dark region, in ﬁgure 3.13(A)-(H)) and 45 ms elsewhere.
Figure 3.13 displays the TMPDM of a cholinergic SAF, which was maintained thanks
to the heterogeneities. Those served as a stable source of wavelets reentries (mother rotor)
as indicated by an arrow on the left atrium appendage (ﬁgure 3.13(A)). The membrane
potential and the electrogram signal revealed a beat-to-beat interval around 90 ms (11
Hz), comparable to that of the chronic AF model (section 3.3.3). This similarity is also
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Figure 3.13 – Cholinergic AF in isotropic tissue using the Courtemanche model. (A)-(H): TMPDM.
(I) Membrane potential computed in the middle of the anterior right atrium. (J) Unipolar electrogram
computed in the middle of the anterior right atrium. (K) Percentage of excited tissue. (L) Number of
wavelets.
conﬁrmed by the percentage of excited tissue (≈ 50%) and the number of wavelets (≈ 5).
Note that around 2.4 s oscillation in the electrogram signal was observable (ﬁgure 3.13(J)),
induced by discontinuities between the tissue and heterogeneities [84].
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3.4 Conclusions
In this chapter several types of arrythmia simulated with the biophysical model have been
presented.
First, a low complex arrythmia involving only one macro-reentrant circuit was exposed.
It was initiated on the monolayer and multilayer 3D model. Second, more complex arryth-
mias characterized by several wavelets and fast rhythm were reviewed. Among these, there
was some unrealistic arrythmia which utilized acetylcholine to initiate and maintain AF,
which could only be found in animal experiments.
These diﬀerent types of arrythmia (atrial ﬂutter, chronic AF, meandering AF and cholin-
ergic AF) are used used in the remainder of the dissertation to measure the spatio-temporal
organization and to investigate atrial therapies.
Part II
Measures of organization
This second part describes several methods to measure and quantify the
spatio-temporal organization during atrial ﬁbrillation (AF). Its ﬁrst chapter (chapter
4) presents spatio-temporal measures of organization as derived from the analysis of
the electrogram signals. Classical signal processing methods are used to evaluate AF
complexity. The second chapter (chapter 5) is focused on AF activities at the cellular
level. The mechanisms responsible for AF perpetuation are analyzed.
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Spatio-temporal
organization 4
4.1 Introduction
DURING atrial ﬁbrillation (AF) several wavebreaks and reentries are involved, lead-ing to an irregular atrial activity. When studying the electrophysiology of AF, the
main interests are: the investigation of wavefront propagation, as well as the mechanisms
responsible for reentry and perpetuation of the arrythmia; the assessment of the electro-
physiological properties of the cardiac substrate from the perspective of optimizing atrial
therapies. Several intra and extra-atrial mapping techniques such as electrogram mapping,
basket catheters or high-resolution video imaging have been used to study the complexity
of the AF dynamics [85–89].
In the 1980s, Allessie et al. [59] mapped the cardiac electrical activity during AF and pro-
vided the ﬁrst experimental evidence supporting Moes multiple wavelets hypothesis [9, 90].
According to this hypothesis, during AF several wavefronts of electrical activity propagate
randomly throughout the surface of both atria, forming complex and ever-changing pat-
terns of electrical activity. Konings and colleagues [89], by using a high density epicardial
mapping system, described the activation pattern during AF in the free wall of the right
atrium. Several authors have suggested, but never proved, that there is a strict correlation
between organization and number of wavelets entering the atrial region close to the record-
ing electrodes [9, 90, 91]. It has been speculated that the likelihood of termination to a
normal rhythm is inversely related to the number of propagating wavelets.
The early methods were mainly based on measurements extracted from atrial rate and,
to a minor extent. Since there is no standard deﬁnition of organization, various approaches
have been adopted to collect AF recordings and several signal processing algorithms have
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been developed to quantitatively assess the spatial and temporal organization of AF. Those
latter approaches can be put into three diﬀerent groups: time-domain, frequency domain
and non-linear dynamics approaches [85]. These methods can be applied to a single signal
or to a set of signals measured at several positions.
One of the main advantages of a biophysical model is the possibility provided to access
each action potential computed at each node of the meshed surface. Using this information
once can: (1) evaluate and track the spatio-temporal evolution of the propagation, (2)
capture an endocardial electrogram at any location. These electrogram signal recordings
are used to compare with those obtained by electrophysiologists in experimental and clinical
studies.
In the ﬁrst part of this chapter, a high density mapping system is used to estimate the
local organization during AF. In the second part, the entire atrium is considered. This
approach is used to investigate the number of regions or electrodes necessary to quantify
AF complexity. Then measures of complexity are deﬁned, two of them based on principal
component analysis, in order to determine the number of electrodes needed on the surface
of the atria to access the dynamics of AF . Next, these measures are applied to monitor
the spatio-temporal evolution for diﬀerent situations: sinoatrial rhythm, chronic AF, me-
andering AF and cholinergic AF. In a later chapter (chapter 7), these methods are used to
measure AF complexity during atrial pacing as well.
4.2 Measures of organization
4.2.1 State of the art
Although most of the research dealing with automated processing and analysis of intracar-
diac signals has been devoted to methods and schemes for recognition and classiﬁcation of
cardiac arrhythmias in implementable devices, interest has recently grown for developing
methods aimed at electrophysiological investigations.
Several diﬀerent indices of signal complexity have been developed and applied to bio-
medical signals, and in particular to electrocardiograms or electrogram signals. These
methods have been applied to a single signal or to a set of recorded signals. The table 4.1
summarizes the main current methods used for the analysis of AF from intra-atrial signals.
These methods are grouped as time-domain, frequency domain and non-linear dynamics
approaches.
The main attempts to interpret the signal processing indexes in terms of electrophys-
iological properties or mechanisms use the concepts of organization, synchronization and
complexity. Unfortunately standard deﬁnitions of these terms in the context of the phe-
nomenon of AF do not exist and none of the various methods proposed in the literature
have yet demonstrated themselves to be useful for the identiﬁcation of regions sustaining
AF [85].
Besides these methods, other signal processing approaches such as pattern matching,
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Time domain
Botteron (1995) [86] Cross-correlation, space constant calculation.
Jais (1996) [92] Complex electrical activity and FF interval.
Sih (1999) [91] Adaptive transfer function estimation.
Barbaro (2000) [93] Comparison of time domain and frequency domain.
Censi (2000) [87] Recurrence plot analysis.
Frequency domain
Sahakian (1992) [94] Magnitude-squared coherence spectra.
Lovett (1997) [95] Coherence spectrogram.
Jalife (1998) [96] Spectral estimation.
Complex dynamics theory-based
Hoekstra (1995) [97] Correlation dimension and correlation entropy.
Pitschner (1998) [98] Fractal dimension.
Berkowitsch (2000) [99] Algorithmic complexity.
Table 4.1 – Main methods to analyze atrial ﬁbrillation.
wavelet-based methods, archetypal analysis, etc. are currently being investigated.
4.2.2 Local high density mapping
To study local organization during AF two standard methods are used in experimen-
tal setups: optical mapping [100] and electrical mapping [89]. Optical mapping enables
the visualization of the wavelets dynamics. The cardiac tissue is stained with ﬂuorescent
voltage-sensitive dye. By illumination, variations of membrane potential are recorded by
a high-speed CCD video camera. Electrical mapping focuses on the depolarization and
repolarization process. A set of electrodes are applied directly onto the epicardium or
endocardium and the electrical potential is recorded.
In the present study, a simulated electrical mapping system, developed by Jacquemet [5],
was used to emulate unipolar electrode recordings (section 2.3.3) in a manner similar to
that used by Konings [89] in experimental studies. The mapping system consists of an array
of 16 by 16 electrodes placed at 1 mm from the tissue on the right anterior atrial free wall
(ﬁgure 4.1). The distance between electrode pairs is 2.25 mm, and the mapped surface is
approximatively 11.4 cm2.
48 Chapter 4. Spatio-temporal organization
Figure 4.1 – Local high density mapping. The electrodes positions (16 x 16) are indicated by dots
and located at 1 mm from the tissue.
4.2.3 Global mapping
Since the atrial geometry is meshed with triangular meshes of diﬀerent spatial resolutions
(50’0000 or 100’000 nodes), it is not conceivable to consider the entire information resulting
from each node. To reduce the complexity of the analysis, the atria are split into regions of
equal area and electrodes are placed in the center of each region to record electrical activity.
The number of regions is deﬁned as:
Number of regions = 2Split level (4.1)
In this way, each atrium is split into 2Splitlevel−1 regions (ﬁgure 4.2). An iterative
procedure is used to split the tissue. Each iteration is designed to split an arbitrarily
shaped surface into two regions of equal area. It is based on the momentum of inertia (2nd
order) taken at the center of gravity of the surface. The momentum of inertia I of the
initial tissue patch is computed as:
I =
∫
V
ρ(x, y, z)
⎡
⎢⎣ y
2 + z2 −xy xz
−xy x2 + z2 −yz
xz −yz x2 + y2
⎤
⎥⎦ dxdydz, (4.2)
where ρ is the density, V the volume and x, y and z are coordinates relative to the center
of gravity of the tissue patch. Under the assumption of a constant monolayer thickness,
ρ is equal to 1 on the surface and 0 elsewhere. The three principal axes of the tissue are
found by computing the eigenvectors of the tensor. The plane that is orthogonal to the ﬁrst
principal axis of inertia, and contains the center of gravity, is described by ax+by+cz with
a, b, c corresponding to the coordinates of the center of gravity. Finally, the plane parallel
to the plane containing the center of gravity is selected. It separates the initial surface into
two regions of equal area (i.e. equal number of nodes).
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 (A) Split level 2  (D) Split level 5
 (B) Split level 3  (E) Split level 6
 (C) Split level 4  (F) Split level 7
Figure 4.2 – Global high density mapping with respect to split level. (A)-(F) Split level 2-7. The
center of gravity of each region where position of electrodes are place are marked by a dot.
4.2.4 Multidimensional signal analysis
To study local organization, multidimensional bipolar electrogram signals computed on the
surface of the high density mapping system are considered. A bipolar electrode is modeled
as the diﬀerence in electric potential between two points close to each other, i.e diﬀerence
between two unipolar electrode signals. Thus a set of 8 by 8 bipolar electrogram signals are
obtained. The correlation space-constant method (see next section), proposed by Botteron
et al. [86], are applied on the signals.
To access global organization, two sets of multidimensional signals are considered on
the split atrial model. The ﬁrst set is that of the unipolar electrogram signals computed
at the center of each region, 1 mm from the surface. The second set of multidimensional
signals uses these same signals, to which the ﬁrst three processing steps described in the
next section are applied. The electrogram signal sampling frequency is 1 kHz. Two diﬀerent
signal processing methods, principal component analysis and entropy, (see next section) are
associated with these signals to evaluate the complexity.
Correlation space-constant
Botteron et al. [86] proposed a measure of organization based on the maximum cross-
correlation between two pairs of signals. The procedure is composed of the following steps
applied on N digital signals xi(t), each one representing a bipolar electrogram recorded by
two electrodes located at di and sampled at 1 kHz:
• ﬁlter the signals with a third-order, zero-phase Butterworth band-pass ﬁlter with
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cutoﬀ frequency at 40 and 250 Hz;
• fake the absolute value of the ﬁltered signals;
• ﬁlter the signals with a third-order, zero-phase Butterworth low-pass ﬁlter with a
cutoﬀ frequency at 20 Hz;
• remove signal mean values and normalize. The resulting ﬁltered signal is called yi;
• correlation coeﬃcients: for each pair of signals yi and yj :
– compute the Euclidean distance di,j = ‖di − dj‖;
– compute the cross-correlation ci,j(τ) between yi and yj;
– the correlation coeﬃcient Ci,j is deﬁned as the maximal cross-correlation Ci,j =
max
τ
(ci,j(τ));
• plot a graphical representation: (1) group together the points with the same distance
di,j, (2) plot the pairs (di,j , Ci,j) and display instead the mean and standard deviation;
• ﬁt the function C(d) = e−d/δ to the data to determine the space constant δ.
An interesting property of this method is that the resulting space constant δ gives an
approximation of the average wavelength λ through the simple formula λ = 2π · δ (see
Botteron [86] and Jacquemet [5] for more details).
Principal component analysis and entropy
Principal component analysis (PCA) [101] (also called Karhunen-Love transform) involves
a mathematical procedure that transforms a number of (possibly) correlated variables into
a (smaller) number of uncorrelated variables called principal components. The ﬁrst prin-
cipal component accounts for as much of the variability in the data as possible, and each
succeeding component accounts for as much of the remaining variability as possible. The
objective of PCA is to discover or to reduce the dimensionality of the data set and to identi-
fy new meaningful underlying variables. The aim is to ﬁnd a set of M orthogonal vectors in
data space that account for as much as possible of the data’s variance. Projecting the data
from their original N-dimensional space onto the M-dimensional subspace spanned by these
vectors then performs a dimensionality reduction that often retains most of the intrinsic
information in the data. This technique is used in various ﬁelds such as signal processing,
biology and economy.
Let xr(t) be the unipolar electrogram computed in the middle of the region r at time t.
Let X(t) = [x1(t), ..., xN (t)]T , where N is the number of regions. In a stationary situation,
the estimation of the sample covariance matrix (CX) of X(t) provides an eﬃcient and
simple way to characterize how the vectors xr(t) are spatially related to each other. From
a symmetric matrix such as the covariance matrix, an orthogonal basis can be calculated
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by ﬁnding its eigenvalues and eigenvectors. The principal components are then given as:
MPC = ME ·X(t), where MPC and ME denote the matrix with the principal component
and eigenvectors, respectively.
The total energy captured in a principal component analysis decomposition of a numer-
ical or experimental data set is deﬁned as the sum of all eigenvalues (µ):
E =
N∑
k=1
µk, (4.3)
where µk is the kth eigenvalue of CX sorted in decreasing order. The relative energy
captured by the kth mode (or principal component), Ek is deﬁned by:
Ek =
µk
N∑
j=1
µj
. (4.4)
A ﬁrst measure of complexity used is (CEig95%), is deﬁned by:
CEig95% = min
{
k
∣∣∣∣∣
k∑
i=1
Ek  0.95
}
. (4.5)
CEig95% may be seen as an “eﬀective” dimension, i.e. the dimension of the hyperplane
the vectors are mostly conﬁned to. By neglecting the latest eigenvalues, 95% of the total
energy is conserved by the projection on the principal components.
The second measure, which is reminiscent of Shannon’s entropy [102], consists of com-
puting a pseudo-entropy of the same eigenvalues:
CEnt = −
N∑
l=1
(
µl∑N
k=1 µk
log
µl∑N
k=1 µk
)
. (4.6)
CEnt quantiﬁes the ﬂatness of the eigenvalue distribution. This measure is continuous,
whereas CEig95% is discrete. The entropy, as deﬁned by (4.6), measures the energy distri-
bution among the modes in the principal component spectra. The entropy is low when the
energy is concentrated in a few modes. A zero entropy indicates that only one eigenfunction,
with maximal energy, is needed to reproduce the dynamics. The entropy increases when
the energy spreads across a large number of modes, indicating complex behavior [103].
To study the time evolution of the complexity, the above measures are derived from
data within moving time windows of one second with an overlap of 0.5 s.
The two following sections present results on the measures of organization for several
types of simulated AF. First, spatial organization is measured locally and globally. Then
temporal evolution of this organization is analyzed.
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4.3 Spatial organization
4.3.1 Local high density mapping
Figure 4.3 presents results using the correlation space-constant method on the high density
mapping system. Four diﬀerent cases were analyzed: (1) sinoatrial rhythm, (2) chronic AF,
(3) meandering AF and (4) cholinergic AF. Electrogram signals were computed in a 8 by 8
grid of bipolar electrodes located in the right atrium free wall. During sinoatrial rhythm,
the correlation coeﬃcient was close to 1 and remained constant for all distances (1-4 cm).
During chronic AF, the correlation was signiﬁcantly smaller due to the multiple wavelet
reentries. The space constants of activation δ measured during chronic and meandering
AF were found to be respectively 1.27 ± 0.24 cm and 1.66 ± 0.24 compared to 1.84 ±
0.36 measured in humans [104]. The exponential curve for the meandering AF was close
to that of chronic AF, although the action potential of the latter was signiﬁcantly shorter.
During cholinergic AF, the space constant was approximatively 3.70 ± 0.70 cm, which was
higher than during chronic or meandering AF. This was at ﬁrst unexpected, since the ad-
dition of heterogeneities should increase wave breaks and reentries. But by analyzing the
transmembrane potential distribution map (TMPDM) of ﬁgure 3.13, it was found that a
mother wavelet anchored on the left atrium appendage was present. This wavelet generated
a periodic wavefront starting from the left atrium and passing through the right atrium,
occasionally producing wavebreaks due to heterogeneities. These induced at ﬁrst the gen-
eration of AF by breaking the wavefront into multiple wavelets due to a diﬀerence of action
potential duration in the tissue. However, heterogeneities favored wavelet anchoring and
generated a stable mother rotor, sweeping other wavelets oﬀ.
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Figure 4.3 – Spatial correlation at the anterior right atrium. 1 Sinoatrial rhythm. 2 Chronic AF.
3 Meandering AF. 4 Cholinergic AF. Means and standard deviations are respectively denoted by circles
and bars.
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4.3.2 Global density mapping
The complexity for the sinoatrial rhythm and for diﬀerent types of AF in terms of the
number of eigenvalues used to achieve 95% of the energy CEig95% and the entropy CEnt
were plotted as a function of the split level for unﬁltered signals and ﬁltered signals in
ﬁgure 4.4 and in ﬁgure 4.5, respectively. The curves presented are the average complexity
derived from 10 measurements of one second each.
The complexity increased with the number of regions even for a normal sinoatrial
rhythm, and saturated rapidly above split level three for unﬁltered electrogram signals,
as well as for the ﬁltered electrogram signals (ﬁgure 4.4, curve (1) and ﬁgure 4.5, curve
(1)).
In the case of atrial ﬁbrillation, CEig95% and CEnt increased with split level and
reached a plateau for split level six for the ﬁltered electrogram signals (ﬁgure 4.5, curves
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Figure 4.4 – Measure of complexity as a function of the split level using unﬁltered electrogram signals.
(A) CEig95%. (B) CEnt. 1 Sinoatrial rhythm. 2 Chronic AF. 3 Meandering AF. 4 Cholinergic AF.
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Figure 4.5 – Measure of complexity as a function of the split level using ﬁltered electrogram signals.
(A) CEig95%. (B) CEnt. 1 Sinoatrial rhythm. 2 Chronic AF. 3 Meandering AF. 4 Cholinergic AF.
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(2-4)). Split level six corresponds to 32 regions per atrium. The area of a tissue patch at
this split level is 1.3 cm2 and the distance between electrodes, placed in the center of each
neighborhood patch, is approximately 1.2 cm. Since there is not additional information
above split level six, this value was used to study temporal complexity evolution in the
next section.
4.4 Temporal organization
Figure 4.6 shows the temporal evolution of complexity for diﬀerent types of AF, using the
ﬁltered electrogram signals. A split level of six was used and a moving time window of one
second, with an overlap of 0.5 s, was used to estimate the covariance matrix (CX) on the
multidimensional signals. Four cases were studied: (1) sinoatrial rhythm, (2) chronic AF,
(3) meandering AF, and (4) cholinergic AF.
For the sinoatrial rhythm and the chronic AF, the measurements remained very stable
over time (ﬁgure 4.6, curves (1-2)). Meandering AF (ﬁgure 4.6, curve (3)) showed a larger
variation, in particularly between 0 and 5 s. After that, the complexity CEig95% and
CEnt were comparable but remained on average lower than to that of chronic AF. During
cholinergic AF (ﬁgure 4.6, curve (4)), the largest variations were visible. The complexity
CEig95% decreased to 10 and CEnt to 2 between 10 and 15 s. This instant corresponds
to a mother rotor anchored around an heterogeneity, which maintained a single principal
wavefront and a few wavelets. But between 0-5 s and after 18 s, the values of the complexity
measure were higher, meaning that several wavelets were present and that a mother rotor
was either not present or less eﬀective. This was conﬁrmed by observing the transmembrane
potential distribution map during the simulation.
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Figure 4.6 – Measure of complexity over time using ﬁltered electrogram signals. (A) CEig95%. (B)
CEnt. 1 Sinoatrial rhythm. 2 Chronic AF. 3 Meandering AF. 4 Cholinergic AF.
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4.5 Conclusions
In this chapter, measures of spatio-temporal organization during sinoatrial rhythm and
diﬀerent types of AF were investigated. High density mapping and a geometrical splitting
of the atrial geometry were shown to be eﬃcient ways of investigation local and global
activity during AF. To simplify the number of electrogram signals needed to quantify AF
organization, a geometrical splitting of the atria was used in order to ﬁnd an optimum
decomposition.
Three signal processing methods were presented to study the complexity of atrial ac-
tivity, two of them based on principal component analysis. Results show that using a split
level six corresponding to 32 regions per atrium was suﬃcient to capture AF complexity.
The corresponding region area is 1.3 cm2 and the distances between electrode localization
is 1.2 cm.
These measures were applied to diﬀerent cases: sinoatrial rhythm, chronic AF, meander-
ing AF and cholinergic AF, and several atrial activities were diﬀerentiated. By observing
the local and global activities, chronic AF and meandering AF exhibited less organized
activity during AF. However, cholinergic AF manifested higher organization during AF,
when there was a mother rotor nearby.
The methods presented will be used in the chapter 7 to quantify AF organization during
atrial electrical stimulation.
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Tracking of phase
singularities 5
5.1 Introduction
AS is now well known, atrial ﬁbrillation (AF) is a common form of cardiac arrythmia,characterized by rapid and irregular atrial activity. Current hypotheses about AFs
suggest that they are caused by: a rapid cell discharge, atrial foci, single reentry circuits,
or multiple functional reentrant circuits [105]. Regardless of the causes initiating AF, it is
always associated with the presence of rotating waves of electrical excitation. The centers,
or cores of these waves generate and maintain AF.
The application of electrical mapping and optical mapping methods to obtain high-
resolution recordings of electrical activities promises to improve considerably the under-
standing of AF mechanisms. When a wavebreak occurs thought the interaction of the
wavefront with anatomical or functional obstacles, a phase singularity (PS) appears (ﬁg-
ure 5.3), whereby electrical waves may rotate uninterruptedly and, in a self-sustaining
manner, give rise to high frequency electrical activity that propagates throughout the tis-
sue [106–109]. The concept of PS has contributed substantially to the current understanding
of mechanisms of spontaneous initiator and maintenance of reentrant arrythmia.
The wave of excitation rotating around a PS for one or more cycles is deﬁned as a rotor.
The identiﬁcation of these PSs is essential in order to be able to analyze the mechanisms
underlying AF in experimental or mathematical models. Understanding the mechanisms of
PS formation, and determining its location and lifespan can be important in the develop-
ment of eﬀective therapies. Eﬀectively, by isolating PSs using surgical ablations (chapter 6)
or by sweeping PSs oﬀ using electrical stimulations (chapter 7), it could be possible to
cardiovert AF into sinoatrial rhythm.
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In the 1990s, Jalife [110] provided evidence of PS being present in an isolated Lagendoﬀ-
perfused rabbit heart using a voltage-sensitive dye [111]. Since then, several biophysical
models have been developed to understand the mechanisms underlying PS formation. Until
now, PS localization and tracking have been studied on cell grids of varying sizes or on
biophysical ventricular models [77, 79, 106, 112–115].
However, neither the experiments nor current state-of-the-art models have been able
to examine the myocardial tissue during AF on human atria and neither they can identify
phase singularities at the core of the reentrant pathways.
This chapter presents a new approach to PS localization and tracking based on a realistic
atrial geometry meshed with triangular elements. This method is applied to several types
of AF (see chapter 3) which can be generated by the biophysical model and PS behavior is
observed in each type.
5.2 Phase singularity detection
5.2.1 Cardiac phase
The phase θ(r, t) is a cardiac variable which uniquely deﬁnes the state of a cell at any time t
and location r [107]. In the past, phase was most often deﬁned as the fraction of time elapsed
following the last activation or event [116]. However, during atrial ﬁbrillation all sites do
not undergo “full-blown” action potential. This makes the deﬁnition of the activation time1
diﬃcult. Therefore, Iyer et al. [117] proposed a deﬁnition of phase that is independent of
the activation time. According to this deﬁnition, two variables are needed to uniquely
calculate the phase. However, in practice, only one variable (the transmembrane potential
Vm) is typically recorded. The required two variables, namely Vm(r, t) and Vm(r, t + τ),
can be obtained from the single recorded signal Vm(r, t) by means of a delay embedding
technique [118].
The delayed embedding technique uses two variables obtained from the transmembrane
potential measured at the same site but with a time delay τ . The measurement at every
site generates a so-called reconstructed state space that is topologically equivalent to the
true state space [119]. Figure 5.1 illustrates schematically these two variables and the phase
θ(r, t).
The three tags A, B and C in ﬁgure 5.1 illustrate the relation between an action poten-
tial and its return map. The tag A represents the phases (0) and (1) described in chapter 2.
They correspond to a rapid change in the transmembrane potential Vm with respect to
time. Thereby for a ﬁxed value of τ , a small variation of Vm(t) may imply a large variation
of Vm(t + τ). Conversely, during the plateau tagged as B, Vm(t) remains relatively con-
stant. Therefore the slope of the corresponding segment of the return map is small. The
repolarization, tag C, is represented approximatively by a decreasing linear segment. This
1The activation time for a given position is deﬁned as the time instant at which the membrane cell
depolarizes.
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Figure 5.1 – Illustration of the meaning of the phase variable. (A) Transmembrane potential. (B)
Return map (Vm(t + τ) vs. Vm(t)) of this action potential for a phase value θ.
representation may vary depending on the time delay τ such as illustrated in ﬁgure 5.2. If
τ is a very small value and tends to zero, the return map tends to be a linear curve with
a slope of 1. Conversely, if τ is set to a too large value, the depolarization phase is not
detected in the phase map (ﬁgure 5.2(D), τ = 200 ms).
The mathematical expression of the phase variable is given by (5.1) and is illustrated
in ﬁgure 5.1(B):
θ(r, t) = arctan
(
Vm(r, t + τ)− V ∗(r)
Vm(r, t)− V ∗(r)
)
. (5.1)
Here V ∗(r) is the potential at the chosen origin of the phase space and r = (x, y, z)
represents the coordinates of the analyzed site. The resulting phase has a value between
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Figure 5.2 – Phase space in function of diﬀerent time delay τ . (A) Transmembrane potential. (B)-(D)
Phase space with τ = 1, 5, 200 ms, respectively.
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-π and π. Any point in the state space around which the closed loop trajectory shown
in ﬁgure 5.1(B) revolves exactly once, is an admissible origin point for computing the
phase [117]. In this study, two diﬀerent points were tested as possible origins:
• the spatial average point, i.e. the mean value of Vm(r, t) over all recorded sites (i.e at
each node of the meshed surface) at time t;
• the temporal average point, i.e. the mean value of Vm(r, t) over all time records at
site r.
The two phase maps resulting from using both of these two origins were very similar.
Only a slight shift of one node on the mesh was sometimes observed. This shift corresponds
to a maximum distance diﬀerence in the range of 200 to 400 µm depending on the spatial
discretized geometry used (50 000 nodes or 100 000 nodes). Since the computation of the
spatial average point is less computationally expensive, it was set as the default origin for
the localization algorithm developed.
A phase map shows the instantaneous value of the phase θ(r, t) for all cells situated at
a site r = (x, y, z) at a particular instant t. Figure 5.3 shows an action potential map and
its corresponding phase map. The tip of the spiral is visually more explicit and intuitive in
the phase map than in the action potential map. This visual eﬀect results from two causes:
• the output value range is smaller for the phase map than for the action potential
map. Indeed, the phase has mainly three distinct values corresponding to the three
possible states shown in ﬁgure 5.3(B). Thereby the diﬀerences are clearer;
• the transmembrane potential Vm is not a unique measure of the state of the heart.
Indeed, during an action potential, a value of say -30 mV is reached twice: once during
the depolarization and once during the repolarization.
20 [mV]−30−80 π0−π
(B) (A) 
TV 
MV
TV 
MV
PS 
Figure 5.3 – (A) Transmembrane potential distribution map. (B) Its corresponding phase map. The
localization of the PS is indicated by an arrow.
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5.2.2 Phase singularity
A unique spatial pattern exists near the tip of the rotating wave: the phase at the exact
center is undeﬁned whereas neighboring sites exhibit a continuous progression of the con-
verging phase value. This center is commonly named the phase singularity. Speciﬁcally,
a PS is present where the line integral of the gradient of the phase around a site equals
±2π [117]. The sign indicates the direction in which the associated wavefront circulates
around the singularity with respect to the close path of the integral. The mathematical
deﬁnition of a PS is:
r
∣∣∣∣
∮
∇θdl = ± 2π (5.2)
5.3 Localizing of phase singularities
At ﬁrst sight, any path used for the integration to detect a PS is conceivable, on condition
that the path is closed. Since the biophysical model is meshed with triangular elements,
the path along the side of the triangle is considered. The length of the discretized closed
path varies according to the situation:
• in the general case, the discretized closed path is the path along three nodes consti-
tuting a triangular mesh. Such a mesh is the smallest element deﬁning the monolayer
structure of the biophysical atrial model. The main advantages are the detection of
all potential PSs and the avoidance of implementing an algorithm to deﬁne a path;
• if a wavelet extremity is anchored around a macroscopic anatomical obstacle, the
discretized path encloses all the nodes constituting the contour of the vein oriﬁce or
valve ring.
These two cases are discussed in the following sections.
5.3.1 Phase singularities in the general case
Generally, the PSs are located in the conductive tissue of the atria. The location of a
potential PS is within the triangular mesh whose corners have three diﬀerent possible phase
values, as depicted in ﬁgure 5.1. In other terms, the sum of the three phase diﬀerences
obtained at each segment of this triangular element must be equal to the value of ± 2π
(see (5.3)). The phase diﬀerences can be associated with a vector linking two adjacent
nodes. Indeed, this value is related to a direction and a location.
Automatic PS localization is performed using (5.2). The continuous closed integral is
changed into a discretized sum of phase diﬀerence values expressed in (5.3). Since the sum
is made over a closed path computing N nodes, the phase θi+1 computed for the last node
corresponds to the ﬁrst element of the discrete sum as illustrated in ﬁgure 5.4. Phase values
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θi are computed using (5.1). The time delay τ is set to 5 ms for the whole process, as this
value is suﬃcient to detect the membrane depolarization. Prior being used in (5.3), each
computed phase diﬀerence 
θi is rescaled in the [−π,+π] interval according to (5.4).
N∑
i=1
ψ (
θi) =
N∑
i=1
ψ (θi+1−θi) = ± 2π (5.3)
with θN+1 = θ1 and ψ(θ) =
⎧⎪⎪⎨
⎪⎪⎩
θ + 2π, if θ < −π
θ − 2π, if θ ≥ π
θ, otherwise
(5.4)
The three nodes forming a triangular mesh are always accessed in a counterclockwise
order as illustrated in ﬁgure 5.4. This ordering corresponds to that of the biophysical
model viewed from the epicardium surface. Thus, the sign of the discrete sum in (5.3),
which indicates the chirality1 is consistent for the whole set of meshes.
5.3.2 Phase singularities anchored around a macroscopic anatomical ob-
stacle
Through simulation it has been noticed that sometimes one wavelet extremity gets anatom-
ically anchored around a vein oriﬁce, a valve ring, or the fossa ovalis. The PS of this wavelet
is close to the center of the macroscopic anatomical obstacle. However, these anatomical
barriers are holes and are therefore not deﬁned by meshes. The potential singularities
cannot be detected by the standard case method presented above.
Instead of summing over a triangular mesh, the sum over all the nodes deﬁning the
contour of a particular vein oriﬁce or valve ring is computed.
In order to be consistent with the discretized sum over a triangular element, the sum
has to be computed over a closed path traversed in a counterclockwise direction. Since the
contour of macroscopic anatomical obstacles is set by nodes randomly stored, the contour
nodes have to be ﬁrst sorted into an appropriate order.
1The chirality associated with a PS corresponds to the direction in which its wavefront circulates around
the singularity.
1 1 1 1(x ,y ,z ,t) θ θ=
2 2 2 2(x ,y ,z ,t)θ θ= 3 3 3 3 (x ,y ,z ,t)θ θ=
1θ∆ 3θ∆
2θ∆
Figure 5.4 – Phase variable on a triangular mesh.
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The direction of rotation around the vein oriﬁce or valve ring is deﬁned by the sign of
the scalar product between the vectors −→n triangle and −→n cross. The sign is positive/negative
if the direction is clockwise/counterclockwise. The vector −→n triangle is the processed normal
of a triangle touching the vein oriﬁce or valve ring. The vector −→n cross is the cross product
between the vectors −→v 1 and −→v 2 deﬁned by three points at the macroscopic anatomical
obstacle as shown in ﬁgure 5.5. In this ﬁgure the direction of −→v 1 or −→v 2 has to be changed
in order to make their cross product point in the counterclockwise direction.
Several singularities can be anatomically anchored at the same time around a macro-
scopic anatomical obstacle, this applies especially for the large mitral and tricuspid valve
(TV) rings. The number of anchored singularities is determined by the result of the dis-
cretized sum in (5.3). Indeed, the quotient of the division by 2π indicates how many PSs
are temporally attached to it. Yet, pairs of singularities with opposite chirality, which are
both anchored at the macroscopic level, are ﬁltered out. This case can be considered as a
unique wave whose wavefront is split into two because of the obstacle. Figure 5.3(B) shows
such a case since only one wavefront crosses the TV.
In order to easily store the position of a PS (formed by three node) in the case of a
wavelet extremity anchored around a vein oriﬁce or a valvular ring, among three nodes
forming the PS, the one on the oriﬁce is selected. The wavefront is deﬁned by the phase
maximum. It is easier to track the tip of the wavelet when it leaves the obstacle.
The procedure to detect the contour nodes at the wavefront is as follows:
1. a suitably chosen threshold is applied to the phase map (the nodes at the macroscopic
anatomical obstacle that are larger than the threshold form non-touching subsets as
depicted in ﬁgure 5.6(1-4));
2. the maximum phase value of every subset is stored as a PS.
This process is launched only if the absolute value of the discrete sum described in (5.3)
is only larger than 2π.
When the process is used, false PS detection may occur due to the fact that this pro-
cedure is unable to diﬀerentiate between a wavelet anchored around an oriﬁce by one of
its extremities and a unique wavelet temporally splits into two because of a macroscopic
anatomical obstacle. Figure 5.6 illustrates such situation: PSs (1) and (4) are true PSs,
trianglen
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Figure 5.5 – Determination of the rotation direction at veins/valves using the sign of a scalar product.
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Figure 5.6 – Illustration of true and false phase singularities detected when several singularities are
anchored around a macroscopic anatomical obstacle. (PSs are numbered).
conversely, PSs (2) and (3) constitute false PS detections. The latter are discarded by the
tracking algorithm. The discrimination method is presented in section 5.4.
5.4 Tracking of phase singularities
In addition to localizing the PSs, we are also interested in automatically tracking them over
a certain period of time.
The tracking method consists of ﬁnding the best association for each pair of successive
phase maps so as to generate trajectories. The best association criterion allows the algo-
rithm to successfully connect two successive representations of the same phase singularity
computed for t and t + τ . This criterion relies on two parameters: the minimal distance
and the sign of the discrete sum.
The minimal distance between two consecutive representations of the same PS is the
main parameter. Indeed, most of the time, the displacement of PSs between two successive
phase maps is small. This distance is computed between the gravity centers of every
triangular element enclosing a PS. In the case of wavelets anchored around a vein oriﬁce or
a valve ring, the distance is computed from the coordinates of the single node considered
as a potential PS.
The sign of the discrete sum (5.3) is a advantageous parameter in the cases where several
PSs detected are close. It helps the tracking algorithm to connect the correct pairs since
the sign of the PS remains unchanged. As mentioned in section 5.2.2, the sign indicates
the direction of rotation at the wavelet tip with respect to the counterclockwise direction
of the closed path.
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The tracking method was made more robust against incorrect connections by adding
the following three constraints:
• a limited search area;
• an exclusion of PSs already assigned;
• a constraint on the creation of new trajectories starting at a vein oriﬁce or valve ring.
These three criteria are discussed in the following sections.
5.4.1 Limited search area
The search for the minimal distance is only processed within a search circle centered on the
PS to be connected. Such a limitation is needed for example, to solve the case in which
a PS “dies” due to a collision with a wavefront or an anatomical obstacle at time t but is
however wrongly linked to a relatively close one at time t + τ .
Zou et al. suggested a radius of 5 mm in [115]. In this study, a radius of 7.63 mm
was chosen in accordance with the following experiment. First, the PSs detected on the
Luo-Rudy I (LRI) membrane kinetics model, which shows the highest wavelet reentrant,
without any distance limitation, are associated by the algorithm. Then a manual check was
performed to determine the maximal distance beyond which the link proved to be incorrect.
Large distances between PSs can occur in the case of wavelet collisions, when spirals
became anchored to a vein oriﬁce or valve ring, or in the case of PS jumps. The leap is due
to repolarization wavebacks. This phenomenon is illustrated in ﬁgure 5.7 on the right of
the PS indicated by an arrow. Because the cells constituting this refractory front cannot
momentarily be stimulated, a part of the activation wavefront (on the right side) stops
while the other part, not located in this refractory area, continues to move. Thus the PS
appears to jump.
(A) (B) 
Figure 5.7 – Illustration of a jumping phase singularity (indicated by an arrow) due to the to a
refractory front. (A) Phase map at instant t. (B) Phase map at instant t + τ
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5.4.2 Exclusion of PSs already assigned
This constraint is especially needed when a PS vanishes. It prevents the linking of a PS
detected at time t, with a PS detected at time t+ τ if the latter has already been assigned
to another, much closer, PS. The expression “much closer” is mathematically expressed by
an arbitrarily chosen distance.
Figure 5.8 demonstrates the utility of the constraint on already assigned PSs. The
algorithm allows a “fusion” between PSs (1) and (2) (ﬁgure 5.8(A)), since they are approx-
imately at the same distance, ﬁgure 5.8(B). Nevertheless, the constraint avoids the merging
of PS (3) with PS (1+2) between ﬁgure 5.8(B) and (C). Indeed PS (1+2) has to die out:
the collision between two wavelets propagating in the same direction generates a junction
of the two wavefronts.
5.4.3 Constraint on the creation of new trajectories starting at vein ori-
ﬁce or valve ring
As explained in section 5.3, the PS localization procedure may detect false PSs. The false
positive detections are at the intersection points of a unique wavelet split in two, due to
macroscopic anatomical obstacles. This error is common in the largest anatomical barriers
such as the valve rings when using the LRI membrane kinetics model, which has the highest
number of wavelets during AF.
The implemented method consists of eliminating new starting trajectory points accord-
ing to the number of potential PSs detected around macroscopic anatomical obstacles. If
a new trajectory is identiﬁed and starts at a vein/valve at which more than two PSs have
been previously detected, it will not be considered as a new PS.
Figure 5.9 shows an example of the use of this constraint. When a single wavelet is
split because of the superior vena cava (SVC), the two new resulting PSs ((2) and (3) in
ﬁgure 5.9(B)) are not considered because of the constraint. They are therefore not assigned
to any trajectory. In ﬁgure 5.9(C) two wavefronts fuse, which results in a merging at the
SVC contour (PS (1+2)). Since only two PSs from the same sign are detected, the inferior
(A) (B) (C) 
1 2 1+2 3 3
Figure 5.8 – Illustration of an exclusion of a PS already assigned.(PSs are numbered and valve/vein
are in dark). (A) Association of PS (1) and (2). (B)-(C) PS (3) cannot be associated to PS (1+2),
because PS (1) and (2) are already associated.
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PS (3) is considered as a trajectory starting point. The PS (3) trajectory will continue in
Figure 5.9(D) and successive phase maps.
(A) (B) (C) (D) 
1 1 2 
3 3 
1+2 
3 
Figure 5.9 – Illustration of the constraint on the creation of new trajectories starting at an oriﬁce.
(PSs are numbered and valve/vein is in dark).
Figure 5.10 illustrates an example of a weakness of the constraint imposed on the cre-
ation of new trajectories starting at a vein oriﬁce or valve ring. An error occurs when a
unique wavelet, which will be split by a macroscopic anatomical barrier, is just tangent to
the obstacle during one phase map as shown in ﬁgure 5.10(B). Since the limitation is only
active when more than two PSs have previously been detected, no constraint is applied in
such a case. Therefore the tangent point is wrongly assimilated as a true PS and a new
trajectory is currently initiated.
(A) (B) (C) 
1 1 2 1 2 
3
Figure 5.10 – Illustration of the weaknesses on the constraint on the creation of new trajectories at
vein oriﬁce or valve ring. (PSs are numbered and valve/vein in dark).
The next three sections present results of the PS localization and tracking applied on
AF simulations in the biophysical model of the atria. The analysis is mainly focused on
simulations performed with the chronic AF model (section 3.3.3) using the LRI membrane
kinetics. First, the total amount of PSs localized on the surface of the atria is estimated.
Next, the tracking algorithm is used to study PSs lifespan. The eﬀect of the fast inward
current Isi, on the LRI membrane kinetics, on the PSs evolution, is investigated. Finally,
the spatial distribution of PSs is considered with the inclusion of heterogeneities, with the
Courtemanche-Ramirez-Nattel (CRN) membrane kinetics model.
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5.5 Number of PSs during simulated AF
The time course of the number of detected PSs per phase map during simulated AF was
studied in detail. In most of the cases, it oscillated between 2 and 30 (ﬁgure 5.11), which
corresponds to 1 and 15 wavelets respectively.
Figure 5.11 shows the three main steps of an AF cycle for chronic AF (LRI membrane
kinetics model, Gsi = 0.055 mS/cm2 with the 50 000 nodes geometry, see section also 3.3.3),
through the number of detected PSs per phase map. The number of detected PSs for the AF
model after a certain delay, increased until it saturated once the ﬁbrillation was sustained.
Then it oscillated around the steady state value. The same comportment was observed
by Clayton and Holden in [112] in their study of the number of ﬁlaments1 detected in the
ventricles. However the increase rates were diﬀerent in the two experiments: a rise of 45
ﬁlaments was observed by Clayton in 0.7 s (64 PSs/s) whereas an increase of 30 PSs was
detected in 2 s (15 PSs/s) in the biophysical model during chronic AF.
During initiation of AF on the right atrium (RA) by a burst pacing lasting 3 seconds,
the mean number of PSs on the RA was 4.4, while it was 0.7 on the left atrium (LA). During
steady state, the average numbers of PSs on the RA and LA were comparable, namely 6.9
PSs and 6.3 PSs, respectively. Finally, when the AF self-terminated, a decreasing average
number of PSs on the LA of 3.5 was observed and 7.2 PSs for the RA.
The number of detected PSs per phase map seemed to depend mainly on the number of
detected PSs in the RA as shown in ﬁgure 5.11 (in gray). This behavior can be explained
by the fact that all simulated AFs were initiated near the sinoatrial node. This explains
the predominant role of the RA. In addition, the RA had a larger tissue surface area than
the LA and the location, number and size of macroscopic anatomical obstacles was more
favorable to wavelet propagation.
At times relatively large variations in the number of detected PSs per phase map were
observed. These ﬂuctuations can be explained by considering the ﬁbrillation phenomenon
1The wavetip of a functionally reentrant wave in two dimensions generalizes to a linear ﬁlament in three
dimensions.
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Figure 5.11 – Time evolution of phase singularities (PSs on the RA are indicated in gray and PSs
on the LA are indicated in black). (A) AF initiation by a burst pacing on the RA. (B) Sustained AF. (C)
Three seconds before self-termination.
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as a model of an extension of a population with a limited amount of resources. At the
beginning, the few wavelets propagated freely and collided with each other, which increased
their numbers. However, once a certain amount was reached, areas of refractory period were
well spread out over the whole surface. Thereby the propagation of wavelets was harder
and most of them vanished, which in turn decreased the area of tissue in the refractory
period.
As depicted in ﬁgure 5.11(B) the number of PSs per phase map ﬂuctuated around a
mean value and it was observed that an odd number of PSs were present. This phenomenon
is explained in the next section. The eﬀect of the slow inward current Gsi on the number
of detected PSs is presented as well.
5.5.1 Parity of the number of detected PSs
It was ﬁrst thought that the number of detected PSs was always even. Indeed wavelets have
always two extremities, so two PSs. In addition, potential incorrect detections at macro-
scopic anatomical obstacles, as explained in section 5.4, mostly come by pairs. However,
it was noticed that sometimes an odd number of PSs was detected. This relates to two
phenomena:
• as shown in ﬁgure 5.12, it may happen that two diﬀerent wavelets have a common
extremity lying within the septum. The septum is the relatively small tissue area that
the left and the right atria have in common. Thus, every wavelet traveling from one
atrium to the other has to pass through it;
• incorrect detections at macroscopic anatomical obstacles may also happen separately.
As explained in section 5.4 (ﬁgure 5.10), when a unique wavefront is just tangent to
a macroscopic anatomical obstacle at which another wavefront is already anchored,
the constraint imposed on the creation of new trajectories does not eﬀectively work.
Figure 5.12 – Phase singularities in the septum.
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5.5.2 Eﬀect of the slow inward current Gsi
The slow inward current Gsi is used as a control parameter to aﬀect the action potential
duration (APD) and restitution properties of the LRI membrane kinetics model (as ex-
plained in chapter 2). Decreasing Gsi reduces the APD and ﬂattens the restitution curve.
As the APD decreases, the mean number of wavelets increases, due to the decrease in
wavelength [105]. Such a trend can be observed in ﬁgure 5.13.
In this study, the initiation phase was separated from the perpetuation phase. Sustained
AF was induced using burst pacing protocol near the sinoatrial (SAN) region on the baseline
membrane kinetics model. The SAN region was paced at a frequency of 20 Hz. After 3
seconds, pacing was stopped and the system evolved freely. Simulated sustained atrial
ﬁbrillation (SSAF) lasting longer than 5 minutes was obtained. Ten seconds after the
beginning of the initiation, the value of the control parameter Gsi was instantaneously
reduced to produce shorter APDs and a ﬂatter restitution curve. Five seconds of SSAF for
each Gsi value (0.085, 0.08, 0.075, 0.070, 0.065, 0.060 and 0.055) was selected to compute
statistics.
In ﬁgure 5.13, statistical boxes have lines at the lower quartile, median, and upper
quartile values. The whiskers are lines extending from each end of the box to show the extent
of the remaining data. For display purposes, the values higher than 45 were considered as
outliers and consequently not displayed. Several (up to 300) of these outliers were found for
a slow inward current Gsi of 0.080 and 0.085 mS/cm2. These outliers are due to artefacts
usually appearing during the initiation or self-termination of the AF simulated with high
values of Gsi. During the AF initiation process by rapid burst pacing near the SAN, when
a wavefront collides with the wave tail of the previous one, its front brooked in several
wavelets for only one phase map.
As expected, the higher the Gsi value is the lower the median value of the PSs.
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Figure 5.13 – Distribution of PSs with respect to Gsi.
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5.6 PSs lifespan during simulated sustained AF
The lifespan of the PSs, detected through diﬀerent simulated sustained atrial ﬁbrillations,
were computed. In all the cases studied, the lifespan of most PSs and of their respective
wavelets were found to be very short. One resulting histogram is shown in ﬁgure 5.14. The
mean cycle length (CL) is indicated. The cycle length is the time interval between two
successive action potential upstrokes. This duration is calculated by using the spatial and
temporal average of beat-to-beat intervals recorded at each node of the meshed surface.
The lifespan distribution of ﬁgure 5.14 is skewed to the left, with 17% of PSs lasting only
5 ms or less. The mean lifespan of PSs was 94 ± 127 ms with a range of 5 ms (one phase map)
to 1260 ms. A total of 69% lasted less than one mean CL (87 ms). The majority of these
short-lived PSs were the result of break-up of broad spatiotemporal periodic waves [106].
Based on the experimentation made on six Langendorﬀ-perfused sheep hearts in the
presence of acetylcholine, Chen et al. [79] obtained signiﬁcantly diﬀerent results: the mean
lifespan of their detected PSs was 19.5 ± 18.3 ms with approximately 98% existing less than
the average cycle length. Such results could be compared by modifying the LRI membrane
kinetics model. The LRI membrane kinetics model with Gsi = 0.080 mS/cm2 was the
closest model to the results of Chen et al.
5.6.1 Eﬀect of the slow inward current Gsi on PSs lifespan
The results illustrated in table 5.1 were found after suppressing all PS durations less than
or equal to 5 ms (one phase map). For all simulations processed with the LRI membrane
kinetics model, AF initiations were identical.
In table 5.1, the percentage of PSs lasting more than one CL decreased from 31% to 0.2%
as the slow inward conductance Gsi was augmented. As already explained, the reason is the
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Figure 5.14 – Lifespan histogram providing from a simulation using the LRI membrane kinetics
model. The dash line indicates the position of the mean cycle length (CL).
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Membrane Kinetics Model % of PSs > CL CL Av. Lifespan Long. Lifespan
LRI (Gsi [mS/cm2])
Gsi = 0.055 31.1% 87 94±127 1265
Gsi = 0.060 26.3% 99 78±89 710
Gsi = 0.065 15.8% 125 66±72 590
Gsi = 0.070 9.7% 131 53±61 545
Gsi = 0.075 5.6% 150 46±58 570
Gsi = 0.080 3.4% 167 46±42 260
Gsi = 0.085 0.2% 232 36±39 245
Table 5.1 – PSs lifespan for diﬀerent values of Gsi for the LRI membrane kinetics model.
augmentation of the CL and hence so of the APD which leads to an augmentation of the
area of refractory tissue. Consequently, at the same time, the limit separating short-living
from long-lasting PSs is increased and the tissue becomes potentially more excitable.
5.6.2 Origin of long-lasting PSs
Some of the PSs are long lasting. One of the reasons is illustrated in ﬁgure 5.15. It displays
the collision between two wavefronts with PS(1) and PS(2) trajectories. Whereas no doubt
exists for PS(2), one could hesitate about the trajectory of PS(1). Indeed, two cases are
most probable:
• the wavelet tip PS(1) in ﬁgure 5.15(C) is a new PS. The appearance of this new PS
is due to the split of one wavelet;
• the PS(1) is the same over the three ﬁgures 5.15(A-C). This continuation is the result
of the merging of two wavefronts with a part of the left-situated wavefront between
ﬁgure 5.15(B-C).
(A)
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Figure 5.15 – Illustration of provenance of long-lasting PSs.
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Since both situations are equal, the continuation solution was chosen arbitrarily for im-
plementation simpliﬁcation. If the ﬁrst case is chosen, an algorithm on wavefront detection
and tracking should be implemented, which was not studied in this work.
5.7 Spatial distribution of PSs
5.7.1 PS localization on a homogenous surface
In order to study the distribution of PSs on the epicardial surface of the atria, the chronic
AF model was used (section 3.3.3). Fibrillation was initiated by a burst pacing near the
sino-atrial node for 3 s at a frequency of 20 Hz. Following simulated sustained AF (10
s after the beginning of burst pacing), PSs were localized and tracked during 5 s. The
coordinates of all PSs were recorded and displayed on the surface of the atrial geometry.
Figure 5.16(A-F) presents the trajectory of PSs with a lifespan longer than 100 ms, 300 ms,
500 ms, 700 ms, 900 ms and 1000 ms, respectively. As expected, longer PS lifespans were
mainly located on the RA, conﬁrming the previous result (section 5.5) that higher numbers
of PSs were found on the RA. The LA, due to its small area, does not allow long lifespans.
The longest lifespan recorded (table 5.1) was localized around the left superior pulmonary
vein.
 (A) Lifespan > 100 ms
 (B) Lifespan > 300 ms
 (C) Lifespan > 500 ms
 (D) Lifespan > 700 ms
 (E) Lifespan > 900 ms
 (F) Lifespan > 1000 ms
Figure 5.16 – Phase singularities localization during sustained AF using the LRI membrane kinetics
model. (A) Trajectories > 100 ms. (B) Trajectories > 300 ms. (C) Trajectories > 500 ms. (D)
Trajectories > 700 ms. (E) Trajectories > 900 ms. (F) Trajectories > 1000 ms.
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5.7.2 PSs localization on an inhomogeneous surface
Three types of inhomogeneity were applied: (1) homogenous, (2) anisotropic and (3) het-
erogeneous. A ﬁber structure was included, based on histological data [5]. The anisotropy
ratio between the longitudinal σl and transverse σt conductivities was set to 9:1 [5]. Het-
erogeneities were included, as previously described in section 3.3.5.
Diﬀerent types of AF model using the CRN membrane kinetics model were used in
these experiments. The meandering AF model (section 3.3.4) was used in the homogeneous
and the anisotropic surface. The cholinergic AF model (section 3.3.5) was implemented on
the heterogeneous surface. A period of ﬁve seconds of sustained AF was selected for each
example of inhomogeneous surface in the PS analysis.
Table 5.2 presented results for the diﬀerent types of inhomogeneity using the CRN
membrane kinetics model. The CRN meandering AF model (see section 3.3.4) was specially
developed to approximate the human atrial cells. Its action potential duration is longer
than the LR1 membrane kinetics model and thus the meandering AF model is harder to
ﬁbrillate. Its percentage of PSs lasting less than one mean CL (table 5.2, homogenous)
was closer to the value obtained by Chen et al. in [79] than the LR1 membrane kinetics
model (table 5.1). Nevertheless, its mean PS lifespan was still too high. The addition of
anisotropy did not aﬀect signiﬁcantly either the percentage of PSs longer than CL or the
average lifespan. However heterogeneity increased the percentage of PSs longer than CL
and their average lifespan. Furthermore, the membrane kinetics model used in addition to
heterogeneity was the cholinergic AF model (section 3.3.5). Such a model has a very short
APD, which allows easy maintenance of reentries.
Figure 5.17 presents the spatial localization of the diﬀerent types of inhomogeneity
included and the trajectories of PSs. The histogram of the lifespans is also displayed.
For a homogeneous surface, PSs were uniformly distributed on both atria. Inclusion of
anisotropy caused PS trajectories to be predominantly oriented along ﬁbers, especially
on the right atrium. Adding heterogeneity, PSs were detected around the discontinuity
islands. Since they were rotating around these islands, the long lifespan of these found for
the Heterogeneity I (table 5.2) was very long (5000 ms).
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Inhomogeneity % of PSs > CL CL Av. Lifespan Long. Lifespan
CRN membrane kinetics model
Homogenous 0.9% 274 30±47 815
Anisotropy 0.5% 253 32±39 340
Heterogeneity I 14.3% 74 48±139 5000
Heterogeneity II 19.6% 89 57±109 1310
Table 5.2 – PSs lifespan for diﬀerent types of Inhomogeneities.
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Figure 5.17 – Phase singularities trajectories for diﬀerent types of inhomogeneities. Cycle length as
indicated by the dashed lines in the lifespan histograms.
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5.8 Conclusions
In this chapter, a new tool is described, which has been developed for a better understanding
of the relatively unknown process of arrhythmias and in particular, atrial ﬁbrillation.
The work was largely divided into three main steps: First the automatic localization
of phase singularities, then their tracking, and ﬁnally the analysis of the obtained results.
Their tracking was used to determine their favorite spatial location and lifespan during dif-
ferent simulations such as AF initiation, sustained AF and AF self-termination. Simulations
were performed using several variants of the Luo-Rudy I and the Courtemanche-Ramirez-
Nattel membrane kinetics model, as well as with the inclusion of diﬀerent inhomogeneities.
Through all simulations it was found that most PSs were mainly located close to the
large anatomical obstacles (MV, TV, SVC and IVC). The long-living PSs were clustered
in space over the right and left atrium free wall. Through the analysis, it was observed
that the PS lifespan depended on the membrane kinetics used for simulations. Relatively
large diﬀerences in the lifespan distribution were noticed (from 31% to 0.2% of PSs lasting
more than one cycle length). The addition of heterogeneities favored PS anchoring and
long lifespan.
The algorithms developed in this study are robust and suitable for studying AF on the
biophysical model of human atria. The PS localization process proposed is dedicated for
a surface meshed with triangular element. The method proposed is a promising tool to
localize and track PSs and can be used to classify several types of pathology associated
with AF.
Part III
Therapies
The third part concerns the therapy methods investigated processes to cardiovert and
prevent atrial arrhythmias. Its ﬁrst part (chapter 6) deals with surgical ablation, a
common clinical procedure. The second chapter (chapter 7) of this part focusses on
more recent techniques using low electrical energy stimulation.
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Surgical and catheter
ablation 6
6.1 Introduction
ABLATION is a surgical procedure that cures atrial ﬁbrillation by interrupting thesustained wavefronts that cause the abnormal heart rhythm. The surgical act involves
making incisions in one or both atria. When the incisions heal, scar tissue forms, which
blocks any abnormal sustained wavefront. In so doing, it corrects all major problems
associated with atrial ﬁbrillation: it stops atrial arrhythmia, it restores normal rhythm
between the atria and the ventricles, and it preserves the ability of the atria to contract on
its own. Present day ablation procedures can eliminate tachyarrhythmia with success rates
between 70% and 100% and complication rates of < 1% to 2% [120].
In the 1980s several surgical procedures were introduced [121–123]. After one decade of
experimental studies Cox et al. proposed an extremely eﬀective ablation pattern based on
the concept of a maze, namely the Maze-III procedure [124–126]. The Maze-III is used for
patients, who need valve replacement. This procedure requires an open-heart operation. It
necessitates a cardiopulmonary bypass that consists of the excision of the atrial appendages,
isolation of the pulmonary veins, and creation of a narrow, tortuous path of atrial tissue
by carefully placed incisions. This directs the sinus node impulses across the atria to the
atrioventricular node. The incisions are placed so that no area is wide enough to sustain
multiple reentry circuits, and thus atrial ﬁbrillation cannot occur.
Over the past ten years, the development of new surgical instruments with energy de-
livered through catheters, provide an alternative to surgical ablation. These techniques
are less invasive and the source of energy delivered by the catheters has several sources:
radiofrequency (RF) , cryoablation, laser and ultrasound [127]. The ﬁrst generation of
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RF energy used in ablation techniques creates a burn in heart tissue, thereby destroying
the areas of the heart generating AF. This burn can cause swelling and narrowing of the
pulmonary vein (PV) openings, sometimes resulting in what is called PV stenosis. Also,
particles of burnt tissue debris from RF ablation may get into the blood stream, causing
blockages and even strokes. Current RF ablation techniques use cooled-tip and low wattage
catheters to avoid these problems. Cryoablation, by freezing heart tissue rather than burn-
ing it, has the potential of eliminating the swelling (stenosis) after ablation. Laser and
ultrasound methods, by not damaging the surface of heart tissue, have the potential of
eliminating the damaged tissue debris that may get into the bloodstream when using RF
ablation.
Based on the maze operation and other compartmentalization of speciﬁc anatomical
features, diﬀerent series of lesion patterns were suggested. An ideal pattern should prevent
AF with the minimum number of ablation lines of minimal length, while allowing for a
good contraction of both atria during sinus rhythm. This optimal ablation pattern is still
unknown [128, 129]. Atrial ablation with ligation of the atrial appendages reduces atrial
function relative to normal controls in sinus rhythm [130]. The clinical signiﬁcance of this
reduction has not yet been accurately assessed. Transthoracic Doppler echocardiography
has been the most frequently used method of measuring atrial contraction after AF surgery,
although its clinical usefulness has not been established [131].
Evaluation of the various lesion patterns is usually performed in clinical studies or in
animal experiments. The main drawbacks of animal experiments are the diﬃculty of access-
ing the whole atria and the diﬀerences between animal and human hearts. An alternative
is the use of a biophysical model of AF to evaluate the eﬀect of diﬀerent ablation patterns
and to bring insight into the underlying mechanisms. Compared to clinical and animal
studies, this approach has the advantage of repeatability of experiments under controlled
conditions. This approach is discussed in this chapter.
In the ﬁrst part, simulations of several standard maze and simpler surgical/RF pro-
cedures are presented applied on the chronic AF model (section 3.3.3). The second part
evaluates the eﬀect of imperfections in the standard Maze-III procedure and in the isolation
of pulmonary veins is studied. In the third part, several isolations of the pulmonary veins
procedure are analyzed. In the fourth part, comparison with clinical study is performed.
Finally, an ideal ablation pattern based on the Maze-III is proposed at the end of this
chapter.
6.2 Modelling ablation patterns
This section presents the diﬀerent ablation patterns used during this work. First the im-
plementation of the ablation line is described. Then the diﬀerent ablation patterns are
introduced: standard mazes, simpler surgical/RF ablation patterns, isolation of the pul-
monary veins and an ideal ablation pattern. Third, imperfect ablation lines are added in the
Maze-III, in the pulmonary veins isolations and in the Mini-Maze proposed by Ruchat [132],
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which is used for the comparison with clinical study.
6.2.1 Ablation lines implementation
Ablation lines are therapeutic interventions that can be easily simulated in a computer
model of atrial ﬁbrillation [133, 134]. In the biophysical model, surgical/RF ablation lines
are simulated by setting the conductivity tensor to zero between the cardiac cells located on
both sides of the ablation line. The lines obtained correspond to ideal ablation lines, con-
tinuous and transmural (monolayer surface). To build an ablation line in the geometry, two
nodes of the triangular mesh are selected (ﬁgure 6.1(A)). A principal vector is constructed
between the starting node (S) and the end node (E). Vectors
−→
SE from the starting node
to its neighbor nodes (Ni) are computed. Each vector is projected on the principal vector
and the vector with the largest projection value is selected as the new starting node (S′)
(ﬁgure 6.1(B)). The principal vector is then updated with this new node (ﬁgure 6.1(C)).
The procedure is repeated until the end node is reached. Finally, the nodes which are
selected during the iteration are part of the ablation line and their conductivities to their
neighbors are set to zero (dashed line in ﬁgure 6.1(D)).
6.3 Simulated ablation patterns
6.3.1 Standard maze patterns
The objective of this section is to outline the diﬀerent surgical procedures that have formerly
been used in the treatment of atrial ﬁbrillation. Four typical maze procedures, including
the standard Cox’s Maze-III, were tested. For which a high success rate was reported
(> 90%) [129], in which both surgical and RF catheter procedures were included. The
Figure 6.1 – Ablation line implementation: (A) Selection of the starting node and the end node. (B)
Update of the starting node. (C) Selection of neighbors node. (D) Nodes on the ablation line.
82 Chapter 6. Surgical and catheter ablation
ablation lines are reported as black lines on the MRI geometry in ﬁgure 6.2. Ablation line
lengths, total boundary lengths (including ablation lines, valves and veins boundaries) and
isolated areas are also indicated. The range of line lengths and isolated regions are highly
variable, from 21.7 cm to 45.2 cm, and from 9.7 cm2 to 32.2 cm2.
The Maze-III (ﬁgure 6.2(A)) procedure isolates the region around the pulmonary veins
(PVs), the left appendage (LA) and right appendage (RA), which represents approxima-
tively 20% of the entire atrial surface. The radiofrequency maze (RF-Maze, ﬁgure 6.2(B))
presented by Sie in [135] is inspired by the previous one but instead of having the PVs ful-
ly encircled by ablation lines, the right superior and inferior pulmonary veins are isolated
separately from the left superior and inferior pulmonary veins. The main diﬀerence lies in
the technique used to create ablation lines. The Maze-III is performed by surgical incisions
and undergoing an open-heart surgery, whereas the RF-Maze use RF ablation, which is
less invasive and time-saving. The radial incision approach maze (RIA-Maze, ﬁgure 6.2(C))
proposed by Nitta in [136] is a quite new experimental maze procedure which involves less
isolated areas, allowing thus a better contraction of the atria. The particularities of this
maze, as its name indicates, are the two radial ablation lines on the left atrium that do not
 (A) Maze−III
45 / 78.5 / 32.2 (19.9%)
 (B) RF−Maze
45.2 / 78.7 / 28.9 (17.9%)
 (C) RIA−Maze
37.3 / 85.2 / 9.7 (6.1%)
 (D) BAP−Maze
21.7 / 55.3 / 17.6 (10.9%)
 (E) Mini−Maze
35.5 / 38.8 / 36.6 (22.8%)
Figure 6.2 – Standard maze patterns. Under each pattern: ablations length (cm) / total boundaries
due to ablation lengths and perimeters of natural obstacles such as veins and valves (cm) / isolated tissue
surface (cm2) (percentage) are indicated. (A) Cox’s Maze-III procedure. (B) Radiofrequency modiﬁed
maze procedure. (C) Radial Approach maze. (D) Bilateral appendage preserving maze. (E) Mini-Maze
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isolate the pulmonary veins. The bilateral appendage-preserving maze procedure (BAP-
Maze, ﬁgure 6.2(D)) suggested by Isobe in [137] preserves the two appendages, which are
presumed to contribute to atrial transport and atrial natriuretic. More recently, Ruchat
and co-workers [132] have proposed the Mini-Maze procedure (Mini-Maze, ﬁgure 6.2(E)).
It is based on the Maze-III but involves only LA compartmentalization
6.3.2 Simpler surgical/RF patterns
Eleven less invasive patterns (ﬁgure 6.3) were also evaluated. Among these, some reﬂect
the most commonly used in the clinic. The ﬁrst row in ﬁgure 6.3 involve right atrial
ablation lines only: a single ablation line through the isthmus between the inferior vena
cava (IVC) and the tricuspid valve (TV) (ﬁgure 6.3(A)), a single ablation line between the
superior vena cava (SVC) and IVC (ﬁgure 6.3(B)), and a combination of the two previous
patterns (ﬁgure 6.3(C)). Two ablation patterns are limited to the left atrium: ablation
lines connecting all four pulmonary veins (ﬁgure 6.3(D)), and ablation lines completely
isolating the pulmonary veins (ﬁgure 6.3(H)). The six remaining ablation patterns involve
both atria (ﬁgure 6.3(E-G) and ﬁgure 6.3(I-K)). The estimated total length of the ablation
lines, approximated by the Euclidian distance between nodes arbitrarily placed along the
line, ranges from 1 cm for the simplest pattern (ﬁgure 6.3(A)) to 45 cm for the Maze-III
pattern of ﬁgure 6.2(A). The ablation patterns on the third line in ﬁgure 6.3 include a
 (A) IO  (B) SIVC  (C) IO+SIVC
 (D) LL  (E) LL+IO  (F) LL+SIVC  (G) LL+IO+SIVC
 (H) PV  (I) PV+IO  (J) PV+SIVC  (K) PV+IO+SIVC
1/48.9/0 3.5/51.4/0 4.5/52.4/0
7.5/55.4/0 8.5/56.4/0 11/58.9/0 12/59.9/0
25/58.6/11.5(7.2%) 26/59.6/11.5(7.2%) 28.5/62.1/11.5(7.2%) 29.5/63.1/11.5(7.2%)
Figure 6.3 – Simple surigical/RF patterns.Under each pattern, ablations length (cm) / total bound-
aries due to ablation lengths and perimeters of natural obstacles such as veins and valves (cm) / isolated
tissue surface (cm2) (percentage) are indicated. (A) Isthmus only, IO. (B) Sup./Inf. vena cava line, SIVC.
(C) IO and SIVC, IO+SIVC. (D) Left line only, LL. (E) Left line and Isthmus, LL+IO. (F) Left line and
Sup./Inf. vena cava line, LL+SIVC. (G) Left line, Isthmus and Sup./Inf. vena cava line, LL+IO+SIVC.
(H) Pulmonary ablation lines, PV. (I) PV and IO, PV+IO. (J) PV and SIVC, PV+SIVC. (K) PV, IO
and SIVC, PV+IO+SIVC.
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complete isolation of the pulmonary vein region, implying that no electrical activity can be
propagated from the pulmonary veins to the atria. The isolated area is 11.5 cm2, i.e. 7.2%
of the whole atrial tissue. For the Maze-III procedure of ﬁgure 6.2(A), the isolated area is
32.2 cm2, i.e. 19.9% of the whole atrial tissue.
6.3.3 Isolation of the pulmonary veins
Pulmonary vein isolation (PVI) is commonly used to treat AF [72, 138]. Increasing the
size of the isolated area possibly eliminates more foci and prevents them from triggering
AF. However, larger isolated areas may be a substrate for atrial ﬂutter (AFL) by creating
narrow conduction isthmuses or anchoring sites. PVI was implemented in diﬀerent patterns
with increasing surface of excluded tissue. Figure 6.4(A-C) presents three diﬀerent sizes of
circular PVI: (A) Individual PVI 5 mm from ostia (10 cm2 excluded area); (B) Individual
PVI 7.5 mm from ostia (17 cm2 excluded area) and (C) Individual PVI 10 mm from ostia
(26 cm2 excluded area) virtually resulting in posterior LA isolation.
Instead of having PVs individually isolated, some techniques isolate the PVs two by
two [139]. Figure 6.4(D-F) presents three patterns with diﬀerent distances d (d = 5, 2.5
and 0 mm) between the set of isolated PVs.
The pattern of ﬁgure 6.4(D) was also combined with linear ablation lines: a roof line
between the two PV isolation areas in the upper left atrial region (ﬁgure 6.4(G)), a left
 Excluded surface around the PVs
 (A) 5 mm  (B) 7.5 mm  (C) 10 mm
 Combined 2x2 PVs
 (D) d=5 mm  (E) d=2.5 mm  (F) d=0 mm
 Combined 2x2 PVs + Linear lines
 (G) Roof line  (H) Lateral line  (I) Roof+Lateral lines
Figure 6.4 – Isolation of the pulmonary veins.
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isthmus line connecting the left PV isolation area and the mitral valve (ﬁgure 6.4(H)), and
both previous lines (ﬁgure 6.4(I)).
This study determines the eﬀect of the distance d (d = 5, 2.5 and 0 mm) between the set
of isolated PVs (ﬁgure 6.4(D-F)). For each linear lesion a conduction gap (see section 6.4)
of 3 mm was also introduced in the middle of the line to evaluate the incidence of AFL.
6.3.4 Proposition of an ideal ablation pattern
The surgical Maze-III is the gold standard for the treatment of AF; however because of tech-
nical diﬃculties and high risks, less invasive ablation alternatives are investigated clinically.
The present study identiﬁes such alternative patterns. Figure 6.5 presents six diﬀerent
modiﬁed Maze-III procedures. Progressively ablation lines were implemented respective-
ly around pulmonary veins (PV), left atrial appendage (LAA), left atrial isthmus (LAI),
Cosio’isthmus (CI) and intercaval lines (SIVC), deﬁning progressively modiﬁed Maze III
patterns: MMP1=PV, MMP2=MMP1+LAA, MMP3=MMP2+LAI, MMP4=MMP3+CI,
MMP5=MMP3+SIVC, MMP6=MMP5+CI.
6.4 Imperfect ablation lines
In clinical procedures, RF ablation lines are sometimes applied only to the endocardial side
and the ablation lines may be incomplete. This introduces gaps allowing atypical ﬂutter or
ﬁbrillation recurrence. Figure 6.6 depicts the two types of problems. The ﬁrst one is due to
a discontinuity in the ablation line when the surgeons misalign two lines. The second one is
the non-transmurality during RF ablation. If the energy delivered by RF or cryo -ablation
is too low or the time of energy application on the tissue is too short, non-transmurality
can occur.
 (A) MMP1
15.1 / 44.9 / 17.6 (10.9%)
 (B) MMP2
23.7 / 53.5 / 27.3 (17.0%)
 (C) MMP3
26.1 / 55.9 / 27.3 (17.0%)
 (D) MMP4
27.1 / 56.9 / 27.3 (17.0%)
 (E) MMP5
29.6 / 59.4 / 27.3 (17.0%)
 (F) MMP6
30.6 / 60.4 / 27.3 (17.0%)
Figure 6.5 – Modiﬁed Maze III patterns. Under each pattern, ablations length (cm) / total boundaries
due to ablation lengths and perimeters of natural obstacles such as veins and valves (cm) / isolated tissue
surface (cm2) (percentage) are indicated.
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Figure 6.6 – Ablation gap types. (A) Discontinuity gap. (B) Non-transmural gap.
6.4.1 Incomplete Maze-III procedure
To reproduce these phenomena, discontinuities in the Maze-III ablation patterns were sim-
ulated. The ﬁrst discontinuity (Gap I in ﬁgure 6.7) was placed along the ablation line
connecting the pulmonary veins and the mitral valve annulus and the second (Gap II in
ﬁgure 6.7) along the ablation line connecting the upper pulmonary veins. Four gap widths
(1.3, 1.7, 2.4, and 3.0 mm) were simulated in the middle of the ablation line; the widest gap
was also tested at both extremities of the ablation line. This protocol allowed the study of
the eﬀect of gap width and position separately with a minimum number of simulations.
6.4.2 Incomplete linear lesion in pulmonary veins isolation
For each linear lesion of the pulmonary vein isolations(ﬁgure 6.4(G)-(H)) a conduction gap
of 3 mm was also introduced in the middle of the line. The objective was the study of AFL
incidence.
6.4.3 Incomplete ablation line in clinical study
Further simulations were performed to compare the results obtained on the biophysical
model with clinical data. The comparison is based on a simpliﬁed Maze-III procedure us-
ing RF ablation (Mini-Maze, ﬁgure 6.2(E)). This pattern has already been applied to 46
Gap 2
Gap 1
45 / 78.5 / 32.2 (19.9%)
Figure 6.7 – Imperfect Cox’s Maze-III procedure. Ablation lines are marked by dark lines and positions
of introduced gaps are indicated by arrows. Gap 1 and Gap 2 have a gap width of either 1.3 mm, 1.7 mm,
2.4 mm and 3.0 mm. Ablations length (cm) / total boundaries due to ablation lengths and perimeters of
natural obstacles such as veins and valves (cm) / isolated tissue surface (cm2) (percentage) are indicated.
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patients with permanent drug refractory AF [132] and it was implemented in the biophys-
ical model. The RF left atrial compartmentalization was performed during mitral valve
repair or replacement in which the patients were divided into two groups: Group I with
endocardial RF application only (20 patients) and Group II with both endo and epicardial
RF application (26 patients). Both groups of patients were similar in terms of age, AF
duration and left atrial size. Group II was modelled using the Mini-Maze of ﬁgure 6.2(E)
with perfect ablation lines, while Group I was simulated in the biophysical model with a
gap width of 3 mm on the left isthmus to mimic non-transmurality of the ablation.
6.5 Simulation protocol
6.5.1 Initiation of AF and application of ablation patterns
Before being able to test the diﬀerent ablation patterns on the biophysical model, sustained
AF needs to be initiated (see chapter 3). To this end, the SAN region was paced at a
frequency of 20 Hz. After 3 seconds, pacing was stopped and the system evolved freely.
Episodes of simulated sustained atrial ﬁbrillation (SSAF) lasting longer than 5 minutes
were obtained. To obtain suitable and random initial conditions (IC), several episodes of
SSAF were selected with at interval of 1 s after the end of the burst pacing (i.e. 10 s
after the beginning of burst pacing) for the application of the ablation patterns (further
details on the ICs are discussed in section 6.5.2). These patterns were applied abruptly,
after which the time to AF termination (TAFT) was documented. If no termination was
observed within 30 seconds the ablation was considered as unsuccessful. This process was
repeated for each of the ablation patterns studied.
For the perfect Maze-III maze procedure, a total of 118 simulations were performed
with initial conditions selected successively with an interval of 1 s during sustained AF.
For each of the three other standard maze patterns (ﬁgure 6.2(B-D)), the other 11 simpler
ablation patterns (ﬁgure 6.3(A-K)), and the pulmonary vein isolation patterns (ﬁgure 6.4),
20 simulations were performed using the ﬁrst 20 ICs used for the Maze-III protocol.
To evaluate the eﬀect of imperfect ablation lines, the 118 initial conditions previously
selected for the perfect Cox’s Maze-III procedure were also used to simulate discontinuities
in this pattern (gaps as shown in ﬁgure 6.3). Next, 20 and 26 time instants respectively
were selected to simulate the Min-Maze ablation in Group I and Group II (ﬁgure 6.2(E)).
For the PVI patterns, 30 ICs were selected to simulate gap in the additional line of the two
pulmonary veins isolation patterns (ﬁgure 6.4(G-H)). Finally, 40 simulations were performed
for the deﬁnition of the appropriate ablation pattern in modiﬁed Maze-III (ﬁgure 6.5(A-F)).
TAFT values for the simulations ranged from 0.25 to 30 s. The computation time was
approximatively 1 h for 1 s of simulation on a standard PC (Pentium-III 1.4 GHz).
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6.5.2 Measure of organization
The state of before the application of the ablation patterns was characterized by two vari-
ables. The ﬁrst variable is the percentage of excited tissue, i.e. percentage of nodes with
an action potential above a ﬁxed threshold (-60 mV). The second variable is the number
of wavelets, deﬁned as the number of connected regions of excited tissue (see chapter 3).
Figure 6.8(A) shows the time course of these two variables as observed in the biophysi-
cal model. The percentage of excited tissue evolved in a range from 25.3% to 72.2% and
the number of wavelets from 1 to 11. The correlation coeﬃcient between the percentage
of excited tissue and the number of wavelets was -0.53. The time course of these vari-
ables exhibited a stationary nature. This was conﬁrmed by comparing these curves to the
corresponding ones observed at a latter time interval (ﬁgure 6.8(B)).
To evaluate the eﬀect of each ablation pattern, the average beat-to-beat interval (AB-
BI) over time was computed at each node of the mesh just after the application of the
ablation patterns. The distribution of these values was displayed as a map on the surface
of the atria. A small ABBI value means short action potential durations inducing re-entries
and rapid multi-wavelet breaks, whereas a large ABBI value means long action potential
durations leading eventually to an atrial cardioversion. ABBI values were documented for
each ablation pattern either for the simulation having the longest time to AF termination
value or for an unsuccessful termination.
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Figure 6.8 – Initial conditions selected for the application of ablation patterns. Percentage of excited
tissue and number of wavelets with respect to time. (A) First initial conditions: IC.1 to IC.6. (B) Last
initial conditions: IC.113 to IC.118.
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6.6 Impact of initial conditions
All of the 118 simulations of the Cox Maze-III procedure were successful in stopping AF,
with a mean TAFT equal to 1.3 s ± 0.8 s (mean ± standard deviation). Figure 6.9(A) and
ﬁgure 6.9(B) show respectively the percentage of excited tissue and the number of wavelets
before application of the Cox Maze-III procedure with respect of the TAFT. The results
suggest that there is no signiﬁcant correlation between AF termination and the percentage
of excited tissue or the number of initial wavelets. This means that a simple isolated
wavelet that is not blocked by the ablation lines may generate or maintain a sustained
atrial ﬁbrillation. Conversely, an initial state having several wavelets may rapidly lead to a
short TAFT value, because these wavelets can block or annihilate another.
6.7 Comparison of the eﬃciency of ablation patterns
The present section present results of ablation procedures applied on chronic AF simulations
(section 3.3.3) in the biophysical model of the atria. First, the results of standard mazes are
presented. Second, a comparison of simpliﬁer ablation patterns patterns is exposed. Third,
results on imperfect Maze-III procedure are discussed. Fourth, isolation of pulmonary veins
patterns are investigated, as well as the eﬀect of gap in these patterns. Fifth, a comparison
with a clinical study is performed. Finally, result obtained with the ideal ablation pattern
is presented.
15 25 30 35 40 45 50 55 60 65
1
2
3
4
5
Percentage of excited tissue
TA
FT
 [s
]
 (A)
1 2 3 4 5 6 7 8 9 10
1
2
3
4
5
Number of initial wavelets
TA
FT
 [s
]
 (B)
Figure 6.9 – (A) TAFT vs. percentage of excited tissue. (B) TAFT vs. number of initial wavelets.
The boxes have lines at the lower quartile, median, and upper quartile values. The whiskers are lines
extending from each end of the box to show the range of the data.
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6.7.1 Standard maze patterns
The percentages of successful conversion for the four standard maze patterns of ﬁgure 6.2
are summarized in table 6.1. The ABBI values were computed for each ablation pattern
and their distributions are shown in ﬁgure 6.10 with grey color code: ABBI value ranged
between 70 ms (in a dark grey color, i.e. short action potential) and 140 ms (in a light
grey color, i.e. long action potential) corresponding to frequencies of 14.3 Hz and 7.1 Hz,
respectively. Among the ablation patterns achieved, the most eﬃcient pattern remains
the standard Cox’s Maze-III procedure, with an AF termination success rate of 100% and
the smallest mean TAFT value of 1.3 s ± 0.8 s. The RF-Maze, which is quite similar to
the Maze-III procedure has also a success rate of 100% with a mean TAFT only slightly
longer (1.6 s ± 0.8 s). The two other maze patterns (RID-Maze and BAP-Maze) which
have isolated regions approximately decreased in half with regard to the Maze-III, have
as a consequence an increase of their mean TAFT. As expected, the larger the isolated
surface, the shorter the time to AF termination is. The residual surface did not induce
wavelets reentries. This eﬀect is conﬁrmed by the distribution of the ABBI value on the
surface of the atria. The RID-Maze and BAP-Maze obtained a low ABBI value (∼ 90 ms)
on the left atrium and right atrium, meaning a short action potential between each wave
front. With the RID-Maze procedure, it appeared some unsuccessful cardioversions lead
to an uncommon ﬂutter around the left appendage (ﬁgure 6.11), not reported in clinical
data [136].
Among the simulated ablation patterns, the most eﬃcient is the Maze-III procedure
with a success rate of 100% and the smallest mean TAFT value of 1.3 ± 0.8 s. This
ablation pattern is able to terminate AF independently of the initial states in the tissue at
the moment of application of the lines.
The success rate obtained is in agreement with clinical data, where the complete surgical
Maze-III pattern had the highest long-term success rate ranging from 80 to 99% [129,
140–142]. Limitations of this surgical maze necessitate the performance of an open-heart
surgery, the time-consuming nature of the procedure and the related complications. RF
ablation represents a less invasive alternative. However the surgical Maze-III procedure is
technically diﬃcult to reproduce using RF due to frequent discontinuities in the ablation
Patterns Mean TAFT Suc. Termination Flutter
Maze-III 1.3 ± 0.8 s 100% 0%
RF-Maze 1.6 ± 0.8 s 100% 0%
RIA-Maze 4.7 ± 2.7 s 75% 25%
BAP-Maze 4.6 ± 3.5 s 100% 0%
Table 6.1 – Mean TAFT for the standard maze procedure patterns.
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70 87.5 105 122.5 140
 (A) Maze−III  (B) RF−Maze
 (C) RID−Maze  (D) BAP−Maze
 (E) Mini−Maze
100% 25.0%
100% 100%
88.0%
ABBI [ms]
Figure 6.10 – Percentage of success rate and distributions of the average beat-to-beat intervals
(ABBI) for each of the standard maze procedures (ablation lines and isolated regions are resented in
dark):
lines, especially if ablation is performed from the endocardial side only.
6.7.2 Simpler surigical/RF patterns
The percentages of successful conversion for the 11 ablation patterns of ﬁgure 6.3 and the
gold standard Maze-III procedure (ﬁgure 6.2(A)) are summarized for comparison in table 6.2
and ordered by decreasing values of the percentage of successful termination. Four groups
can be distinguished: (1) a group with a success rate of 100%, (2) a group with a success
rate from 80% to 95%, (3) a group with a success rate from 60% to 65%, and (4) a group
with a success rate from 20% to 25%. The more complex the ablation patterns, the lower
the TAFT values. It should be noted that there is a large standard deviation in TAFT
values for all ablation patterns. The best result with the shortest TAFT is obtained by the
standard Maze-III procedure.
The corresponding distributions of ABBI are shown in ﬁgure 6.12. ABBI values ranged
between 70 ms (in dark grey) and 140 ms (in light grey) corresponding to frequencies of
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t = 13100 ms
t = 13120 ms
t = 13140 ms
t = 13160 ms
t = 13180 ms
t = 13200 ms
t = 13220 ms
t = 13240 ms
Membrane potential [mV]
Figure 6.11 – RID-Maze: Uncommon ﬂutter around left appendage. (ablation lines are dark marked
and wave front are in gray color level.):
14.3 Hz and 7.1 Hz, respectively. The ablation patterns with a minimum number of lines
led to low values of ABBI, indicating no decrease in the rate of AF. The ablation patterns
isolating the pulmonary veins (ﬁgure 6.12(H–K)) led to a higher left atrial ABBI (> 100
ms) indicating longer intervals between activations. Only the standard Maze-III procedure
resulted in a high ABBI in both atria (ﬁgure 6.10(A)).
As expected, the ablation pattern with only a 1 cm right isthmus line (IO in ﬁg-
ure 6.12(A)) was the least eﬃcient, with a success rate of 20% and many wavelets still
present on both atria after ablation. This limited pattern, originally intended to cure atrial
ﬂutter [143], has very little eﬀect on the more complex dynamics of AF. This may be ob-
served in the distribution of ABBI with low values ranging from 80 to 90 ms (ﬁgure 6.12(A))
indicating the absence of slowing down in atrial activity. The second least eﬀective pattern
is the one with an ablation line between both venae cavae (SIVC in in ﬁgure 6.12(B)). This
pattern is not commonly used in clinical interventions but is presented here as part of a
systematic study. It led to a success rate of 25% and a distribution of ABBI slightly dif-
ferent from the previous pattern, namely with ABBI values lower than 80 ms in the region
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Patterns Mean TAFT Suc.Termination
Maze-III 1.3 ± 0.8 s 100.0%
PV+IO+SIVC (K) 6.0 ± 5.0 s 100.0%
LL+SIVC (F) 7.0 ± 5.4 s 100.0%
LL+IO+SIVC (G) 9.8 ± 6.6 s 100.0%
PV+IO (I) 7.8 ± 7.2 s 95.0%
LL+IO (E) 8.8 ± 5.4 s 90.0%
PV+SIVC (J) 10.1 ± 4.5 s 80.0%
PV (H) 15.8 ± 9.8 s 65.0%
LL (D) 11.9 ± 8.5 s 60.0%
IO+SIVC (C) 16.3 ± 8.8 s 60.0%
SIVC (B) 15.1 ± 11.6 s 25.0%
IO (A) 16.2 ± 3.4 s 20.0%
Table 6.2 – Mean TAFT for the simpler patterns.
around the pulmonary veins and the right atrial free wall (ﬁgure 6.12(B)). If the simpliﬁed
IO and SIVC patterns, leading to a very low success rate, were excluded, three groups could
be identiﬁed in the results obtained with the biophysical model (6.2). The ﬁrst group has
a success rate ranging from 60 to 65% and implies ablation patterns with lines only in the
right or only in the left atrium. The ﬁrst pattern in this group is a combination of IO+SIVC
with a total ablation length of 4.5 cm (ﬁgure 6.12(C)). Interestingly, this pattern involving
right atrial lines only signiﬁcantly modiﬁed the distribution of ABBI in the left atrium
with values > 120 ms indicating slower activity (ﬁgure 6.12(C)). This type of pattern has
been tested in a clinical study by Garg et al. [141] to determine whether lesions could be
applied only in the right atrium to suppress the risk associated with catheter ablation in
the left atrium. They reported that AF was suppressed in the long-term in 67% of the
patients following right atrial compartmentalization, which may be compared to the 60%
obtained with the biophysical model. Only two other patterns implying lines in the left
atrium led to similar results in terms of success rate and ABBI distribution: the LL pat-
tern (ﬁgure 6.12(D)) with a total ablation length of 7.5 cm, and the PV pattern with a full
isolation of the pulmonary veins (ﬁgure 6.12(H)). These patterns led to a success rate of
60% and 65% respectively. The isolation of the pulmonary veins did not aﬀect the success
rate considerably, whereas some diﬀerences in the ABBI values in the left atrium could be
observed (> 130 ms for the PV pattern and < 120 ms for the LL pattern). The success rate
obtained with the biophysical model for these patterns is somewhat in contradiction with
clinical experiments of ablation in the region of the pulmonary veins reporting a long-term
success rate of 82% [142] This diﬀerence may be partly explained by the fact that the AF
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Maze−III
 (A) IO  (B) SIVC  (C) IO+SIVC
 (D) LL  (E) LL+IO  (F) LL+SIVC  (G) LL+IO+SIVC
 (H) PV  (I) PV+IO  (J) PV+SIVC  (K) PV+IO+SIVC
20% 25% 60%
60% 90% 100% 100%
65% 95% 80% 100%
ABBI [ms]
Figure 6.12 – Percentage of success rate and distributions of the average beat-to-beat intervals
(ABBI) for each of the 11 simpler ablation patterns studied (ablation lines and isolated regions are
resented in white): (A). Isthmus only, IO. (B). Sup./Inf. vena cava line, SIVC. (C). IO and SIVC,
IO+SIVC. (D). Left line only, LL. (E). Left line and Isthmus, LL+IO. (F). Left line and Sup./Inf. vena
cava line, LL+SIVC (G). Left line, Isthmus and Sup./Inf. vena cava line, LL+IO+SIVC. (H). Pulmonary
ablation lines, PV. (I). PV and IO, PV+IO. (J). PV and SIVC, PV+SIVC. (K). PV, IO and SIVC,
PV+IO+SIVC. (L). Cox’s Maze-III, Maze-III.
model is based on multiple reentrant wavelets (similar to a permanent AF in the clinical
setting implying a diseased atrial tissue), which is very diﬀerent to the focal AF due to
ectopic beats (atrial foci) generally located in the pulmonary veins and acting as triggers
for AF [72] (and closer of a paroxysmal form of AF in the clinical setting with a surrounding
healthy atrial tissue). The results obtained in the ﬁrst group of ablation patterns conﬁrmed
the fact that lines in the right or in the left atrium only are not suﬃcient to isolate all multi-
wavelet reentries. Notice that ablation lines in the right atrium could impact the ABBI
distribution in the left atrium, while on the other hand left lines had little eﬀect on wavelet
reentry in the right atrium. A second group was identiﬁed with a success rate ranging from
80 to 95%. All patterns in this group are based on the LL or the PV pattern with one
ablation line added in the right atrium (the IO or the SIVC line). The addition of the SIVC
line to the PV pattern (ﬁgure 6.12(J)) increased the success rate from 65% to 80%, while
the addition of the IO line to the same PV pattern (ﬁgure 6.12(I)) increased the success
rate from 65% to 95%. Similarly, by adding the IO line to the LL pattern (ﬁgure 6.12(E)),
the success rate increased from 60% to 90%. However, for all 3 patterns in this group, the
ABBI distribution showed no signiﬁcant reduction of the activity in the right atrium. The
third group of ablation patterns shows a success rate comparable to the Maze-III proce-
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dure. The best approaches are the LL pattern with an SIVC line (ﬁgure 6.12(F)) and the
LL or PV patterns with both an IO and an SIVC line (ﬁgure 6.12(G),(K)). They both lead
to a 100% success rate. Interestingly, for all these successful patterns, the ABBI values
were lower in the right atrium as compared to the Maze-III, suggesting the persistence of
residual wavelets and reentries not aﬀecting termination. The easiest pattern to implement
and, furthermore, with the shortest total ablation length is the LL+SIVC pattern.
However, as mentioned earlier, our model does not take into account focal AF with
triggers in the pulmonary veins. Therefore in clinical experiments, patterns without full
isolation of the pulmonary veins could lead to worse results.
6.7.3 Imperfect Maze-III procedure
The results of simulations of discontinuities in the Maze-III are listed in table 6.3. The
success rates obtained with the gap in the ablation line between the upper pulmonary veins
(Gap II in ﬁgure 6.7) are similar to those of the Maze-III (100%). The activation maps
showed that wavelets passing through this gap were blocked later by the other ablation
lines connecting the four pulmonary veins. Therefore, the position or size of this gap was
not critical for the success of AF termination and the means TAFTs were similar.With
the gap between the pulmonary veins and mitral valve annulus (Gap I in ﬁgure 6.7) the
success rates were aﬀected by both width and location. The eﬀect of the gap location was
a decrease in success rate as the gap was moved towards the mitral annulus. Furthermore,
the wider the gap (except for a gap value of 1.3 mm which had no eﬀect), the lower the
Position Gap I Position Gap II
Mean TAFT Suc. Term. MV Flutter Mean TAFT Suc. Term. AF
Gap widths at the middle position
1.3 mm 1.4 ± 0.8 s 100.0% 0.0% 1.4 0.6 s 100.0% 0.0%
1.7 mm 1.4 ± 0.9 s 89.0% 11.0% 1.4 0.9 s 100.0% 0.0%
2.4 mm 1.4 ± 0.8 s 82.2% 17.8% 1.4 0.8 s 100.0% 0.0%
3.0 mm 1.4 ± 0.8 s 79.7% 20.3% 1.4 0.7 s 100.0% 0.0%
Gap positions with 3 mm width
Up/Left 1.4 ± 0.8 s 79.7% 20.3% 1.4 0.7 s 100.0% 0.0%
Middle 1.4 ± 0.9 s 79.7% 20.3% 1.4 0.7 s 100.0% 0.0%
Down/Right 1.3 ± 0.7 s 72.0% 28.0% 1.4 0.7 s 100.0% 0.0%
Table 6.3 – Eﬀect of discontinuities in the Maze-III: mean TAFT and percentage of successful termi-
nation.
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termination rate. In both cases the decrease of the success rate was linked to the presence
of an uncommon ﬂutter around the mitral valve. Figure 6.13 shows this phenomenon as
observed by means of the biophysical model.
The results show that a gap, whatever its size or location placed between the upper
pulmonary veins, has no eﬀect on the success rate (Gap II in table 6.3). When the mech-
anism of AF is self-perpetuation based on multiple reentries, only three lines out of four
are needed for the pulmonary vein connections. This phenomenon is conﬁrmed by the
high success rate observed in simulations with patterns LL+SIVC and LL+IO+SIVC (ﬁg-
ure 6.12(F),(G)) which include only three lines (without gap) between the pulmonary veins.
By looking at the activation maps, some observable wavelets still passing through this gap
were further blocked by ablation lines. On the other hand, a gap positioned along the ab-
lation line connecting the pulmonary veins and the mitral annulus (Gap I in table 6.3) can
signiﬁcantly decrease the success rate due to a ﬂutter around the mitral valve (a phenom-
enon already clinically observed [55]). This decrease in success rate is more important for
gaps close to the mitral annulus since the presence of ﬂutter is facilitated. Success rate also
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Figure 6.13 – Uncommon ﬂutter around mitral valve. (ablation lines are dark marked and wave front
are in gray color level.):
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decreased as the gap width was increased from 1.7 to 3 mm. This suggests that for small
gaps, conduction blocks may occur, therefore preserving the eﬀect of the ablation line. If
no conduction block is associated with the gap, atrial ﬂutter will occur. Mapping studies
in animals indicate that gaps smaller than 5 mm in ablation lines may result in conduction
blocks [144].
6.7.4 Isolation of pulmonary veins
The results of PVs isolations are listed in table 6.4. The excluded surface around PVs with
radius of 10 mm showed higher sinus rhythm (SR) conversion as expected. However, a
higher rate of AFL was obtained with 7.5 mm.
The patterns using combined two by two PVs and linear lines obtained signiﬁcantly
higher success rates (90%) if they were combined with the roof and lateral line. For the
roof and left isthmus lines combined with PV isolation, the success rate is also given for
incomplete ablation lines with a gap (W.G).
6.7.5 Comparison of simulations with clinical data
Results obtained with the Mini-Maze for both the biophysical model and the clinical ex-
periments are summarized in table 6.5. For Group II (with perfect ablation lines in the
biophysical model and both endo- and epicardial RF ablation in the clinic) the percentage
PVI SR (W.G) AF (W.G) AFL (W.G)
Exclude surface around the PVs
5 mm 10% 85% 5%
7.5 mm 25% 50% 25%
10 mm 60% 30% 10%
Combined 2x2 PVs
5 mm 55% 25% 20%
2.5 mm 30% 45% 25%
0 mm 65% 30% 5%
Combined 2x2 PVs + Linear Lines
Roof 40% (10%) 55% (60%) 5% (30%)
Lateral 40% (25%) 20% (30%) 40% (45%)
Roof+Lateral 90% 10% 0%
Table 6.4 – Pulmonary veins isolations. Simulations performed with a gap are denoted with W.G.
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Mini-Maze SR AF AFL p
patterns clinical/computer clinical/computer clinical/computer clinical/computer
Group I 12(60%) / 13(65%) 4(20%) / 2(10%) 4(20%) / 5(25%) 0.66
Group II 24(92%) / 23(88%) 2(8%) / 3(12%) 0(0%) / 0(0%) 0.64
Table 6.5 – Comparison between clinical data and biophysical simulations.
of conversion to sinus rhythm was 88% (with simulations) and 92% (clinical data), which
was slightly lower than for the complete Maze-III. For Group I (with a discontinuous abla-
tion line in the biophysical model and only an endocardial RF ablation in the clinic) this
percentage was found to be decreased and atypical left atrial ﬂutter was observed both
in the biophysical model and in patients. No signiﬁcant diﬀerence was observed between
the clinical data and the computer results. Figure 6.10(E) represents the corresponding
ABBI distribution for the Group II. When compared to the full Maze-III, the Mini-Maze
procedure, despite right atrial appendage removal, leads to ABBI values close to 80 ms
in the right atrium, meaning persistent wavelet activity. The ABBI distribution was very
similar to those obtained with the other ablation patterns also implying an isolation of the
pulmonary veins (ﬁgure 6.12(H)-(K)).
The clinical results show that Group I patients have a signiﬁcantly lower success rate
(60%) compared to the Group II patients (92%), highlighting the importance of transmu-
rality of the ablation pattern. These data, as well as the presence of left atrial ﬂutter for
Group I patients, are conﬁrmed by our biophysical model, and no signiﬁcant statistical
diﬀerence was observed between clinical and computer data using a Fisher’s exact test.
6.7.6 Proposition of an ideal ablation pattern
Table 6.6 summarizes the result obtained with the progressive modiﬁed Maze III procedure
and for 40 simulations per pattern with diﬀerent initial conditions. The most eﬃcient were
MMP5, MMP6 and Maze III with a 100% success rate. The main diﬀerence was expressed
in decreasing mean TAFT with a correlation coeﬃcient R= - 0.8. Note the inﬂexion point
at 100% success rate and a TAFT value of 7.5 s (MMP5), signifying that no additional lines
were mandatory beyond this limit (ﬁgure 6.14). For two patterns (MMP1 and MMP2) an
uncommon ﬂutter around the mitral valve was observed in 2.5% and 10% of the cases,
respectively. For the other patterns, ﬂutters were avoided thanks to the left atrial isthmus
(LAI) line.
The result from the biophysical model suggested that Maze-III can be simpliﬁed in its
right atrial pattern to a single line joining superior to inferior vena cava. This remains to
be validated in clinical settings.
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Patterns Suc. Termination AF Flutter TAFT
P1 55.0% 42.5% 2.5% 13.5 ± 7.1 s
P2 65.0% 25.0% 10.0% 13.4 ± 9.4 s
P3 80.0% 20.0% 0.0% 11.6 ± 8.1 s
P4 95.0% 5.0% 0.0% 9.5 ± 7.1 s
P5 100.0% 0.0% 0.0% 7.5 ± 7.6 s
P6 100.0% 0.0% 0.0% 5.1 ± 5.0 s
Maze III 100.0% 0.0% 0.0% 1.3 ± 0.8 s
Table 6.6 – Statistic for the modiﬁed Maze III patterns.
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Figure 6.14 – Percentage of cardioversions vs. TAFT for the modiﬁed Maze III patterns.
6.7.7 Limitations
Even though the results obtained with the atrial model are consistent with clinical ob-
servations, some of the limitations should be highlighted. In this study, the number of
simulations performed with the standard Maze-III procedure is identical to that of patients
in the literature, i.e. 118 patients. However, a direct comparison between computer simula-
tions and clinical data is diﬃcult, since the geometry of the biophysical model was one and
the same during the whole experiment, whereas the atrial anatomy diﬀers in each patient.
First, in contrast to surgical operations, during computer simulations all elements of the
ablation lines were applied instantaneously. Also, when simulating non-transmural ablation
lines, one gap of arbitrary width was introduced into a line of the biophysical model, while
during clinical endocardial ablation many gaps of unknown size can be present. Moreover
the fact that the AF model takes into account reentrant wavelets only and cannot be used
in the case of rapid foci, should be highlighted. For instance, if a rapid focus appears in
the pulmonary vein region, incomplete ablation lines around pulmonary veins (ﬁgure 6.7
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Gap II) will not necessarily prevent AF reinitiation. Finally, in order to keep computation
time within a tractable range, a simpliﬁed atrial model was used. The single layer cell
model does not include anisotropic fast-conducting regions, ﬁber orientation, crista termi-
nalis and pectinate muscles, which may all play a role during AF [17, 145]. A version of
the model incorporating some of these aspects has been developed at the expense of an in-
creased complexity and computational load. The inclusion of such details requires validated
morphological data.
6.8 Conclusions
This chapter shows how a computer model of human atria can be used to compare existing
surgical or RF ablation procedures and to study the eﬀect of imperfect ablation lines.
The results of our the simulated ablation lines conﬁrm the high performance of the gold
standard Maze-III procedure, and suggest that the development of less invasive patterns
needs to include ablation lines in both the right an the left atrium. It has also been observed
in the simulations that some lines are more sensitive to imperfections (for example due to
non-transmurality of ablation) than others, leading generally to the presence of uncommon
atrial ﬂutter after ablation, a phenomenon also observed in the clinic. A comparison of
the simulation data with clinical data shows no signiﬁcant diﬀerence in the case of patients
suﬀering from permanent AF.
A new ablation pattern that can be proposed on the basis of the results of these sim-
ulation studies is as follow. The Maze-III procedure can be simpliﬁed in its right atrial
pattern to a single line joining superior to inferior vena cava. This remains to be conﬁrmed
clinically.
These results indicate that, through an interaction with clinicians involved in surgical
procedures, biophysical models are promising tools for the investigation of patterns.
Therapeutic pacing 7
7.1 Introduction
THE advantages of pacing the heart electrically were well known as far back as theearly 1900s [146, 147]. Current permanent pacemakers consist of a source of electrical
current that is linked to the cardiac muscle by a wire (lead) and controlled by an integrated
circuit. If the sinoatrial node does not generate intrinsic electrical impulses in a regular
manner, the pacemaker sends an electrical current down the lead to stimulate the heart.
The current depolarizes the cardiac cells at the tip of the lead, and this depolarization
propagates across the myocardium in a normal fashion.
Early pacemakers were large, bulky external devices that used vacuum tubes, powered
by an external AC current source. External electric stimuli were frequently too traumatic
for patients, and the AC-operated pacemaker could fail during a power blackout. Rune
Elmqvist developed the ﬁrst implantable pacemaker at the prompting of Dr. Ake Senning,
a surgeon at the Karolinska Institute in Stockholm, in 1958.
At present, various types of sophisticated pacemakers are currently on the market:
single-chamber or multi-chamber pacemakers. Pacemakers that synchronize both the atria
and ventricles are called dual-chamber pacemakers. Some pacemakers use adaptable pacing
algorithms such as burst or ramp pacing to terminate atrial or ventricular arrhythmias [148,
149].
Pacemakers are inserted for a variety of heart conditions including sick sinus syndrome,
supraventricular bradycardia, heart block and ventricular bradycardia. The pacemakers are
individually programmed to maintain the patient’s natural, intrinsic heart rhythm, which
usually falls between 50 and 70 beats per minutes. On the other hand, during ventricular
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tachycardia or ﬁbrillation, an implantable deﬁbrillator is adopted. The deﬁbrillators use one
or more of three basic modes of operation [150]: low-energy (0.5 to 2 Joules) cardioversion,
deﬁbrillation1 (∼ 30 Joules) and antitachycardia pacing (ATP). Most devices in use today
employ high-energy deﬁbrillation for ventricular tachycardia. This short-circuits the rapid
ventricular rhythms by sending at a pace faster than the already accelerated ventricular
rate. The aim is to depolarize the heart muscle at the right moment, interrupting the
abnormal rhythm and thereby halting the tachycardia. The main motivation to develop
ATP of atrial ﬁbrillation (AF) is the fact that pacing is below the threshold of pain compared
to deﬁbrillation. Other advantages of using ATP are: reversible impact (when compared
to ablation procedures) and better tolerance (when compared to medication).
These days, interest in AF therapies has considerably increased. It is well known that
atrial ﬂutter (AFL) can be terminated by pacing [151]. However, no pacing therapy has yet
proved to be eﬀective in AF termination, probably due to its complex dynamics, the variable
number of wavelets, and the shorter and variable excitable gap2 during AF. Mitchell et al.
showed that ATP treatments (50 Hz burst pacing of 2 seconds duration) are ineﬀective in
terminating persistent atrial ﬁbrillation in humans [152].
However, the possibility of local atrial capture3 has been demonstrated in animal and
human experiments, both in electrically induced and spontaneous AF. Allessie et al. showed
for electrically induced AF in dogs that it is possible to capture a region of atrial tissue
with a diameter of about 6 cm by rapid pacing [153]. The rate of the paced atria is faster
than the original rate but does not lead to termination, due sometimes to a loss of capture.
Daoud et al. performed pacing in a human right atrium during electrically induced type
I AF (pacing with a cycle length 10-50 ms less than the mean atrial cycle length up to
110 ms) [154]. Local capture and distant eﬀects in the left atrium could be observed but
not termination. Pandozi et al. assessed the possibility of local capture in patients with
spontaneous chronic atrial ﬁbrillation (pacing with cycle length of 250 ms, decreased by 10
ms every 10 ms down to a cycle length of 100 ms) [155]. Local capture was obtained in
87.2% of the pacing sites, with a preference for the lateral wall over the atrial roof or the
septum.
Most techniques pace at a single site, leading to a region of capture with a diameter of
approximatively 4-6 cm (generally in the right atrium). It has been suggested that multi-site
pacing could be more eﬃcient in capturing both atria [156]. Pacing could then be stopped
when atrial activation becomes organized on the whole surface, leading to termination.
The main problem is how to optimize this therapeutic pacing system and synchronize the
diﬀerent pacing sites.
Since no optimal solutions come out of clinical and experimental experience, simulations
1Deﬁbrillation is the use of an electric shock, administered either through a device on the exterior of the
chest wall or directly to the exposed heart muscle, to restart or normalize heart rhythms.
2The excitable gap is a short period within the cycle of the atrioventricular or intraventricular conduction
allowing the passage of an impulse, which at other times would be blocked in transit.
3The capture is a region of the tissue where no reentries are present and the only possible wavefronts are
generated by the stimulation of the pacemaker.
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are proposed as an alternative to explore atrial therapies by electrical stimulations. In this
study, a biophysical model of the human atria is used to investigate ATP during atrial
arrythmia. It aims at helping electrophysiologists to optimize the following parameters:
• position and number of electrodes needed for sensing atrial activity;
• position and number of electrodes needed for pacing;
• pacing frequencies and amplitudes;
• determination of variables (reﬂecting atrial activation in the tissue such as excitable
gap, degree of organization) that can be used to control pacing;
• sequence and timing for multi-site pacing.
This chapter presents preliminary results on these topics. First, section 7.2 presents an
algorithm for pacing and the diﬀerent pacing sites that have been investigated during this
research. Second, section 7.3 shows why atrial ﬂutter can be pace-terminated more easily
than AF. Finally, section 7.4 presents antitachypacing strategies on the diﬀerent types of
AF previously presented in chapter 3. To quantify the eﬃciency of the ATP procedure, the
methods presented in chapter 4 are used to measure the degree of organization.
7.2 Pacing methods
7.2.1 Introduction
Pacing can be used to control1 a tissue region during arrythmia. The main problem is
to ﬁnd the time instant at which the tissue is in its resting state (i.e. the excitable gap)
to ensure that the stimulus applied propagates through the tissue. The stimulus should
be delivered late enough to avoid the eﬀective refractory period (ERP) of the tissue but
early enough to stay away from “encroachment” of an external wavefront, resulting from a
distant reentry or spiral generated by a mother rotor2. Figure 7.1 presents the time course
of the membrane potential of a node on the surface of the atria and the electrogram signal
computed at the same site during sustained AF. The highlighted time instants (in dark)
represent the instants at which the tissue is in its resting state (Vm  75 mV). Depending
on the type of AF, the excitable gap ranges from 70 ms to 180 ms.
7.2.2 Pacing algorithms
State-of-the-art
When applying ATP, the optimal pacing frequency can be determined by diﬀerent methods.
Early approaches performed by Allessie et al. [153] were experimented on animals. They
1A region under control by pacing is an area where no reentries are present and only wavefronts are
generated by the stimulation of the pacemaker.
2A mother rotor is a stable source of reentry that generates multiple wavelet breaks
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Figure 7.1 – Excitable gap (in dark). Example of simulation using the chronic AF model. (A)
Transmembrane potential. (B) Electrogram signal.
used pacing intervals 10 ms shorter than the local median ﬁbrillation interval, subsequently
shortened by steps of 1 ms. In 1997, Pandozi and co-workers [155] demonstrated that
local capture by atrial pacing was possible in human atria. They used decremental pacing
starting from the average AF cycle length. These procedures are usually performed in an
open-loop fashion. Their main disadvantage compared to a closed-loop method, is that
stimuli are always generated independently of the state of the tissue. In a closed-loop
system, stimuli are delivered only if a wavefront is not present under the pacing electrode,
avoiding the application of an ineﬀective stimulus. In pacing devices, the term closed-loop
refers to a pacing system, which takes into account the return cycle length1 [157]. In the
present study, the term closed-loop is used in the general sense.
In 2000, Ditto and colleagues chose an interesting chaos control approach to determine
the pacing frequency [158]. Their results presented on the application and evaluation of
chaos control for slowing and regularizing local electrical activation of the right atrium of
humans during induced AF. In the technical literature, the term chaos refers to a process
that appears to be random and disordered but is in fact of a deterministic nature. The
basic idea is the following: the dynamics of a chaotic process in the state space can be
characterized by unstable ﬁxed points (UFP). In the vicinity of an UFP, there are regions
of space in which the point is attracting (stable manifold), and others where it is repulsive
(unstable manifold). The aim of chaos control is to apply a small perturbation to the
system evolving on an unstable manifold and to bring it to a stable one [159]. In the case
of ATP pacing, the UFP was determined using the beat-to-beat interval (BBI) histogram.
This method [158] consisted of constructing a Poincare´ map [160], in which the nth interbeat
interval (In) was plotted against the previous interval (In−1). Then, during a learning phase,
the unstable ﬁxed points were identiﬁed on the Poincare´ map. Finally, the intervention
phase consisted in applying precisely-timed stimuli to place the next Poincare´ map point
1The return cycle length is the time period between the last pulse of an ATP and the ﬁrst spontaneous
depolarization detected post-ATP.
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onto the stable manifold of the identiﬁed ﬁxed point [161].
In 2000, Peterson and Link [162] have suggested a schema patent for pacing based on
monophasic action potential (MAP) recordings, this consists of obtaining a signal corre-
sponding to the action potential of a tissue patch. The stimulus is delivered during the
repolarization phase of the tissue, just after the eﬀective refractory period (ERP). The
diﬃculty in this method resides in the MAP recordings, which is still not possible with a
pacemaker as well as the detection of ERPs.
Development of pacing algorithms in the biophysical model
In the present study, four diﬀerent procedures were implemented and evaluated with the
biophysical model:
1. open-loop pacing at a constant frequency;
2. open-loop pacing with a ramp protocol;
3. closed-loop pacing with rate adaptation;
4. closed-loop pacing with rate adaptation and a ramp protocol.
The ﬁrst algorithm paces at a constant frequency over time. This frequency was deter-
mined from the BBI histogram. The second algorithm uses a ramp protocol. The initial
frequency is incremented or decremented between each stimulation pacing. These two algo-
rithms are similar to the one Allessie et al. [153] used and belongs of course to the category
of open-loop algorithms.
Based on the Peterson’s patent closed-loop algorithm [162], the two last algorithms
(algorithm 3 and 4) were developed. Instead of using the MAP recordings and detecting
the ERP phase repolarization, which is not always an easy task in an electronic device, the
upstroke phase (section 2.2, ﬁgure 2.2) of the depolarization was used. The detection of the
upstroke is easier because of the fast and large variations of the transmembrane potential.
The upstroke phase can be detected in two diﬀerent manners by the MAP recordings or
by the electrogram signals. The upstroke is represented by a fast variation from a positive
peak to a negative peak value in the electrogram signal (ﬁgure 7.1(B)). In the biophysical
model, the MAP signals were used to detected the upstroke to save computation time and
to avoid having to compute the electrogram signals during simulations.
The schemes of algorithm 3 and 4 are presented simultaneously in ﬁgure 7.2. The
presence of the ramp protocol diﬀerentiates algorithm 3 and 4. Two parameters are involved
in algorithm 4: 1) the waiting time τ and 2) the increment (underdrive pacing) or decrement
(overdrive pacing) of the waiting time value τ . The initial value of τ is taken to be the
median value of the BBIs histogram.
The main diﬀerence between the two ﬁrst algorithms and the two last ones is the closed-
loop protocol. Since in an open-loop pacing method, the pacing is delivered at a constant
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Figure 7.2 – Flow chart of the closed-loop pacing algorithm (3 and 4) and an electrogram signal
with the waiting time τ is also presented. If a ramp protocol is used (algorithm 4, in dashed line), this
parameter can be incremented (underdrive pacing) or decremented (overdrive pacing).
frequency, a stimulus could be generated even during the resting period of the tissue. But
this stimulus cannot induce a wavefront propagation. In a closed-loop pacing method, if
a wavefront is detected during the waiting time τ , no stimulus is delivered (ﬁgure 7.2).
Another advantage of a closed-loop system is that less stimuli are delivered, so saving
pacemaker batteries.
As results obtained were quite similar with open- or closed- loop algorithms, only results
with the algorithms 3 and 4 are presented in this study. Using open-loop algorithms, the
time to reach the control of a region is longer due to the ineﬀectiveness of some stimuli,
which were delivered during the eﬀective refractory period.
7.2.3 Pacing rates and pacing sites
This section deals with the initial value of the waiting time τ previously described, as well
as the diﬀerent sites of pacing investigated during this study.
A priori, any pacing frequency value is possible for the waiting time τ . Since there
is an excitable gap between two successive beats, the choice of the pacing frequency is
determined by the BBIs histogram computed at the pacing site. Since the pacing frequency
is the number of complete cycles over a period of time, it is obtained by taking the reciprocal
value of BBI value.
Figure 7.3 presents the BBI histograms of three diﬀerent types of simulated AF: chronic
AF, meandering AF and cholinergic AF. The BBIs distribution varies considerably depend-
ing on the type of AF. In chronic AF, the BBI shows a large dispersion compared to the
meandering and cholinergic AF. Meandering AF and cholinergic AF demonstrate a single
mode around 250 ms and 80 ms, respectively. In this study, the median value of the BBI
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Figure 7.3 – Examples of BBIs histogram computed in the middle of the right atrium free wall. (A)
Chronic AF: min. value = 17.6 ms, max. value = 172.5 ms, mean value = 87.9 ms and median value
= 80.8 ms. (B) Meandering AF: min value = 106.0 ms, max. value = 394.4 ms, mean value = 255.4
ms and median value = 263.6 ms. (C) Cholinergic AF: min value = 33.4 ms, max. value = 135.0 ms,
mean value = 81.5 ms and median value = 80.1 ms.
histogram was chosen for the initial value of the waiting time τ . This insures that a stimulus
can always be generated and propagated. If the minimum value is chosen and overdrive
pacing is applied, wavefronts cannot be generated. When decreasing τ , stimuli are applied
during the refractory period of the tissue. If the maximum value of the BBI histogram is
chosen as the initial τ value, meaning that the initial pacing frequency is low, only overdrive
pacing can be used to ensure stimuli to be delivered during the excitable gap. Also, the
probability of having a wavefront under the pacing site is high.
Note that in current pacing devices, pacing algorithms are applied depending on the
beat-to-beat interval of the last 5 to 10 beats. Furthermore, during pacing, a ramp protocol
or a burst can be applied.
Figure 7.4 presents the diﬀerent pacing sites (S1-S6) investigated in this research. The
pacing algorithms (3 and 4) are used for single site pacing as well as for multi-site pacing.
E denotes the position of the computed electrogram signal used to observe organization
during AF pacing. It is located at 2.25 cm from S1.
Pacing is initiated by injecting intracellular current (Istim = 80 µA/cm2) in a small
region of approximatively 3 mm2 during 2 ms.
7.2.4 Evaluation of pacing eﬃciency
To follow the evolution of the spatio-temporal complexity during ATP of diﬀerent types of
AF (chronic, meandering and cholinergic), the methods described in chapter 4 are used:
high density mapping and multidimensional electrogram signal analysis. The signal dura-
tion used to compute the spatial correlation with the hight density mapping system is 1
s. In order to observe the global organization of both atria, the spatial multidimensional
signal analysis with a split level 6 (32 electrodes per atrium, placed at equal distances, see
section 4.2.3) is used with a moving time window of 1 s and an overlap of 0.5 s.
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Figure 7.4 – Pacing sites. The diﬀerent pacing sites experimented are indicated: S1,S2, S3, S4, S5
and S6. E is the position used to compute an electrogram signal. The majors vessels and valves are
included: tricuspid valve (TV), mitrale valve (MV), superior vena cava (SVC), inferior vena cava (IVC),
coronary sinus (CS) and fossa ovalis (FO).
The next two sections present results of ATP, using algorithm 3 and 4, applied to dif-
ferent types of atrial arrhythmias simulated (see chapter 3) with the biophysical model
of the human atria. First, ATP is used on atrial ﬂutters simulated on the 3D homoge-
neous monolayer and the 3D inhomogeneous multilayer model. These experiments aim at
conﬁrming clinal results. Second, ATP is investigated for diﬀerent types of AFs: chronic
AF, meandering AF and cholinergic AF. These results are compared with that of ongoing
clinical research.
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7.3 Pacing atrial ﬂutter
Since the biophysical model can reproduce AFLs in the 3D homogeneous monolayer (sec-
tion 3.2.1) and in the 3D inhomogeneous 3D multilayered model (section 3.2.2), ATP is
applied to these two diﬀerent cases. Usually, in clinical practice, the pacing electrode is
placed in the right atrium appendage (RAA). In the biophysical model, AFL pacing is
evaluated at two diﬀerent sites: the isthmus region and the RAA.
7.3.1 Pacing AFL in the 3D homogeneous monolayer model
Section 3.2.1 presented how an atrial ﬂutter can be simulated using the 3D monolayer
model. This kind of ﬂutter presents overly rapid contractions of the atria at a rate of
400 bpm (beat per minute). By pacing in the isthmus region (ﬁgure 7.4, site S6) with an
initial waiting time τ set to the median value of the BBI, it was possible to pace-terminate
the ﬂutter using an increasing or decreasing ramp protocol with a 1 or 2 ms increment or
decrement, respectively. The position of the pacing site was chosen in the narrowest region
along the pathway of the macro-reentrant circuit. This favored the creation of a block in
the opposite direction.
By pacing in the right atrium appendage, as is usually performed in clinical practice,
no AFL termination could be achieved. The wavefront generated by the pacing site could
not interrupt the AFL circuit. Since the ﬂutter generates a single wavefront and wavetail,
the extra wavefront introduced by the pacing site did not aﬀect the circuit. In fact, the
stimulus generated two wavefronts: one of them collided with the wavefront of the ﬂutter
and the second one generated a new wavefront.
This phenomenon is illustrated in ﬁgure 7.5 with an action potential propagating in a
1D ring model. Because of the position chosen, a block in the opposite direction was not
observed.
The wavefront was not conﬁned to a region such as the isthmus, but propagated in
all directions of the tissue and so regenerated a reentry. The tissue of the monolayer 3D
model is homogenous and isotropic, which maintains a stable macro-reentrant circuit. In
a conﬁguration in which anisotropy is present, AFL termination could be obtained. This
situation is described in the next section.
7.3.2 Pacing AFL in the 3D inhomogeneous multilayer model
In section 3.2.2, it has been shown that atrial ﬂutter in the multilayer 3D model could be
initiated by properly timed electrical stimuli. The rate of the simulated AFL was 333 bmp
(180 ms of cycle lenght) on average. This section presents how this AFL can be terminated
using rapid pacing or overdrive pacing (at a rate higher than the reentrant process). Two
pacing sites were investigated. The ﬁrst one was located in the isthmus region (ﬁgure 7.4,
site S6), since this position corresponds to the narrowest region along the pathway of the
macro-reentry, so that it is easy to create a block in the direction opposite to that of the
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Figure 7.5 – Unsuccessful termination of AFL pacing. (A)-(B) Single wavefront (WF1) propagating
in the clockwise direction. (C) Stimulus (S) applied. (D) Generation of two new wavefronts (WF1 and
WF2). WF3 will collapse with WF1 and WF2 will maintain the reentry.
reentrant circuit. The second position was located in the right atrial appendage (RAA)
(ﬁgure 7.4, site S2), which corresponds more with the antitachypacing pacemaker currently
used clinically, due to the accessibility of RAA to implement an electrode. As in the previous
section, the pacing protocol used a ramp.
Figure 7.6 presents the transmembrane potential distribution map for an example of
pacing in the RAA with a decremented ramp of 1 ms (overdrive pacing). The mechanisms
involved in this case to pace-terminate the AFL depends on two factors. The ﬁrst one
is the perturbation of the stable rhythm (ﬁgure 7.6(A-C)) as shown in ﬁgure 7.6(D). The
wavefront anchored around the tricuspid valve (TV) was momentary unanchored, which
modiﬁed the cycle length. The second factor is the wavefront collapsing at the wave tail
leading to the annihilation of the circuit (ﬁgure 7.6(G-H)).
In addition to these two factors, another factor has been found to be responsible for AFL
termination. A reentry situated in the isthmus region (ﬁgure 7.7) around the coronary sinus
(CS) was present and a new wavefront propagated in a direction opposite to the direction
of the macro-reentry of the AFL. The collision of the two wavefronts cancelled both of them
and the macro-reentry was destroyed.
When applying pacing in the isthmus region (ﬁgure 7.4, site S6), another phenomenon
was generally involved in pace-termination. The wavefront generated by the pacing elec-
trode propagated in two opposite directions, namely the septum and the RAA. The ﬁrst
front collided with the main wavefront of the macro-reentry and collapsed, whereas the
second one was blocked by the refractory period of the macro-reentry tail.
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Figure 7.6 – Pacing atrial ﬂutter in the right atrium. Mechanism leading to AFL termination. (A)-
(H): TMPDM. (A) Pacing site (indicated by an arrow) in the RAA. (B)-(C) Macro-reentrant around the
tricuspid valve (TV). (D) Macro-reentrant circuit modiﬁed due to the wavefront (indicated by an arrow)
unanchored around the tricuspid valve. (E)-(F) Modiﬁcation of the macro-reentrant circuit. (G)-(H)
Annihilation of the ﬂutter.
These results are in accordance with results published by Sinha et al. [163] They demon-
strated in a 2D model that under certain conditions, successful termination of arrythmia
requires the presence of inhomogeneous regions. In the present study the isthmus region
has a slow conduction velocity compared to the rest of the tissue.
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Figure 7.7 – Pacing atrial ﬂutter in the right atrium: reentry in the isthmus region leading to AFL
termination (A)-(D): TMPDM. (A) The region between CS and IVC is still in refractory period. (B)-(C)
Wavelet anchored around CS. (D) Collision of the macro-reentrant wavefront and the wavefront anchored
around CS leading to AFL termination.
7.4 Pacing atrial ﬁbrillation
Electrophysiologists have found that the right anterior atrial free wall is an eﬀective site
for pacing, with a largest area of capture during atrial pacing [155]. In the biophysical
model, the sensor and stimulation electrodes were placed at the same position, located in
the middle of the high density mapping system (ﬁgure 4.1 and ﬁgure 7.4, site S1). The
antitachypacing method was tested for three diﬀerent types of AF (see chapter 3): chronic,
meandering and cholinergic, and for some other sites as described in ﬁgure 7.4. Since during
AF, the macrostructure plays a minor role, all the simulations were performed using the
monolayer 3D model to save computation time.
7.4.1 Pacing chronic AF
Figure 7.8 presents the evolution of the spatial correlation on the high density mapping
during chronic AF pacing in the right atrium free wall (ﬁgure 7.4, site S1). Signal lengths
used to compute the spatial correlation were 5 s during sinoatrial rhythm and 1 s during
AF. Curves (1) and (2) correspond to the sinoatrial rhythm and chronic AF, respectively.
The other intermediate curves show the evolution of the local organization during ATP,
after 2 s, 5 s and 10 s. As shown in this ﬁgure, after 10 s of pacing, the right anterior
atrium free wall was completely under control. The correlation coeﬃcient was close to 1.
To observe the global organization of both atria, the spatial multidimensional signals
analysis with a split level 6 (32 electrodes per atrium placed at equal distances, see section
4.2.3) was used on a moving time window of one second with an overlap of 0.5 s. Fig-
ure 7.9 shows the time evolution of the two measures of complexity CEig95% and CEnt
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Figure 7.8 – Spatial correlation during pacing of chronic AF. (1) Sinoatrial rhythm. (2) Chronic AF.
Evolution of spatial correlation after pacing of 2 s, 5 s and 10 s.
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Figure 7.9 – Measure of complexity during pacing of chronic AF. (A) CEig95%. (B) CEnt. (1)
Chronic AF. (2) Pacing.
(section 4.2.4). During sinoatrial rhythm, CEig95% and CEnt values were respectively 5
and 1.5 (ﬁgure 4.6). As expected, the complexity decreased over time but never reached a
value lower than 15 for the CEig95% and 2.4 for CEnt. This means that a residual AF was
still present on the left atrium. Even under control, oscillations were observable in curve (2)
(ﬁgure 7.9(A),(B)), corresponding to an imperfect control and some reentries were present
in the controlled area.
Figure 7.10 presents the transmembrane potential distribution map during pacing. The
pacing site on the right atrium free wall is indicated by an arrow. At the beginning (t =
410 ms) the control was only eﬀective in a small region around the pacing site. After 2
s of pacing the region under control reached a diameter of 4.5 cm. After 10 s, the entire
right atrium was under control, and only residual wavelets reentries were present on the
left atrium (ﬁgure 7.10(F)).
An electrode (ﬁgure 7.4(E)) placed at 2.25 cm from the pacing site recorded an electro-
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Figure 7.10 – Pacing in the right atrium free wall during chronic AF. (A)-(F) TMPDM. The pacing
site is indicated by an arrow. (G) Electrogram signal computed at 2.25 cm from the pacing site (S1) in
the direction of right atrium appendage. (H) Beat-to-beat intervals computed at the same site of the
measured electrogram signal.
gram signal (ﬁgure 7.10(G)). This one shows irregularities before 1.5 s. After the control
became eﬀective, this signal became periodic. The frequency of the electrogram signal fol-
lowed the pacing rate of the stimulation, that is 13.3 Hz. Figure 7.10(H) presents the BBI
computed at the same site as the electrogram signal. During the ﬁrst 30 samples, the BBIs
ranged from 50 to 150 ms. Under control, the BBIs stayed stable around 75 ms, which
corresponded to the pacing frequency of 13.3 Hz. Note that a loss of control was detected
between the 60th and the 70th sample.
After full control of the right atrium was obtained, a decrement rate of 1 ms was used
between each stimulus. By decreasing the pacing rate, the diastolic interval (DI) increased.
Since the APD depends on the DI, by decreasing DI, the APD increased according to the
restitution curve (section 2.2, ﬁgure 3.9). The goal was to modify the tissue properties and
guide the atrial rate to sinoatrial rhythm. Figure 7.11 presents the result obtained after
decrementing the pacing rate. The position of measurement selected was as used previously.
After 2 s, the electrogram signal became irregular (ﬁgure 7.11(A)), showing a loss of control
and the onset of reentries. Figure 7.11(B) shows the evolution of the BBIs. By decreasing
the pacing, the BBIs increased from 70 ms to 100 ms for the ﬁrst 20 samples. The region
was controlled by the pacing rate. After 2 s, the BBIs became irregular and ranged between
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Figure 7.11 – Decrementing the pacing rate after control during chronic AF. (A).Electrogram signal
(B). Beat-to-beat intervals.
50 and 150 ms, meaning a loss of control and the onset of reentries.
The other site of pacing was used during ATP (ﬁgure 7.4, site S2−5). When pacing in
the right or left appendage only (S2−3), similar results were obtained. Only one atrium
could be controlled by pacing.
The advantage of pacing in the septum is that both atria could be controlled at the same
time [164–166]. The sites (S4 and S5) were proposed as pacing sites. The transmembrane
potential distribution map during AF pacing at site S4 is illustrated in ﬁgure 7.12. After 10
s of pacing, both atria were under control, and no residual wavelets were present. The only
wavefronts were generated by the delivered stimulation. However, the anchored wavefront
(indicated in ﬁgure 7.12(B) by arrows) was still a factor generating AF, because, when
pacing was stopped or the rate of pacing reduced after 10 s, AF was reinitiated.
In contrast to pacing at site S4, there was no control when pacing at site S5. This is
due to several oriﬁces present in this region. Wavefronts generated by the pacing could not
propagate over the atria. It was also observed that a wave anchored around the coronary
sinus (CS) was present, which prevented the stimulation from propagating.
The results obtained using incremental or decremented pacing during chronic AF were
not satisfactory. The action potential duration (APD) of this type of AF was very short
with an average cycle length of 89 ms. So by incrementing the pacing rate (overdrive
pacing), stimuli were performed during the eﬀective refractory period (ERP) and no wave
could be propagated. By decrementing the rate, loss of capture was observed due to the
penetration of reentrant wavelets in the region of capture.
As a single site can almost control either the entire right or left atrium, two pacing sites
were used to attempt to control both atria. Several combinations of pacing sites were used
(ﬁgure 7.4). The diﬃculty when using multi-site pacing was to take into account the local
activity under a speciﬁc pacing site as well as the wavefront generated by the other site.
When considering only the wavefront generated by the other pacing site, the local activity
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Figure 7.12 – Pacing in superior septum during chronic AF. (A)-(D) TMPDM. (A) The pacing site
is indicated by S4. (B) The two arrows indicate wavelets anchored around the left inferior pulmonary
vein(LIPV) and the superior vena cava(SVC), respectively. When ATP was reduced or stopped, AF was
regenerated.
was neglected, and the stimulation delivered could not spread due to the fact that the tissue
was in the ERP. However, when considering only the state of the tissue at the pacing site,
the wavefronts generated by the other pacing sites were ignored, as result useless extra
stimuli would be generated.
The position of the ﬁrst pacing site was in the RAA and the second one in the left
atrium appendage (LAA) (ﬁgure 7.4, sites S2 and S3). With this method, a full control of
the atria was obtained. However, when the pacing was stopped, the ﬁbrillation resumed due
to residual wavelets. These residual wavelets were generated at the collision border between
fronts generated by the two pacing sites or by reentries, caused by wavelets anchored around
pulmonary veins as shown in ﬁgure 7.12(B).
7.4.2 Pacing meandering AF
During meandering AF, the dynamic of the wavelets is more organized than during chronic
AF. The average number of wavelets is approximatively 3 compared to 6 during chronic
AF. Furthermore, the wavelength during meandering AF is longer than that of the chronic
AF. Based on these observations, pace termination of AF meandering can be expected.
This type of AF is close to AF type I and/or II, according to Wells’classiﬁcation [167].
Figure 7.13 presents evolution of spatial correlation on the high density mapping during
meandering AF pacing in the middle of the right atrium (ﬁgure 7.4, site S1). The continuous
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Figure 7.13 – Spatial correlation during pacing of meandering AF. Evolution of spatial correlation
after constant pacing of 2 s, 5 s and 10 s (continuous line). The dashed lines represent pacing using
a ramp protocol after 10 s, 12 s and 15 s. Means and standard deviations are respectively denoted by
circles and bars.
curves represent pacing at a constant rate of 150 ms and the dashed curves, the pacing using
a decrement ramp protocol of 1 ms. During constant pacing at 5 s, no control was obtained
with a correlation value higher than 0.8. But at 10 s, this value decreased to 0.7, meaning
that a loss of control occurred. Conversely, during the ramp protocol pacing, the correlation
increased over time (10-15 s), until the maximum correlation of 1 after 15 s.
Figure 7.14 shows the spatial organization during pacing. Curves (1) and (2) correspond
to regular pacing and ramp protocol pacing, respectively. After 15 s of pacing using a
constant pacing interval, the complexity expressed by CEig95% and CEnt did not vary
considerably, staying over 20 and around 3, respectively. No control was obtained during
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Figure 7.14 – Measure of complexity during pacing of meandering AF. (A) CEig95%. (B) CEnt.
(1) Pacing in the right atrium free wall without ramp protocol. (2) Pacing in the right atrium free wall
with decrement ramp protocol of 1 ms. (3) Pacing in the superior septum with a decrement of 1 ms.
(4) Pacing in the superior septum with a decrement of 2 ms.
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the whole process. However, after 18 s AF self-termination has taken place, which would
have appeared if no pacing was applied. The conclusion of this observation is that regular
ATP pacing is not a mechanism leading to pace-termination.
On the other hand, pacing with a decremented ramp of 1 ms (ﬁgure 7.14(2)) induced a
decrease of complexity over time. Once again, AF termination was not completely due to
the ATP protocol. AF was terminated by the annihilation of mutual wavelets as previously
mentioned. However, using the decreasing ramp protocol, atrial reorganization was appar-
ent. By modifying the local dynamics, the action potential duration (APD) of the system
was changed. When the rate of pacing decreased, the diastolic interval (DI) adjusted itself,
as well as the APD, following the restitution curve (section 3.3.4, ﬁgure 3.11). So, the APD
became longer and termination was facilitated.
One of the speciﬁc characteristics of the meandering AF is the very low number of
wavelets (2-4) with a few wavelets reentries, due to the long APD. Also, a large spatial
dispersion of action potential duration is present on the surface of the atria. When applying
the pacing, the wavefronts generated by the stimuli could not propagate in an isotropic and
circular manner and wave breaks could appear. By decrementing the pacing rate, it was
possible to slowly modify the spatial APD distribution, which allowed for a better control
of the atria and prevented reentries during pacing.
Figure 7.15 shows an example of this phenomenon during pacing in the superior part of
the septum (ﬁgure 7.4, site S4). At 1145 ms the atria were still not fully under control. A
reentry wavelet situated in the septum was observable. After 1150 ms of constant pacing,
both atria were controlled. Two wavefronts spread thought the left and right atrium, re-
spectively. If pacing was stopped, AF termination occurred. By continuing the stimulation,
a reentry emerged on the right posterior atrium (indicated by an arrow in ﬁgure 7.15(D)).
To avoid this mechanism of reentry and to permanently control the atria, a ramp pro-
tocol was tested with increments of 1 and 2 ms (underdrive pacing). By increasing the
waiting time τ by 1 or 2 ms between each successive stimulation, it was possible to pace
terminate AF. Figure 7.14 (curves (3) and (4)) displays the evolution of complexity during
pacing in the septum region. The complexity decreased very rapidly compared to what was
observed when pacing in the right atrium free wall. With an increment of 1 ms, control
was obtained after 10 ms and 5 ms with a decrement of 2 ms.
As one pacing electrode was suﬃcient to pace-terminate meandering AF, multi-site
pacing with this type of AF is not necessary, and it was not investigated in the present
study.
7.4.3 Pacing cholinergic AF
Figure 7.16 and ﬁgure 7.17 present the evolution of spatial correlation curve on the high
density mapping and the spatial organization during chronic AF, respectively. After 10 s
of pacing in the right atrium free wall (ﬁgure 7.4, site S1), the correlation coeﬃcient of the
local organization did not reach 1 as in chronic AF pacing. Due to the heterogeneities, a
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Figure 7.15 – Pacing in septum (site S4) during meandering AF. (A)-(D) MPSPM. (A) The pacing
site is indicated by an arrow. (D) The arrow indicates the reentry due to the spatial distribution of the
action potential duration on the right atrium.
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Figure 7.16 – Spatial correlation during pacing of cholinergic AF. (1) Sinoatrial rhythm. (2) Cholin-
ergic AF. Evolution of spatial correlation after pacing of 2 s, 5 s and 10 s. Means and standard deviations
are respectively denoted by circles and bars.
full control of the right anterior free wall was not possible, and persistent reentries were
still present. First, heterogeneities did not allow the wavefront generated by the stimula-
tion to propagate in a homogeneous manner. Some patches with diﬀerent ERP induced
wave breaks. Second, a mother wavelet anchored on the left atrium appendage generated
wavefronts colliding with wavefronts generated by the stimulation. It was never possible
to unanchor this mother rotor. By observing the time evolution of the global organization
(ﬁgure 7.17), the complexity CEig95% and CEnt did not decrease as much as during chronic
AF pacing.
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Figure 7.17 – Measure of complexity during pacing of cholinergic AF. (A) CEig95%. (B) CEnt. (1)
Cholinergic AF. (2) Pacing.
As the mother rotor was close to the left appendage, the pacing site S3 and the middle of
the mother rotor tip were used as pacing sites. The results obtained were not satisfactory.
The mother rotor persisted. When pacing in the site S3, the generated wavefront could not
propagate and spread due to the wavefront generated by the mother rotor. Furthermore, the
wavefront produced by the stimulation could not reach the spiral tip of the mother rotor. As
the ERP in the tip region was very short (45 ms in the tissue and 95 ms in the heterogeneities
region), an excitable gap was almost non-existent, and the ERP restitution curve was
completely ﬂattened (ﬁgure 3.11) resulting in a very stable state of the action potential
duration. Therefore the stimulation could not be introduced or could not propagate to
unanchor the mother rotor, even when the stimulation was applied in the middle of the tip.
7.5 Conclusions
The present chapter has shown therapeutic pacing experimented on a biophysical model.
A closed-loop algorithm based on beat-to-beat intervals was proposed to investigate anti-
tachypacing. An increasing/decreasing ramp protocol can be used with this method. It was
used to pace terminate atrial ﬂutter as well as less complex atrial ﬁbrillation. As reported
in the literature, the eﬀectiveness of atrial ATP therapies has been shown to diminish as
the arrythmia cycle length shortens below 200 ms [168].
The results obtained conﬁrm that atrial ﬂutter can be pace-terminated by pacing in the
right atrium appendage or in the isthmus region.
Depending on the type of atrial ﬁbrillation, the model demonstrated that chronic AF
could not be pace terminated. But a region of 4-6 cm of diameter can be controlled when
pacing in the right atrium and both atria can be controlled when pacing in the septum
region. However, AF resumed when control was stopped due to reentries anchored around
pulmonary veins. Multisite pacing has been tested and control was observed but AF termi-
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nation could not be achieved due to wavelet collisions near the controlled region borders.
During meandering AF, pace termination was accomplished with a ramp protocol and
with an electrode placed on the right atrium or in the septum region.
In another case, simulation of the pacing of cholinergic AF showed no control was
obtained during the whole process, even with multisite pacing.
The results obtained with the biophysical model are in accordance with the results
obtained by electrophysiologists during clinical procedure: atrial ﬂutter could be pace-
terminated and local capture was obtained with complex atrial ﬁbrillation.
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Conclusion 8
THE work presented in this thesis is a part of a larger project to establish a general re-search framework for atrial ﬁbrillation (AF). It is the continuation of the two previous
theses accomplished by Olivier Blanc [4] and Vincent Jacquemet [5]. These works focused
mainly on the development of a biophysical model of the human atria: development of an
atrial geometry, implementation of membrane kinetics models and study of electrogram
signal morphology.
Now the biophysical model has reached an advanced stage, it can be used as an eﬃcient
tool to study AF as well as atrial therapies. Hypotheses can be investigated or validated
and propositions of new strategies on therapies can be made. The current work brings to
light the fact that, for the ﬁrst time, a biophysical model of the human atria can be used
to investigate AF treatments.
Investigation of atrial therapies by means of a biophysical model has several advantages
when compared to animal or human experiment. First, from an economical point of view,
simulation requires a major investment in the development phase (scientists and computers)
and only limited maintenance costs. With clinical experiments, the cost includes at the
very least surgeons and electrophysiologists time, animals, and operation rooms. Second,
the main drawback of animal experiments is the diﬃculty of accessing the whole atria
and the diﬀerence between animal and human hearts. Finally, compared to clinical and
animal studies, simulation presents the advantage of repeatability of the experiments under
controlled conditions.
In spite of the presents limitations due to computer power, results obtained with the bio-
physical model were comparable to those obtained in clinical experiments, which validated
ﬁrst the biophysical model. Then, new therapeutic strategies were proposed to clinicians.
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Those strategies should be assessed in a clinical environment.
The purpose of the current work has been ﬁrstly the development of methods to de-
termine the organization during AF and to diﬀerentiate diﬀerent types of AF. Secondly,
investigation of atrial therapies using a biophysical model of human atria has been consid-
ered. This thesis demonstrates that the biophysical model can now be used as a standard
tool to investigate new therapies. Furthermore, biophysical modeling has now reached a
point of maturity which, in light of the future developments, justiﬁes sharing results with
a broad cardiologist audience.
In this chapter the most important issues and contributions presented in this thesis are
reviewed. Then possible extensions of the presented work are discussed.
8.1 Summary of achievements
In this thesis, the major achievements can be summarized as follows.
Atrial arrhythmias
The biophysical model was used to simulate various types of atrial arrhythmia. In the
continuation of the previous work by Jacquemet [5], which presented diﬀerent types of
AF, the simulation of atrial ﬂutter (AFL) was integrated. The AFLs were simulated in a
monolayer 3D biophysical model as well as in the multilayer 3D model. Diﬀerent macro-
reentry circuits were observed depending of the inclusion of slow and fast velocity conduction
regions and boundaries. Stable AFL type I, which is the most common type of AFL, was
obtained for a few seconds.
Measures of organization
Measures of organization were developed to quantify and classify diﬀerent types of AF. The
AF organization was evaluated at the electrogram signal level, as well as at the cellular
level.
In chapter 4, a high density mapping system and a geometrical splitting of the atrial
geometry had permitted the investigation of local and global activities during AF. Signal
processing methods based on principal component analysis were applied to the electrogram
signals. Results showed that using 64 electrodes uniformly distributed on the surface of
the atria, it was possible to capture AF complexity. Four types of atrial arrythmia were
investigated with the biophysical model: atrial ﬂutter, chronic AF, meandering AF and
cholinergic AF.
In chapter 5, a new algorithm for phase singularity detection and tracking was proposed
to study organization at the cellular level. This method classiﬁes diﬀerent types of AF
and their evolution over time. Through all simulations it was found that major phase
singularities were mainly located close to the large anatomical obstacles and long-living
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phase singularities were clustered in space over the right and left atrium free wall.
Therapies
During this work, two diﬀerent atrial therapies were investigated: surgical/catheter ablation
and low energy electrical stimulation.
In chapter 6, the biophysical model was used ﬁrst to study the eﬃciency of ablation
procedure. The results conﬁrmed the superiority of aggressive surgical procedures to termi-
nate chronic AF. It was also observed in the simulations that some lines are more sensitive
to imperfections than others, leading generally to the presence of uncommon atrial ﬂutter
after ablation. The results obtained were conﬁrmed by those from clinical studies. Further-
more, an ideal ablation pattern was proposed using the biophysical model. The Maze-III
procedure could be simpliﬁed in the right atrial atrium to a single line joining superior to
inferior vena cava.
In chapter 7, the second therapeutic approach investigated was the therapeutic pacing.
An algorithm for pacing and diﬀerent pacing sites were investigated during this work. Anti-
tachycardia pacing on diﬀerent types of AF was experimented; the simulations showed that
more organized arrythmias such as atrial ﬂutter or meandering AF can be pace terminated.
Whereas, only local capture was possible on more complex AF. The results obtained with
the biophysical model are in agreement with clinical studies.
8.2 Perspectives
The work presented in this thesis can be extended in various ways.
Biophysical model of the human atria
The biophysical model of human atria could be improved by adding more realistic het-
erogeneity, anisotropy and ﬁbrosis based on physiological data from the literature. But
these data are still not available and further investigations need to be performed in vitro
by electrophysiologists before being implemented in the model.
Atrial arrhythmias
Several arrythmias were presented in this research work: ﬂutter, chronic AF, meandering
AF and cholinergic AF. The initiation of the actual ﬂutter can still be improved by multiple
stimuli, with an appropriately chosen delay. In addition, anisotropic velocity conduction
in the isthmus region should be added to facilitate AFL initiation by burst pacing or
simultaneous stimulations delivered from several sites. The pathway of the typical counter-
clockwise ﬂutter is not stable. Further understanding of this mechanism and in particular
the role of the crista terminalis needs to be investigated to obtain a sustained ﬂutter.
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Therapies
In the present work, deﬁbrillation was not investigated due to the fact that deﬁbrillation
uses energy above the threshold of pain. Also, to simulate deﬁbrillation, a bidomain model
needs to be implemented to consider the extra- and the intracellular current ﬂows.
The ablation procedures were applied on a healthy model of atria. It is known that
during AF, atria are usually dilated. The next step will be to dilate the geometry, either
on the right atrium or left atrium, to ﬁt real physiological conditions.
Antitachycardia pacing algorithms could be improved by implementing more sophisti-
cated algorithms. One solution consists of using prediction methods to predict the next
beat-to-beat interval and applying a stimulus during the excitable gap. Other approaches,
not based on beat-to-beat intervals, could be based directly on the analysis of the electro-
gram signals. Signals processing techniques such as matching pursuit, wavelets analysis,
hidden Markov model and dynamic time warping may be an issue to analyze the morphol-
ogy of the signals.
It has been shown that chronic and cholinergic AF could not be pace-terminated by
antitachypacing. By combining ablation and pacing techniques, solutions could be found
to cardiovert AF.
Anti-arrhythmic drugs could be tested on the atria. By changing the properties of
the membrane kinetics on the biophysical model, simulation of drug therapies could be
investigated. Prior to that, an appropriate knowledge of the cellular conditions inducing
AF needs to be acquired, as well as the implementation of more appropriate membrane
kinetics models.
Extension to the heart
Since the biophysical model of the human atria is well established, one of its possible
extensions would be to add the ventricles. The addition of these and a 3D thorax model will
allow one to compute surface electrocardiograms, comparable to what clinicians can observe.
By modifying the substrate generating AF, modiﬁcation on the surface electrocardiograms
are induced. The comparison between simulated and clinical electrocardiograms, could lead
to a better understanding of AF pathologies. Thus, the biophysical model of human atria
can indeed assist clinicians in their diagnostics.
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